[
  {
    "element_id": "page_1_seq_0",
    "page_number": 1,
    "element_type": "text",
    "markdown": "Suspected cancer:\nrecognition and referral\nNICE guideline\nPublished: 23 June 2015\nLast updated: 12 January 2026\nwww.nice.org.uk/guidance/ng12\n\u00a9 NICE 2026. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-\nconditions#notice-of-rights).",
    "raw_text": "Suspected cancer:\nrecognition and referral\nNICE guideline\nPublished: 23 June 2015\nLast updated: 12 January 2026\nwww.nice.org.uk/guidance/ng12\n\u00a9 NICE 2026. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-\nconditions#notice-of-rights)."
  },
  {
    "element_id": "page_2_seq_0",
    "page_number": 2,
    "element_type": "text",
    "markdown": "Your responsibility\nThe recommendations in this guideline represent the view of NICE, arrived at after careful\nconsideration of the evidence available. When exercising their judgement, professionals\nand practitioners are expected to take this guideline fully into account, alongside the\nindividual needs, preferences and values of their patients or the people using their service.\nIt is not mandatory to apply the recommendations, and the guideline does not override the\nresponsibility to make decisions appropriate to the circumstances of the individual, in\nconsultation with them and their families and carers or guardian.\nAll problems (adverse events) related to a medicine or medical device used for treatment\nor in a procedure should be reported to the Medicines and Healthcare products Regulatory\nAgency using the Yellow Card Scheme.\nLocal commissioners and providers of healthcare have a responsibility to enable the\nguideline to be applied when individual professionals and people using services wish to\nuse it. They should do so in the context of local and national priorities for funding and\ndeveloping services, and in light of their duties to have due regard to the need to eliminate\nunlawful discrimination, to advance equality of opportunity and to reduce health\ninequalities. Nothing in this guideline should be interpreted in a way that would be\ninconsistent with complying with those duties.\nCommissioners and providers have a responsibility to promote an environmentally\nsustainable health and care system and should assess and reduce the environmental\nimpact of implementing NICE recommendations wherever possible.",
    "raw_text": "Your responsibility\nThe recommendations in this guideline represent the view of NICE, arrived at after careful\nconsideration of the evidence available. When exercising their judgement, professionals\nand practitioners are expected to take this guideline fully into account, alongside the\nindividual needs, preferences and values of their patients or the people using their service.\nIt is not mandatory to apply the recommendations, and the guideline does not override the\nresponsibility to make decisions appropriate to the circumstances of the individual, in\nconsultation with them and their families and carers or guardian.\nAll problems (adverse events) related to a medicine or medical device used for treatment\nor in a procedure should be reported to the Medicines and Healthcare products Regulatory\nAgency using the Yellow Card Scheme.\nLocal commissioners and providers of healthcare have a responsibility to enable the\nguideline to be applied when individual professionals and people using services wish to\nuse it. They should do so in the context of local and national priorities for funding and\ndeveloping services, and in light of their duties to have due regard to the need to eliminate\nunlawful discrimination, to advance equality of opportunity and to reduce health\ninequalities. Nothing in this guideline should be interpreted in a way that would be\ninconsistent with complying with those duties.\nCommissioners and providers have a responsibility to promote an environmentally\nsustainable health and care system and should assess and reduce the environmental\nimpact of implementing NICE recommendations wherever possible."
  },
  {
    "element_id": "page_3_seq_0",
    "page_number": 3,
    "element_type": "text",
    "markdown": "Contents\nOverview ...................................................................................................................................... 6\nWho is it for? .......................................................................................................................................... 6\nIntroduction .................................................................................................................................. 7\nSafeguarding children ........................................................................................................................... 7\nHow the guideline is organised ............................................................................................................ 7\nRecommendation wording in guideline updates ................................................................................ 8\nRecommendations organised by site of cancer ....................................................................... 9\n1.1 Lung and pleural cancers ................................................................................................................ 9\n1.2 Upper gastrointestinal tract cancers ............................................................................................. 11\n1.3 Lower gastrointestinal tract cancers ............................................................................................. 14\n1.4 Breast cancer ................................................................................................................................... 16\n1.5 Gynaecological cancers .................................................................................................................. 17\n1.6 Urological cancers ........................................................................................................................... 19\n1.7 Skin cancers ..................................................................................................................................... 22\n1.8 Head and neck cancers .................................................................................................................. 24\n1.9 Brain and central nervous system cancers ................................................................................... 25\n1.10 Haematological cancers ................................................................................................................ 26\n1.11 Sarcomas ......................................................................................................................................... 29\n1.12 Childhood cancers ......................................................................................................................... 30\n1.13 Non-site-specific symptoms ........................................................................................................ 31\nRecommendations on patient support, safety netting and the diagnostic process .............33\n1.14 Patient information and support ................................................................................................... 33\n1.15 Safety netting ................................................................................................................................. 35\n1.16 The diagnostic process ................................................................................................................. 35\nRecommendations organised by symptom and findings of primary care investigations .....37\nAbdominal symptoms ........................................................................................................................... 37\nBleeding ................................................................................................................................................. 43",
    "raw_text": "Contents\nOverview ...................................................................................................................................... 6\nWho is it for? .......................................................................................................................................... 6\nIntroduction .................................................................................................................................. 7\nSafeguarding children ........................................................................................................................... 7\nHow the guideline is organised ............................................................................................................ 7\nRecommendation wording in guideline updates ................................................................................ 8\nRecommendations organised by site of cancer ....................................................................... 9\n1.1 Lung and pleural cancers ................................................................................................................ 9\n1.2 Upper gastrointestinal tract cancers ............................................................................................. 11\n1.3 Lower gastrointestinal tract cancers ............................................................................................. 14\n1.4 Breast cancer ................................................................................................................................... 16\n1.5 Gynaecological cancers .................................................................................................................. 17\n1.6 Urological cancers ........................................................................................................................... 19\n1.7 Skin cancers ..................................................................................................................................... 22\n1.8 Head and neck cancers .................................................................................................................. 24\n1.9 Brain and central nervous system cancers ................................................................................... 25\n1.10 Haematological cancers ................................................................................................................ 26\n1.11 Sarcomas ......................................................................................................................................... 29\n1.12 Childhood cancers ......................................................................................................................... 30\n1.13 Non-site-specific symptoms ........................................................................................................ 31\nRecommendations on patient support, safety netting and the diagnostic process .............33\n1.14 Patient information and support ................................................................................................... 33\n1.15 Safety netting ................................................................................................................................. 35\n1.16 The diagnostic process ................................................................................................................. 35\nRecommendations organised by symptom and findings of primary care investigations .....37\nAbdominal symptoms ........................................................................................................................... 37\nBleeding ................................................................................................................................................. 43"
  },
  {
    "element_id": "page_4_seq_0",
    "page_number": 4,
    "element_type": "text",
    "markdown": "Gynaecological symptoms ................................................................................................................... 44\nLumps or masses .................................................................................................................................. 45\nNeurological symptoms in adults ......................................................................................................... 48\nPain ......................................................................................................................................................... 49\nRespiratory symptoms .......................................................................................................................... 51\nSkeletal symptoms ................................................................................................................................ 53\nSkin or surface symptoms .................................................................................................................... 55\nUrological symptoms ............................................................................................................................ 58\nNon-specific features of cancer .......................................................................................................... 61\nPrimary care investigations .................................................................................................................. 68\nSymptoms in children and young people ............................................................................................ 73\nTerms used in this guideline .......................................................................................................83\nChildren .................................................................................................................................................. 83\nChildren and young people .................................................................................................................. 83\nConsistent with ...................................................................................................................................... 83\nDirect access ......................................................................................................................................... 83\nImmediate .............................................................................................................................................. 83\nNon-urgent ............................................................................................................................................ 83\nPersistent ............................................................................................................................................... 83\nRaises the suspicion of ......................................................................................................................... 84\nSafety netting ........................................................................................................................................ 84\nSuspected cancer pathway referral .................................................................................................... 84\nUnexplained ........................................................................................................................................... 84\nUrgent ..................................................................................................................................................... 84\nVery urgent ............................................................................................................................................ 84\nYoung people ......................................................................................................................................... 85\nRecommendations for research .................................................................................................86\nKey recommendations for research .................................................................................................... 86",
    "raw_text": "Gynaecological symptoms ................................................................................................................... 44\nLumps or masses .................................................................................................................................. 45\nNeurological symptoms in adults ......................................................................................................... 48\nPain ......................................................................................................................................................... 49\nRespiratory symptoms .......................................................................................................................... 51\nSkeletal symptoms ................................................................................................................................ 53\nSkin or surface symptoms .................................................................................................................... 55\nUrological symptoms ............................................................................................................................ 58\nNon-specific features of cancer .......................................................................................................... 61\nPrimary care investigations .................................................................................................................. 68\nSymptoms in children and young people ............................................................................................ 73\nTerms used in this guideline .......................................................................................................83\nChildren .................................................................................................................................................. 83\nChildren and young people .................................................................................................................. 83\nConsistent with ...................................................................................................................................... 83\nDirect access ......................................................................................................................................... 83\nImmediate .............................................................................................................................................. 83\nNon-urgent ............................................................................................................................................ 83\nPersistent ............................................................................................................................................... 83\nRaises the suspicion of ......................................................................................................................... 84\nSafety netting ........................................................................................................................................ 84\nSuspected cancer pathway referral .................................................................................................... 84\nUnexplained ........................................................................................................................................... 84\nUrgent ..................................................................................................................................................... 84\nVery urgent ............................................................................................................................................ 84\nYoung people ......................................................................................................................................... 85\nRecommendations for research .................................................................................................86\nKey recommendations for research .................................................................................................... 86"
  },
  {
    "element_id": "page_5_seq_0",
    "page_number": 5,
    "element_type": "text",
    "markdown": "Rationale and impact ...................................................................................................................88\nProstate-specific antigen testing for prostate cancer ...................................................................... 88\nContext .........................................................................................................................................90\nFinding more information and committee details .....................................................................92\nUpdate information .....................................................................................................................93",
    "raw_text": "Rationale and impact ...................................................................................................................88\nProstate-specific antigen testing for prostate cancer ...................................................................... 88\nContext .........................................................................................................................................90\nFinding more information and committee details .....................................................................92\nUpdate information .....................................................................................................................93"
  },
  {
    "element_id": "page_6_seq_0",
    "page_number": 6,
    "element_type": "text",
    "markdown": "This guideline replaces CG27.\nThis guideline partially replaces CG122.\nThis guideline is partially replaced by HTG690.\nThis guideline is the basis of QS96, QS124, QS130, QS203 and QS90.\nThis guideline should be read in conjunction with QS155.\nOverview\nThis guideline covers identifying children, young people and adults with symptoms that\ncould be caused by cancer. It outlines appropriate investigations in primary care, and\nselection of people to refer for a specialist opinion. It aims to help people understand what\nto expect if they have symptoms that may suggest cancer.\nWho is it for?\n\u2022 Healthcare professionals\n\u2022 People involved in clinical governance in both primary and secondary care\n\u2022 People with suspected cancer and their families and/or carers.",
    "raw_text": "This guideline replaces CG27.\nThis guideline partially replaces CG122.\nThis guideline is partially replaced by HTG690.\nThis guideline is the basis of QS96, QS124, QS130, QS203 and QS90.\nThis guideline should be read in conjunction with QS155.\nOverview\nThis guideline covers identifying children, young people and adults with symptoms that\ncould be caused by cancer. It outlines appropriate investigations in primary care, and\nselection of people to refer for a specialist opinion. It aims to help people understand what\nto expect if they have symptoms that may suggest cancer.\nWho is it for?\n\u2022 Healthcare professionals\n\u2022 People involved in clinical governance in both primary and secondary care\n\u2022 People with suspected cancer and their families and/or carers."
  },
  {
    "element_id": "page_7_seq_0",
    "page_number": 7,
    "element_type": "text",
    "markdown": "Introduction\nSafeguarding children\nRemember that child maltreatment:\n\u2022 is common\n\u2022 can present anywhere\n\u2022 may co-exist with other health problems, including suspected cancer.\nSee NICE's guideline on child maltreatment for clinical features that may be associated\nwith maltreatment.\nPeople have the right to be involved in discussions and make informed decisions\nabout their care, as described in NICE's information on making decisions about your\ncare.\nWe have used the terms 'men' and 'women' in some recommendations on gender-\nrelated cancers, but they also apply to people who have changed or are in the\nprocess of changing gender, and who retain the relevant organs.\nMaking decisions using NICE guidelines explains how we use words to show the\nstrength (or certainty) of our recommendations (although this may not apply to\nrecommendations made before 2009; see the section on recommendation wording in\nguideline updates below). It also has information about prescribing medicines\n(including off-label use), professional guidelines, standards and laws (including on\nconsent and mental capacity) and safeguarding.\nHow the guideline is organised\nThe recommendations in this guideline have been organised into 3 separate sections to\nhelp healthcare professionals find the relevant information easily. The recommendations\nfor investigation and referral organised by site of suspected cancer are also presented in",
    "raw_text": "Introduction\nSafeguarding children\nRemember that child maltreatment:\n\u2022 is common\n\u2022 can present anywhere\n\u2022 may co-exist with other health problems, including suspected cancer.\nSee NICE's guideline on child maltreatment for clinical features that may be associated\nwith maltreatment.\nPeople have the right to be involved in discussions and make informed decisions\nabout their care, as described in NICE's information on making decisions about your\ncare.\nWe have used the terms 'men' and 'women' in some recommendations on gender-\nrelated cancers, but they also apply to people who have changed or are in the\nprocess of changing gender, and who retain the relevant organs.\nMaking decisions using NICE guidelines explains how we use words to show the\nstrength (or certainty) of our recommendations (although this may not apply to\nrecommendations made before 2009; see the section on recommendation wording in\nguideline updates below). It also has information about prescribing medicines\n(including off-label use), professional guidelines, standards and laws (including on\nconsent and mental capacity) and safeguarding.\nHow the guideline is organised\nThe recommendations in this guideline have been organised into 3 separate sections to\nhelp healthcare professionals find the relevant information easily. The recommendations\nfor investigation and referral organised by site of suspected cancer are also presented in"
  },
  {
    "element_id": "page_8_seq_0",
    "page_number": 8,
    "element_type": "text",
    "markdown": "tables of recommendations organised by symptoms and investigation findings. Either\nsection should be used in conjunction with the recommendations on patient support,\nsafety netting and the diagnostic process.\nRecommendation wording in guideline updates\nNICE began using standard wording to denote the strength of recommendations in\nguidelines that started development after January 2009. It does not apply to any\nrecommendations ending [2005] (see update information for details about how\nrecommendations are labelled). In particular, for recommendations labelled [2005] the\nword 'consider' may not necessarily be used to denote the strength of the\nrecommendation.",
    "raw_text": "tables of recommendations organised by symptoms and investigation findings. Either\nsection should be used in conjunction with the recommendations on patient support,\nsafety netting and the diagnostic process.\nRecommendation wording in guideline updates\nNICE began using standard wording to denote the strength of recommendations in\nguidelines that started development after January 2009. It does not apply to any\nrecommendations ending [2005] (see update information for details about how\nrecommendations are labelled). In particular, for recommendations labelled [2005] the\nword 'consider' may not necessarily be used to denote the strength of the\nrecommendation."
  },
  {
    "element_id": "page_9_seq_0",
    "page_number": 9,
    "element_type": "text",
    "markdown": "Recommendations organised by site of\ncancer\nUse this guideline to guide referrals. If still uncertain about whether a referral is\nneeded, consider contacting a specialist (see the recommendations on the diagnostic\nprocess). Consider a review for people with any symptom associated with increased\ncancer risk who do not meet the criteria for referral or investigative action (see the\nrecommendations on safety netting).\n1.1 Lung and pleural cancers\nLung cancer\n1.1.1 Refer people using a suspected cancer pathway referral for lung cancer if they:\n\u2022 have chest X-ray findings that suggest lung cancer or\n\u2022 are aged 40 and over with unexplained haemoptysis. [2015]\n1.1.2 Offer an urgent chest X-ray (to be done within 2 weeks) to assess for lung cancer\nin people aged 40 and over if they have 2 or more of the following unexplained\nsymptoms, or if they have ever smoked and have 1 or more of the following\nunexplained symptoms:\n\u2022 cough\n\u2022 fatigue\n\u2022 shortness of breath\n\u2022 chest pain\n\u2022 weight loss\n\u2022 appetite loss. [2015]",
    "raw_text": "Recommendations organised by site of\ncancer\nUse this guideline to guide referrals. If still uncertain about whether a referral is\nneeded, consider contacting a specialist (see the recommendations on the diagnostic\nprocess). Consider a review for people with any symptom associated with increased\ncancer risk who do not meet the criteria for referral or investigative action (see the\nrecommendations on safety netting).\n1.1 Lung and pleural cancers\nLung cancer\n1.1.1 Refer people using a suspected cancer pathway referral for lung cancer if they:\n\u2022 have chest X-ray findings that suggest lung cancer or\n\u2022 are aged 40 and over with unexplained haemoptysis. [2015]\n1.1.2 Offer an urgent chest X-ray (to be done within 2 weeks) to assess for lung cancer\nin people aged 40 and over if they have 2 or more of the following unexplained\nsymptoms, or if they have ever smoked and have 1 or more of the following\nunexplained symptoms:\n\u2022 cough\n\u2022 fatigue\n\u2022 shortness of breath\n\u2022 chest pain\n\u2022 weight loss\n\u2022 appetite loss. [2015]"
  },
  {
    "element_id": "page_10_seq_0",
    "page_number": 10,
    "element_type": "text",
    "markdown": "1.1.3 Consider an urgent chest X-ray (to be done within 2 weeks) to assess for lung\ncancer in people aged 40 and over with any of the following:\n\u2022 persistent or recurrent chest infection\n\u2022 finger clubbing\n\u2022 supraclavicular lymphadenopathy or persistent cervical lymphadenopathy\n\u2022 chest signs consistent with lung cancer\n\u2022 thrombocytosis. [2015]\nMesothelioma\n1.1.4 Refer people using a suspected cancer pathway referral for mesothelioma if they\nhave chest X-ray findings that suggest mesothelioma. [2015]\n1.1.5 Offer an urgent chest X-ray (to be done within 2 weeks) to assess for\nmesothelioma in people aged 40 and over, if:\n\u2022 they have 2 or more of the following unexplained symptoms or\n\u2022 they have 1 or more of the following unexplained symptoms and have ever\nsmoked or\n\u2022 they have 1 or more of the following unexplained symptoms and have been\nexposed to asbestos:\n\uff0d cough\n\uff0d fatigue\n\uff0d shortness of breath\n\uff0d chest pain\n\uff0d weight loss\n\uff0d appetite loss. [2015]",
    "raw_text": "1.1.3 Consider an urgent chest X-ray (to be done within 2 weeks) to assess for lung\ncancer in people aged 40 and over with any of the following:\n\u2022 persistent or recurrent chest infection\n\u2022 finger clubbing\n\u2022 supraclavicular lymphadenopathy or persistent cervical lymphadenopathy\n\u2022 chest signs consistent with lung cancer\n\u2022 thrombocytosis. [2015]\nMesothelioma\n1.1.4 Refer people using a suspected cancer pathway referral for mesothelioma if they\nhave chest X-ray findings that suggest mesothelioma. [2015]\n1.1.5 Offer an urgent chest X-ray (to be done within 2 weeks) to assess for\nmesothelioma in people aged 40 and over, if:\n\u2022 they have 2 or more of the following unexplained symptoms or\n\u2022 they have 1 or more of the following unexplained symptoms and have ever\nsmoked or\n\u2022 they have 1 or more of the following unexplained symptoms and have been\nexposed to asbestos:\n\uff0d cough\n\uff0d fatigue\n\uff0d shortness of breath\n\uff0d chest pain\n\uff0d weight loss\n\uff0d appetite loss. [2015]"
  },
  {
    "element_id": "page_11_seq_0",
    "page_number": 11,
    "element_type": "text",
    "markdown": "1.1.6 Consider an urgent chest X-ray (to be done within 2 weeks) to assess for\nmesothelioma in people aged 40 and over with either:\n\u2022 finger clubbing or\n\u2022 chest signs compatible with pleural disease. [2015]\n1.2 Upper gastrointestinal tract cancers\nOesophageal cancer\n1.2.1 Refer people using a suspected cancer pathway referral for oesophageal cancer\nif they:\n\u2022 have dysphagia or\n\u2022 are aged 55 and over, with weight loss, and they have any of the following:\n\uff0d upper abdominal pain\n\uff0d reflux\n\uff0d dyspepsia. [2015, amended 2025]\n1.2.2 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor oesophageal cancer in people with haematemesis. [2015]\n1.2.3 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor oesophageal cancer in people aged 55 or over with:\n\u2022 treatment-resistant dyspepsia or\n\u2022 upper abdominal pain with low haemoglobin levels or\n\u2022 raised platelet count with any of the following:\n\uff0d nausea\n\uff0d vomiting",
    "raw_text": "1.1.6 Consider an urgent chest X-ray (to be done within 2 weeks) to assess for\nmesothelioma in people aged 40 and over with either:\n\u2022 finger clubbing or\n\u2022 chest signs compatible with pleural disease. [2015]\n1.2 Upper gastrointestinal tract cancers\nOesophageal cancer\n1.2.1 Refer people using a suspected cancer pathway referral for oesophageal cancer\nif they:\n\u2022 have dysphagia or\n\u2022 are aged 55 and over, with weight loss, and they have any of the following:\n\uff0d upper abdominal pain\n\uff0d reflux\n\uff0d dyspepsia. [2015, amended 2025]\n1.2.2 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor oesophageal cancer in people with haematemesis. [2015]\n1.2.3 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor oesophageal cancer in people aged 55 or over with:\n\u2022 treatment-resistant dyspepsia or\n\u2022 upper abdominal pain with low haemoglobin levels or\n\u2022 raised platelet count with any of the following:\n\uff0d nausea\n\uff0d vomiting"
  },
  {
    "element_id": "page_12_seq_0",
    "page_number": 12,
    "element_type": "text",
    "markdown": "\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain or\n\u2022 nausea or vomiting with any of the following:\n\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain. [2015]\nPancreatic cancer\n1.2.4 Refer people using a suspected cancer pathway referral for pancreatic cancer if\nthey are aged 40 and over and have jaundice. [2015]\n1.2.5 Consider an urgent, direct access CT scan (to be done within 2 weeks), or an\nurgent ultrasound scan if CT is not available, to assess for pancreatic cancer in\npeople aged 60 and over with weight loss and any of the following:\n\u2022 diarrhoea\n\u2022 back pain\n\u2022 abdominal pain\n\u2022 nausea\n\u2022 vomiting\n\u2022 constipation\n\u2022 new-onset diabetes. [2015]",
    "raw_text": "\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain or\n\u2022 nausea or vomiting with any of the following:\n\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain. [2015]\nPancreatic cancer\n1.2.4 Refer people using a suspected cancer pathway referral for pancreatic cancer if\nthey are aged 40 and over and have jaundice. [2015]\n1.2.5 Consider an urgent, direct access CT scan (to be done within 2 weeks), or an\nurgent ultrasound scan if CT is not available, to assess for pancreatic cancer in\npeople aged 60 and over with weight loss and any of the following:\n\u2022 diarrhoea\n\u2022 back pain\n\u2022 abdominal pain\n\u2022 nausea\n\u2022 vomiting\n\u2022 constipation\n\u2022 new-onset diabetes. [2015]"
  },
  {
    "element_id": "page_13_seq_0",
    "page_number": 13,
    "element_type": "text",
    "markdown": "Stomach cancer\n1.2.6 Consider a suspected cancer pathway referral for people with an upper\nabdominal mass consistent with stomach cancer. [2015]\n1.2.7 Refer people using a suspected cancer pathway referral for stomach cancer if\nthey:\n\u2022 have dysphagia or\n\u2022 are aged 55 and over, with weight loss, and they have any of the following:\n\uff0d upper abdominal pain\n\uff0d reflux\n\uff0d dyspepsia. [2015, amended 2025]\n1.2.8 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor stomach cancer in people with haematemesis. [2015]\n1.2.9 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor stomach cancer in people aged 55 or over with:\n\u2022 treatment-resistant dyspepsia or\n\u2022 upper abdominal pain with low haemoglobin levels or\n\u2022 raised platelet count with any of the following:\n\uff0d nausea\n\uff0d vomiting\n\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain or",
    "raw_text": "Stomach cancer\n1.2.6 Consider a suspected cancer pathway referral for people with an upper\nabdominal mass consistent with stomach cancer. [2015]\n1.2.7 Refer people using a suspected cancer pathway referral for stomach cancer if\nthey:\n\u2022 have dysphagia or\n\u2022 are aged 55 and over, with weight loss, and they have any of the following:\n\uff0d upper abdominal pain\n\uff0d reflux\n\uff0d dyspepsia. [2015, amended 2025]\n1.2.8 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor stomach cancer in people with haematemesis. [2015]\n1.2.9 Consider non-urgent, direct access upper gastrointestinal endoscopy to assess\nfor stomach cancer in people aged 55 or over with:\n\u2022 treatment-resistant dyspepsia or\n\u2022 upper abdominal pain with low haemoglobin levels or\n\u2022 raised platelet count with any of the following:\n\uff0d nausea\n\uff0d vomiting\n\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain or"
  },
  {
    "element_id": "page_14_seq_0",
    "page_number": 14,
    "element_type": "text",
    "markdown": "\u2022 nausea or vomiting with any of the following:\n\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain. [2015]\nGall bladder cancer\n1.2.10 Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to\nassess for gall bladder cancer in people with an upper abdominal mass\nconsistent with an enlarged gall bladder. [2015]\nLiver cancer\n1.2.11 Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to\nassess for liver cancer in people with an upper abdominal mass consistent with\nan enlarged liver. [2015]\n1.3 Lower gastrointestinal tract cancers\nColorectal cancer\nRecommendations 1.3.1 to 1.3.4 are adapted from NICE's diagnostics guidance on\nquantitative faecal immunochemical testing to guide colorectal cancer pathway\nreferral in primary care.\n1.3.1 Offer quantitative faecal immunochemical testing (FIT) using HM-JACKarc or\nOC-Sensor to guide referral for suspected colorectal cancer in adults:",
    "raw_text": "\u2022 nausea or vomiting with any of the following:\n\uff0d weight loss\n\uff0d reflux\n\uff0d dyspepsia\n\uff0d upper abdominal pain. [2015]\nGall bladder cancer\n1.2.10 Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to\nassess for gall bladder cancer in people with an upper abdominal mass\nconsistent with an enlarged gall bladder. [2015]\nLiver cancer\n1.2.11 Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to\nassess for liver cancer in people with an upper abdominal mass consistent with\nan enlarged liver. [2015]\n1.3 Lower gastrointestinal tract cancers\nColorectal cancer\nRecommendations 1.3.1 to 1.3.4 are adapted from NICE's diagnostics guidance on\nquantitative faecal immunochemical testing to guide colorectal cancer pathway\nreferral in primary care.\n1.3.1 Offer quantitative faecal immunochemical testing (FIT) using HM-JACKarc or\nOC-Sensor to guide referral for suspected colorectal cancer in adults:"
  },
  {
    "element_id": "page_15_seq_0",
    "page_number": 15,
    "element_type": "text",
    "markdown": "\u2022 with an abdominal mass or\n\u2022 with a change in bowel habit or\n\u2022 with iron-deficiency anaemia or\n\u2022 aged 40 and over with unexplained weight loss and abdominal pain or\n\u2022 aged under 50 with rectal bleeding and either of the following unexplained\nsymptoms:\n\uff0d abdominal pain\n\uff0d weight loss or\n\u2022 aged 50 and over with any of the following unexplained symptoms:\n\uff0d rectal bleeding\n\uff0d abdominal pain\n\uff0d weight loss or\n\u2022 aged 60 and over with anaemia even in the absence of iron deficiency.\nFIT should be offered even if the person has previously had a negative FIT\nresult through the NHS bowel cancer screening programme. People with a\nrectal mass, an unexplained anal mass or unexplained anal ulceration do not\nneed to be offered FIT before referral is considered. [2023]\n1.3.2 Refer adults using a suspected cancer pathway referral for colorectal cancer if\nthey have a FIT result of at least 10 micrograms of haemoglobin per gram of\nfaeces. [2023]\n1.3.3 For people who have not returned a faecal sample or who have a FIT result below\n10 micrograms of haemoglobin per gram of faeces:\n\u2022 safety netting processes should be in place\n\u2022 referral to an appropriate secondary care pathway should not be delayed if\nthere is strong clinical concern of cancer because of ongoing unexplained",
    "raw_text": "\u2022 with an abdominal mass or\n\u2022 with a change in bowel habit or\n\u2022 with iron-deficiency anaemia or\n\u2022 aged 40 and over with unexplained weight loss and abdominal pain or\n\u2022 aged under 50 with rectal bleeding and either of the following unexplained\nsymptoms:\n\uff0d abdominal pain\n\uff0d weight loss or\n\u2022 aged 50 and over with any of the following unexplained symptoms:\n\uff0d rectal bleeding\n\uff0d abdominal pain\n\uff0d weight loss or\n\u2022 aged 60 and over with anaemia even in the absence of iron deficiency.\nFIT should be offered even if the person has previously had a negative FIT\nresult through the NHS bowel cancer screening programme. People with a\nrectal mass, an unexplained anal mass or unexplained anal ulceration do not\nneed to be offered FIT before referral is considered. [2023]\n1.3.2 Refer adults using a suspected cancer pathway referral for colorectal cancer if\nthey have a FIT result of at least 10 micrograms of haemoglobin per gram of\nfaeces. [2023]\n1.3.3 For people who have not returned a faecal sample or who have a FIT result below\n10 micrograms of haemoglobin per gram of faeces:\n\u2022 safety netting processes should be in place\n\u2022 referral to an appropriate secondary care pathway should not be delayed if\nthere is strong clinical concern of cancer because of ongoing unexplained"
  },
  {
    "element_id": "page_16_seq_0",
    "page_number": 16,
    "element_type": "text",
    "markdown": "symptoms (for example, abdominal mass). [2023]\n1.3.4 Clinicians should consider if people need additional help, information or support\nto return their sample. [2023]\n1.3.5 Consider a suspected cancer pathway referral for colorectal cancer in adults with\na rectal mass. [2015, amended 2023]\nAnal cancer\n1.3.6 Consider a suspected cancer pathway referral for anal cancer in people with an\nunexplained anal mass or unexplained anal ulceration. [2015]\n1.4 Breast cancer\n1.4.1 Refer people using a suspected cancer pathway referral for breast cancer if they\nare:\n\u2022 aged 30 and over and have an unexplained breast lump with or without pain\nor\n\u2022 aged 50 and over with any of the following symptoms in one nipple only:\n\uff0d discharge\n\uff0d retraction\n\uff0d other changes of concern. [2015]\n1.4.2 Consider a suspected cancer pathway referral for breast cancer in people:\n\u2022 with skin changes that suggest breast cancer or\n\u2022 aged 30 and over with an unexplained lump in the axilla. [2015]\n1.4.3 Consider non-urgent referral in people aged under 30 with an unexplained breast\nlump with or without pain. See also recommendations 1.16.2 and 1.16.3 for",
    "raw_text": "symptoms (for example, abdominal mass). [2023]\n1.3.4 Clinicians should consider if people need additional help, information or support\nto return their sample. [2023]\n1.3.5 Consider a suspected cancer pathway referral for colorectal cancer in adults with\na rectal mass. [2015, amended 2023]\nAnal cancer\n1.3.6 Consider a suspected cancer pathway referral for anal cancer in people with an\nunexplained anal mass or unexplained anal ulceration. [2015]\n1.4 Breast cancer\n1.4.1 Refer people using a suspected cancer pathway referral for breast cancer if they\nare:\n\u2022 aged 30 and over and have an unexplained breast lump with or without pain\nor\n\u2022 aged 50 and over with any of the following symptoms in one nipple only:\n\uff0d discharge\n\uff0d retraction\n\uff0d other changes of concern. [2015]\n1.4.2 Consider a suspected cancer pathway referral for breast cancer in people:\n\u2022 with skin changes that suggest breast cancer or\n\u2022 aged 30 and over with an unexplained lump in the axilla. [2015]\n1.4.3 Consider non-urgent referral in people aged under 30 with an unexplained breast\nlump with or without pain. See also recommendations 1.16.2 and 1.16.3 for"
  },
  {
    "element_id": "page_17_seq_0",
    "page_number": 17,
    "element_type": "text",
    "markdown": "information about seeking specialist advice. [2015]\n1.5 Gynaecological cancers\nOvarian cancer\nThe recommendations in this section have been incorporated from NICE's guideline on\novarian cancer and have not been updated. The recommendations for ovarian cancer\napply to women aged 18 and over.\n1.5.1 Make a referral to a gynaecological cancer service using a suspected cancer\npathway referral if physical examination identifies ascites and/or a pelvic or\nabdominal mass (which is not obviously uterine fibroids). [2011, amended 2020]\n1.5.2 Carry out tests in primary care (see recommendations 1.5.6 to 1.5.9) if a woman\n(especially if aged 50 or over) reports having any of the following symptoms on a\npersistent or frequent basis \u2013 particularly more than 12 times per month:\n\u2022 persistent abdominal distension (women often refer to this as 'bloating')\n\u2022 feeling full (early satiety) and/or loss of appetite\n\u2022 pelvic or abdominal pain\n\u2022 increased urinary urgency and/or frequency. [2011]\n1.5.3 Consider carrying out tests in primary care (see recommendations 1.5.6 to 1.5.9) if\na woman reports unexplained weight loss, fatigue or changes in bowel habit.\n[2011]\n1.5.4 Advise any woman who is not suspected of having ovarian cancer to return to her\nGP if her symptoms become more frequent and/or persistent. [2011]\n1.5.5 Carry out appropriate tests for ovarian cancer (see recommendations 1.5.6 to\n1.5.9) in any woman aged 50 or over who has experienced symptoms within the\nlast 12 months that suggest irritable bowel syndrome (IBS), because IBS rarely\npresents for the first time in women of this age. (See NICE's guideline on irritable",
    "raw_text": "information about seeking specialist advice. [2015]\n1.5 Gynaecological cancers\nOvarian cancer\nThe recommendations in this section have been incorporated from NICE's guideline on\novarian cancer and have not been updated. The recommendations for ovarian cancer\napply to women aged 18 and over.\n1.5.1 Make a referral to a gynaecological cancer service using a suspected cancer\npathway referral if physical examination identifies ascites and/or a pelvic or\nabdominal mass (which is not obviously uterine fibroids). [2011, amended 2020]\n1.5.2 Carry out tests in primary care (see recommendations 1.5.6 to 1.5.9) if a woman\n(especially if aged 50 or over) reports having any of the following symptoms on a\npersistent or frequent basis \u2013 particularly more than 12 times per month:\n\u2022 persistent abdominal distension (women often refer to this as 'bloating')\n\u2022 feeling full (early satiety) and/or loss of appetite\n\u2022 pelvic or abdominal pain\n\u2022 increased urinary urgency and/or frequency. [2011]\n1.5.3 Consider carrying out tests in primary care (see recommendations 1.5.6 to 1.5.9) if\na woman reports unexplained weight loss, fatigue or changes in bowel habit.\n[2011]\n1.5.4 Advise any woman who is not suspected of having ovarian cancer to return to her\nGP if her symptoms become more frequent and/or persistent. [2011]\n1.5.5 Carry out appropriate tests for ovarian cancer (see recommendations 1.5.6 to\n1.5.9) in any woman aged 50 or over who has experienced symptoms within the\nlast 12 months that suggest irritable bowel syndrome (IBS), because IBS rarely\npresents for the first time in women of this age. (See NICE's guideline on irritable"
  },
  {
    "element_id": "page_18_seq_0",
    "page_number": 18,
    "element_type": "text",
    "markdown": "bowel syndrome in adults). [2011]\n1.5.6 Measure serum CA125 in primary care in women with symptoms that suggest\novarian cancer (see recommendations 1.5.1 to 1.5.5). [2011]\n1.5.7 If serum CA125 is 35 IU/ml or greater, arrange an ultrasound scan of the abdomen\nand pelvis. [2011]\n1.5.8 If the ultrasound suggests ovarian cancer, make a referral to a gynaecological\ncancer service using a suspected cancer pathway referral. [2011, amended\n2020]\n1.5.9 For any woman who has normal serum CA125 (less than 35 IU/ml), or CA125 of\n35 IU/ml or greater but a normal ultrasound:\n\u2022 assess her carefully for other clinical causes of her symptoms and investigate\nif appropriate\n\u2022 if no other clinical cause is apparent, advise her to return to her GP if her\nsymptoms become more frequent and/or persistent. [2011]\nEndometrial cancer\n1.5.10 Refer women using a suspected cancer pathway referral for endometrial cancer if\nthey are aged 55 and over with post-menopausal bleeding (unexplained vaginal\nbleeding more than 12 months after menstruation has stopped because of the\nmenopause). [2015]\n1.5.11 Consider a suspected cancer pathway referral for endometrial cancer in women\naged under 55 with post-menopausal bleeding. [2015]\n1.5.12 Consider a direct access ultrasound scan to assess for endometrial cancer in\nwomen aged 55 and over with:\n\u2022 unexplained symptoms of vaginal discharge who:\n\uff0d are presenting with these symptoms for the first time or",
    "raw_text": "bowel syndrome in adults). [2011]\n1.5.6 Measure serum CA125 in primary care in women with symptoms that suggest\novarian cancer (see recommendations 1.5.1 to 1.5.5). [2011]\n1.5.7 If serum CA125 is 35 IU/ml or greater, arrange an ultrasound scan of the abdomen\nand pelvis. [2011]\n1.5.8 If the ultrasound suggests ovarian cancer, make a referral to a gynaecological\ncancer service using a suspected cancer pathway referral. [2011, amended\n2020]\n1.5.9 For any woman who has normal serum CA125 (less than 35 IU/ml), or CA125 of\n35 IU/ml or greater but a normal ultrasound:\n\u2022 assess her carefully for other clinical causes of her symptoms and investigate\nif appropriate\n\u2022 if no other clinical cause is apparent, advise her to return to her GP if her\nsymptoms become more frequent and/or persistent. [2011]\nEndometrial cancer\n1.5.10 Refer women using a suspected cancer pathway referral for endometrial cancer if\nthey are aged 55 and over with post-menopausal bleeding (unexplained vaginal\nbleeding more than 12 months after menstruation has stopped because of the\nmenopause). [2015]\n1.5.11 Consider a suspected cancer pathway referral for endometrial cancer in women\naged under 55 with post-menopausal bleeding. [2015]\n1.5.12 Consider a direct access ultrasound scan to assess for endometrial cancer in\nwomen aged 55 and over with:\n\u2022 unexplained symptoms of vaginal discharge who:\n\uff0d are presenting with these symptoms for the first time or"
  },
  {
    "element_id": "page_19_seq_0",
    "page_number": 19,
    "element_type": "text",
    "markdown": "\uff0d have thrombocytosis or\n\uff0d report haematuria or\n\u2022 visible haematuria and:\n\uff0d low haemoglobin levels or\n\uff0d thrombocytosis or\n\uff0d high blood glucose levels. [2015]\nCervical cancer\n1.5.13 Consider a suspected cancer pathway referral for women if, on examination, the\nappearance of their cervix is consistent with cervical cancer. [2015]\nVulval cancer\n1.5.14 Consider a suspected cancer pathway referral for vulval cancer in women with an\nunexplained vulval lump, ulceration or bleeding. [2015]\nVaginal cancer\n1.5.15 Consider a suspected cancer pathway referral for vaginal cancer in women with\nan unexplained palpable mass in or at the entrance to the vagina. [2015]\n1.6 Urological cancers\nProstate cancer\n1.6.1 Refer people using a suspected cancer pathway referral for prostate cancer if\ntheir prostate feels malignant on digital rectal examination. [2015]",
    "raw_text": "\uff0d have thrombocytosis or\n\uff0d report haematuria or\n\u2022 visible haematuria and:\n\uff0d low haemoglobin levels or\n\uff0d thrombocytosis or\n\uff0d high blood glucose levels. [2015]\nCervical cancer\n1.5.13 Consider a suspected cancer pathway referral for women if, on examination, the\nappearance of their cervix is consistent with cervical cancer. [2015]\nVulval cancer\n1.5.14 Consider a suspected cancer pathway referral for vulval cancer in women with an\nunexplained vulval lump, ulceration or bleeding. [2015]\nVaginal cancer\n1.5.15 Consider a suspected cancer pathway referral for vaginal cancer in women with\nan unexplained palpable mass in or at the entrance to the vagina. [2015]\n1.6 Urological cancers\nProstate cancer\n1.6.1 Refer people using a suspected cancer pathway referral for prostate cancer if\ntheir prostate feels malignant on digital rectal examination. [2015]"
  },
  {
    "element_id": "page_20_seq_0",
    "page_number": 20,
    "element_type": "text",
    "markdown": "1.6.2 Consider a prostate-specific antigen (PSA) test and digital rectal examination to\nassess for prostate cancer in people with:\n\u2022 any lower urinary tract symptoms, such as nocturia, urinary frequency,\nhesitancy, urgency or retention or\n\u2022 erectile dysfunction or\n\u2022 visible haematuria. [2015]\n1.6.3 Consider referring people with possible symptoms of prostate cancer, as\nspecified in recommendation 1.6.2, using a suspected cancer pathway referral for\nprostate cancer if their PSA levels are above the threshold for their age in table 1.\nTake into account the person's preferences and any comorbidities when making\nthe decision. [2021]\nTable 1 Age-specific PSA thresholds for people\nwith possible symptoms of prostate cancer\nAge (years) Prostate-specific antigen threshold (micrograms/litre)\nBelow 40 Use clinical judgement\n40 to 49 More than 2.5\n50 to 59 More than 3.5\n60 to 69 More than 4.5\n70 to 79 More than 6.5\nAbove 79 Use clinical judgement\nFor a short explanation of why the committee made the 2021 recommendation and\nhow it might affect practice, see the rationale and impact section on PSA testing for\nprostate cancer.\nFull details of the evidence and the committee's discussion are in evidence review A:\nPSA testing for prostate cancer.",
    "raw_text": "1.6.2 Consider a prostate-specific antigen (PSA) test and digital rectal examination to\nassess for prostate cancer in people with:\n\u2022 any lower urinary tract symptoms, such as nocturia, urinary frequency,\nhesitancy, urgency or retention or\n\u2022 erectile dysfunction or\n\u2022 visible haematuria. [2015]\n1.6.3 Consider referring people with possible symptoms of prostate cancer, as\nspecified in recommendation 1.6.2, using a suspected cancer pathway referral for\nprostate cancer if their PSA levels are above the threshold for their age in table 1.\nTake into account the person's preferences and any comorbidities when making\nthe decision. [2021]\nTable 1 Age-specific PSA thresholds for people\nwith possible symptoms of prostate cancer\nAge (years) Prostate-specific antigen threshold (micrograms/litre)\nBelow 40 Use clinical judgement\n40 to 49 More than 2.5\n50 to 59 More than 3.5\n60 to 69 More than 4.5\n70 to 79 More than 6.5\nAbove 79 Use clinical judgement\nFor a short explanation of why the committee made the 2021 recommendation and\nhow it might affect practice, see the rationale and impact section on PSA testing for\nprostate cancer.\nFull details of the evidence and the committee's discussion are in evidence review A:\nPSA testing for prostate cancer."
  },
  {
    "element_id": "page_20",
    "page_number": 20,
    "element_type": "table",
    "markdown": "Table 1 on Page 20\n\n| Age (years)   | Prostate-specific antigen threshold (micrograms/litre)   |\n|:--------------|:---------------------------------------------------------|\n| Below 40      | Use clinical judgement                                   |\n| 40 to 49      | More than 2.5                                            |\n| 50 to 59      | More than 3.5                                            |\n| 60 to 69      | More than 4.5                                            |\n| 70 to 79      | More than 6.5                                            |\n| Above 79      | Use clinical judgement                                   |",
    "raw_text": "Age (years)\tProstate-specific antigen threshold (micrograms/litre)\nBelow 40\tUse clinical judgement\n40 to 49\tMore than 2.5\n50 to 59\tMore than 3.5\n60 to 69\tMore than 4.5\n70 to 79\tMore than 6.5\nAbove 79\tUse clinical judgement"
  },
  {
    "element_id": "page_21_seq_0",
    "page_number": 21,
    "element_type": "text",
    "markdown": "Bladder cancer\n1.6.4 Refer people using a suspected cancer pathway referral for bladder cancer if they\nare:\n\u2022 aged 45 and over and have:\n\uff0d unexplained visible haematuria without urinary tract infection or\n\uff0d visible haematuria that persists or recurs after successful treatment of\nurinary tract infection or\n\u2022 aged 60 and over and have unexplained non-visible haematuria and either\ndysuria or a raised white cell count on a blood test. [2015]\n1.6.5 Consider non-urgent referral for bladder cancer in people aged 60 and over with\nrecurrent or persistent unexplained urinary tract infection. [2015]\nRenal cancer\n1.6.6 Refer people using a suspected cancer pathway referral for renal cancer if they\nare aged 45 and over and have:\n\u2022 unexplained visible haematuria without urinary tract infection or\n\u2022 visible haematuria that persists or recurs after successful treatment of\nurinary tract infection. [2015]\nTesticular cancer\n1.6.7 Consider a suspected cancer pathway referral for testicular cancer in men if they\nhave a non-painful enlargement or change in shape or texture of the testis.\n[2015]\n1.6.8 Consider a direct access ultrasound scan for testicular cancer in men with\nunexplained or persistent testicular symptoms. [2015]",
    "raw_text": "Bladder cancer\n1.6.4 Refer people using a suspected cancer pathway referral for bladder cancer if they\nare:\n\u2022 aged 45 and over and have:\n\uff0d unexplained visible haematuria without urinary tract infection or\n\uff0d visible haematuria that persists or recurs after successful treatment of\nurinary tract infection or\n\u2022 aged 60 and over and have unexplained non-visible haematuria and either\ndysuria or a raised white cell count on a blood test. [2015]\n1.6.5 Consider non-urgent referral for bladder cancer in people aged 60 and over with\nrecurrent or persistent unexplained urinary tract infection. [2015]\nRenal cancer\n1.6.6 Refer people using a suspected cancer pathway referral for renal cancer if they\nare aged 45 and over and have:\n\u2022 unexplained visible haematuria without urinary tract infection or\n\u2022 visible haematuria that persists or recurs after successful treatment of\nurinary tract infection. [2015]\nTesticular cancer\n1.6.7 Consider a suspected cancer pathway referral for testicular cancer in men if they\nhave a non-painful enlargement or change in shape or texture of the testis.\n[2015]\n1.6.8 Consider a direct access ultrasound scan for testicular cancer in men with\nunexplained or persistent testicular symptoms. [2015]"
  },
  {
    "element_id": "page_22_seq_0",
    "page_number": 22,
    "element_type": "text",
    "markdown": "Penile cancer\n1.6.9 Consider a suspected cancer pathway referral for penile cancer in men if they\nhave:\n\u2022 a penile mass or ulcerated lesion, when a sexually transmitted infection has\nbeen excluded as a cause or\n\u2022 a persistent penile lesion after treatment for a sexually transmitted infection\nhas been completed. [2015]\n1.6.10 Consider a suspected cancer pathway referral for penile cancer in men with\nunexplained or persistent symptoms affecting the foreskin or glans. [2015]\n1.7 Skin cancers\nMalignant melanoma of the skin\n1.7.1 Refer people using a suspected cancer pathway referral for melanoma if they\nhave a suspicious pigmented skin lesion with a weighted 7-point checklist score\nof 3 or more. [2015]",
    "raw_text": "Penile cancer\n1.6.9 Consider a suspected cancer pathway referral for penile cancer in men if they\nhave:\n\u2022 a penile mass or ulcerated lesion, when a sexually transmitted infection has\nbeen excluded as a cause or\n\u2022 a persistent penile lesion after treatment for a sexually transmitted infection\nhas been completed. [2015]\n1.6.10 Consider a suspected cancer pathway referral for penile cancer in men with\nunexplained or persistent symptoms affecting the foreskin or glans. [2015]\n1.7 Skin cancers\nMalignant melanoma of the skin\n1.7.1 Refer people using a suspected cancer pathway referral for melanoma if they\nhave a suspicious pigmented skin lesion with a weighted 7-point checklist score\nof 3 or more. [2015]"
  },
  {
    "element_id": "page_23_seq_0",
    "page_number": 23,
    "element_type": "text",
    "markdown": "Weighted 7-point checklist\nMajor features of the lesions (scoring 2 points each):\n\u2022 change in size\n\u2022 irregular shape\n\u2022 irregular colour.\nMinor features of the lesions (scoring 1 point each):\n\u2022 largest diameter 7 mm or more\n\u2022 inflammation\n\u2022 oozing\n\u2022 change in sensation.\n1.7.2 Refer people using a suspected cancer pathway referral if dermoscopy suggests\nmelanoma of the skin. [2015]\n1.7.3 Consider a suspected cancer pathway referral for melanoma in people with a\npigmented or non-pigmented skin lesion that suggests nodular melanoma. [2015]\nSquamous cell carcinoma\n1.7.4 Consider a suspected cancer pathway referral for people with a skin lesion that\nraises the suspicion of squamous cell carcinoma. [2015]\nBasal cell carcinoma\n1.7.5 Consider routine referral for people if they have a skin lesion that raises the\nsuspicion of a basal cell carcinoma. (Typical features of basal cell carcinoma",
    "raw_text": "Weighted 7-point checklist\nMajor features of the lesions (scoring 2 points each):\n\u2022 change in size\n\u2022 irregular shape\n\u2022 irregular colour.\nMinor features of the lesions (scoring 1 point each):\n\u2022 largest diameter 7 mm or more\n\u2022 inflammation\n\u2022 oozing\n\u2022 change in sensation.\n1.7.2 Refer people using a suspected cancer pathway referral if dermoscopy suggests\nmelanoma of the skin. [2015]\n1.7.3 Consider a suspected cancer pathway referral for melanoma in people with a\npigmented or non-pigmented skin lesion that suggests nodular melanoma. [2015]\nSquamous cell carcinoma\n1.7.4 Consider a suspected cancer pathway referral for people with a skin lesion that\nraises the suspicion of squamous cell carcinoma. [2015]\nBasal cell carcinoma\n1.7.5 Consider routine referral for people if they have a skin lesion that raises the\nsuspicion of a basal cell carcinoma. (Typical features of basal cell carcinoma"
  },
  {
    "element_id": "page_24_seq_0",
    "page_number": 24,
    "element_type": "text",
    "markdown": "include: an ulcer with a raised rolled edge; prominent fine blood vessels around a\nlesion; or a nodule on the skin [particularly pearly or waxy nodules].) [2015]\n1.7.6 Only consider a suspected cancer pathway referral for people with a skin lesion\nthat raises the suspicion of a basal cell carcinoma if there is particular concern\nthat a delay may have a significant impact, because of factors such as lesion site\nor size. [2015]\n1.7.7 Follow NICE's guidance on improving outcomes for people with skin tumours\nincluding melanoma for advice on who should excise suspected basal cell\ncarcinomas. [2015]\n1.8 Head and neck cancers\nLaryngeal cancer\n1.8.1 Consider a suspected cancer pathway referral for laryngeal cancer in people\naged 45 and over with:\n\u2022 persistentunexplained hoarseness or\n\u2022 an unexplained lump in the neck. [2015]\nOral cancer\n1.8.2 Consider a suspected cancer pathway referral for oral cancer in people with\neither:\n\u2022 unexplained ulceration in the oral cavity lasting for more than 3 weeks or\n\u2022 a persistent and unexplained lump in the neck. [2015]\n1.8.3 Consider an urgent referral (for an appointment within 2 weeks) for assessment\nfor possible oral cancer by a dentist in people who have either:\n\u2022 a lump on the lip or in the oral cavity or",
    "raw_text": "include: an ulcer with a raised rolled edge; prominent fine blood vessels around a\nlesion; or a nodule on the skin [particularly pearly or waxy nodules].) [2015]\n1.7.6 Only consider a suspected cancer pathway referral for people with a skin lesion\nthat raises the suspicion of a basal cell carcinoma if there is particular concern\nthat a delay may have a significant impact, because of factors such as lesion site\nor size. [2015]\n1.7.7 Follow NICE's guidance on improving outcomes for people with skin tumours\nincluding melanoma for advice on who should excise suspected basal cell\ncarcinomas. [2015]\n1.8 Head and neck cancers\nLaryngeal cancer\n1.8.1 Consider a suspected cancer pathway referral for laryngeal cancer in people\naged 45 and over with:\n\u2022 persistentunexplained hoarseness or\n\u2022 an unexplained lump in the neck. [2015]\nOral cancer\n1.8.2 Consider a suspected cancer pathway referral for oral cancer in people with\neither:\n\u2022 unexplained ulceration in the oral cavity lasting for more than 3 weeks or\n\u2022 a persistent and unexplained lump in the neck. [2015]\n1.8.3 Consider an urgent referral (for an appointment within 2 weeks) for assessment\nfor possible oral cancer by a dentist in people who have either:\n\u2022 a lump on the lip or in the oral cavity or"
  },
  {
    "element_id": "page_25_seq_0",
    "page_number": 25,
    "element_type": "text",
    "markdown": "\u2022 a red or red and white patch in the oral cavity consistent with erythroplakia or\nerythroleukoplakia. [2015]\n1.8.4 Consider a suspected cancer pathway referral by the dentist for oral cancer in\npeople when assessed by a dentist as having either:\n\u2022 a lump on the lip or in the oral cavity consistent with oral cancer or\n\u2022 a red or red and white patch in the oral cavity consistent with erythroplakia or\nerythroleukoplakia. [2015]\nThyroid cancer\n1.8.5 Consider a suspected cancer pathway referral for thyroid cancer in people with\nan unexplained thyroid lump. [2015]\n1.9 Brain and central nervous system cancers\nAdults\n1.9.1 Consider an urgent, direct access, MRI scan of the brain (or CT scan if MRI is\ncontraindicated; to be done within 2 weeks) to assess for brain or central nervous\nsystem cancer in adults with progressive, sub-acute loss of central neurological\nfunction. [2015]\nChildren and young people\n1.9.2 Consider a very urgent referral (for an appointment within 48 hours) for\nsuspected brain or central nervous system cancer in children and young people\nwith newly abnormal cerebellar or other central neurological function. [2015]",
    "raw_text": "\u2022 a red or red and white patch in the oral cavity consistent with erythroplakia or\nerythroleukoplakia. [2015]\n1.8.4 Consider a suspected cancer pathway referral by the dentist for oral cancer in\npeople when assessed by a dentist as having either:\n\u2022 a lump on the lip or in the oral cavity consistent with oral cancer or\n\u2022 a red or red and white patch in the oral cavity consistent with erythroplakia or\nerythroleukoplakia. [2015]\nThyroid cancer\n1.8.5 Consider a suspected cancer pathway referral for thyroid cancer in people with\nan unexplained thyroid lump. [2015]\n1.9 Brain and central nervous system cancers\nAdults\n1.9.1 Consider an urgent, direct access, MRI scan of the brain (or CT scan if MRI is\ncontraindicated; to be done within 2 weeks) to assess for brain or central nervous\nsystem cancer in adults with progressive, sub-acute loss of central neurological\nfunction. [2015]\nChildren and young people\n1.9.2 Consider a very urgent referral (for an appointment within 48 hours) for\nsuspected brain or central nervous system cancer in children and young people\nwith newly abnormal cerebellar or other central neurological function. [2015]"
  },
  {
    "element_id": "page_26_seq_0",
    "page_number": 26,
    "element_type": "text",
    "markdown": "1.10 Haematological cancers\nLeukaemia in adults\n1.10.1 Consider a very urgent full blood count (within 48 hours) to assess for leukaemia\nin adults with any of the following:\n\u2022 pallor\n\u2022 persistent fatigue\n\u2022 unexplained fever\n\u2022 unexplained persistent or recurrent infection\n\u2022 generalised lymphadenopathy\n\u2022 unexplained bruising\n\u2022 unexplained bleeding\n\u2022 unexplained petechiae\n\u2022 hepatosplenomegaly. [2015]\nLeukaemia in children and young people\n1.10.2 Refer children and young people for immediate specialist assessment for\nleukaemia if they have unexplained petechiae or hepatosplenomegaly. [2015]\n1.10.3 Offer a very urgent full blood count (within 48 hours) to assess for leukaemia in\nchildren and young people with any of the following:\n\u2022 pallor\n\u2022 persistent fatigue\n\u2022 unexplained fever\n\u2022 unexplained persistent infection",
    "raw_text": "1.10 Haematological cancers\nLeukaemia in adults\n1.10.1 Consider a very urgent full blood count (within 48 hours) to assess for leukaemia\nin adults with any of the following:\n\u2022 pallor\n\u2022 persistent fatigue\n\u2022 unexplained fever\n\u2022 unexplained persistent or recurrent infection\n\u2022 generalised lymphadenopathy\n\u2022 unexplained bruising\n\u2022 unexplained bleeding\n\u2022 unexplained petechiae\n\u2022 hepatosplenomegaly. [2015]\nLeukaemia in children and young people\n1.10.2 Refer children and young people for immediate specialist assessment for\nleukaemia if they have unexplained petechiae or hepatosplenomegaly. [2015]\n1.10.3 Offer a very urgent full blood count (within 48 hours) to assess for leukaemia in\nchildren and young people with any of the following:\n\u2022 pallor\n\u2022 persistent fatigue\n\u2022 unexplained fever\n\u2022 unexplained persistent infection"
  },
  {
    "element_id": "page_27_seq_0",
    "page_number": 27,
    "element_type": "text",
    "markdown": "\u2022 generalised lymphadenopathy\n\u2022 persistent or unexplained bone pain\n\u2022 unexplained bruising\n\u2022 unexplained bleeding. [2015]\nMyeloma\n1.10.4 Offer the following to assess for myeloma in people aged 60 and over with\npersistent bone pain, particularly back pain, or unexplained fracture:\n\u2022 a full blood count and\n\u2022 blood tests for:\n\uff0d calcium\n\uff0d plasma viscosity or erythrocyte sedimentation rate\n\uff0d paraprotein, using serum protein electrophoresis\n\uff0d free light chains contained in serum.\nIf serum free light chain testing is not available, use a Bence\u2013Jones test\nto check for free light chains contained in urine. [2015, amended 2025]\n1.10.5 Refer people using a suspected cancer pathway referral if the results of the blood\ntests outlined in recommendation 1.10.4 suggest myeloma. [2015, amended\n2025]\nNon-Hodgkin's lymphoma\nSeparate recommendations have been made for adults and for children and young people\nto reflect that there are different referral pathways. In practice young people (aged 16 to\n24) may be referred using either pathway depending on their age and local arrangements.",
    "raw_text": "\u2022 generalised lymphadenopathy\n\u2022 persistent or unexplained bone pain\n\u2022 unexplained bruising\n\u2022 unexplained bleeding. [2015]\nMyeloma\n1.10.4 Offer the following to assess for myeloma in people aged 60 and over with\npersistent bone pain, particularly back pain, or unexplained fracture:\n\u2022 a full blood count and\n\u2022 blood tests for:\n\uff0d calcium\n\uff0d plasma viscosity or erythrocyte sedimentation rate\n\uff0d paraprotein, using serum protein electrophoresis\n\uff0d free light chains contained in serum.\nIf serum free light chain testing is not available, use a Bence\u2013Jones test\nto check for free light chains contained in urine. [2015, amended 2025]\n1.10.5 Refer people using a suspected cancer pathway referral if the results of the blood\ntests outlined in recommendation 1.10.4 suggest myeloma. [2015, amended\n2025]\nNon-Hodgkin's lymphoma\nSeparate recommendations have been made for adults and for children and young people\nto reflect that there are different referral pathways. In practice young people (aged 16 to\n24) may be referred using either pathway depending on their age and local arrangements."
  },
  {
    "element_id": "page_28_seq_0",
    "page_number": 28,
    "element_type": "text",
    "markdown": "Adults\n1.10.6 Consider a suspected cancer pathway referral for non-Hodgkin's lymphoma in\nadults presenting with unexplained lymphadenopathy or splenomegaly. When\nconsidering referral, take into account any associated symptoms, particularly\nfever, night sweats, shortness of breath, pruritus or weight loss. [2015]\nChildren and young people\n1.10.7 Consider a very urgent referral (for an appointment within 48 hours) for specialist\nassessment for non-Hodgkin's lymphoma in children and young people\npresenting with unexplained lymphadenopathy or splenomegaly. When\nconsidering referral, take into account any associated symptoms, particularly\nfever, night sweats, shortness of breath, pruritus or weight loss. [2015]\nHodgkin's lymphoma\nSeparate recommendations have been made for adults and for children and young people\nto reflect that there are different referral pathways. In practice young people (aged 16 to\n24) may be referred using either pathway depending on their age and local arrangements.\nAdults\n1.10.8 Consider a suspected cancer pathway referral for Hodgkin's lymphoma in adults\npresenting with unexplained lymphadenopathy. When considering referral, take\ninto account any associated symptoms, particularly fever, night sweats,\nshortness of breath, pruritus, weight loss or alcohol-induced lymph node pain.\n[2015]\nChildren and young people\n1.10.9 Consider a very urgent referral (for an appointment within 48 hours) for specialist\nassessment for Hodgkin's lymphoma in children and young people presenting\nwith unexplained lymphadenopathy. When considering referral, take into account",
    "raw_text": "Adults\n1.10.6 Consider a suspected cancer pathway referral for non-Hodgkin's lymphoma in\nadults presenting with unexplained lymphadenopathy or splenomegaly. When\nconsidering referral, take into account any associated symptoms, particularly\nfever, night sweats, shortness of breath, pruritus or weight loss. [2015]\nChildren and young people\n1.10.7 Consider a very urgent referral (for an appointment within 48 hours) for specialist\nassessment for non-Hodgkin's lymphoma in children and young people\npresenting with unexplained lymphadenopathy or splenomegaly. When\nconsidering referral, take into account any associated symptoms, particularly\nfever, night sweats, shortness of breath, pruritus or weight loss. [2015]\nHodgkin's lymphoma\nSeparate recommendations have been made for adults and for children and young people\nto reflect that there are different referral pathways. In practice young people (aged 16 to\n24) may be referred using either pathway depending on their age and local arrangements.\nAdults\n1.10.8 Consider a suspected cancer pathway referral for Hodgkin's lymphoma in adults\npresenting with unexplained lymphadenopathy. When considering referral, take\ninto account any associated symptoms, particularly fever, night sweats,\nshortness of breath, pruritus, weight loss or alcohol-induced lymph node pain.\n[2015]\nChildren and young people\n1.10.9 Consider a very urgent referral (for an appointment within 48 hours) for specialist\nassessment for Hodgkin's lymphoma in children and young people presenting\nwith unexplained lymphadenopathy. When considering referral, take into account"
  },
  {
    "element_id": "page_29_seq_0",
    "page_number": 29,
    "element_type": "text",
    "markdown": "any associated symptoms, particularly fever, night sweats, shortness of breath,\npruritus or weight loss. [2015]\n1.11 Sarcomas\nSeparate recommendations have been made for adults and for children and young people\nto reflect that there are different referral pathways. In practice young people (aged 16 to\n24) may be referred using either pathway depending on their age and local arrangements.\nBone sarcoma in adults\n1.11.1 Consider a suspected cancer pathway referral for adults if an X-ray suggests the\npossibility of bone sarcoma. [2015]\nBone sarcoma in children and young people\n1.11.2 Consider a very urgent referral (for an appointment within 48 hours) for specialist\nassessment for children and young people if an X-ray suggests the possibility of\nbone sarcoma. [2015]\n1.11.3 Consider a very urgent direct access X-ray (to be done within 48 hours) to assess\nfor bone sarcoma in children and young people with unexplained bone swelling or\npain. [2015]\nSoft tissue sarcoma in adults\n1.11.4 Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to\nassess for soft tissue sarcoma in adults with an unexplained lump that is\nincreasing in size. [2015]\n1.11.5 Consider a suspected cancer pathway referral for adults if they have ultrasound\nscan findings that are suggestive of soft tissue sarcoma or if ultrasound findings\nare uncertain and clinical concern persists. [2015]",
    "raw_text": "any associated symptoms, particularly fever, night sweats, shortness of breath,\npruritus or weight loss. [2015]\n1.11 Sarcomas\nSeparate recommendations have been made for adults and for children and young people\nto reflect that there are different referral pathways. In practice young people (aged 16 to\n24) may be referred using either pathway depending on their age and local arrangements.\nBone sarcoma in adults\n1.11.1 Consider a suspected cancer pathway referral for adults if an X-ray suggests the\npossibility of bone sarcoma. [2015]\nBone sarcoma in children and young people\n1.11.2 Consider a very urgent referral (for an appointment within 48 hours) for specialist\nassessment for children and young people if an X-ray suggests the possibility of\nbone sarcoma. [2015]\n1.11.3 Consider a very urgent direct access X-ray (to be done within 48 hours) to assess\nfor bone sarcoma in children and young people with unexplained bone swelling or\npain. [2015]\nSoft tissue sarcoma in adults\n1.11.4 Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to\nassess for soft tissue sarcoma in adults with an unexplained lump that is\nincreasing in size. [2015]\n1.11.5 Consider a suspected cancer pathway referral for adults if they have ultrasound\nscan findings that are suggestive of soft tissue sarcoma or if ultrasound findings\nare uncertain and clinical concern persists. [2015]"
  },
  {
    "element_id": "page_30_seq_0",
    "page_number": 30,
    "element_type": "text",
    "markdown": "Soft tissue sarcoma in children and young people\n1.11.6 Consider a very urgent, direct access ultrasound scan (to be done within\n48 hours) to assess for soft tissue sarcoma in children and young people with an\nunexplained lump that is increasing in size. [2015]\n1.11.7 Consider a very urgent referral (for an appointment within 48 hours) for children\nand young people if they have ultrasound scan findings that are suggestive of\nsoft tissue sarcoma or if ultrasound findings are uncertain and clinical concern\npersists. [2015]\n1.12 Childhood cancers\nNICE has published a guideline on babies, children and young people's experience of\nhealthcare.\nNeuroblastoma\n1.12.1 Consider very urgent referral (for an appointment within 48 hours) for specialist\nassessment for neuroblastoma in children with a palpable abdominal mass or\nunexplained enlarged abdominal organ. [2015]\nRetinoblastoma\n1.12.2 Consider referral for ophthalmological assessment using a suspected cancer\npathway referral for retinoblastoma in children with an absent fundal ('red') reflex.\nIf there is new-onset squint that occurs together with an absent fundal ('red')\nreflex, see the recommendation on new-onset squint with loss of fundal 'red'\nreflex in NICE's guideline on suspected neurological conditions. [2015]\nWilms' tumour\n1.12.3 Consider very urgent referral (for an appointment within 48 hours) for specialist",
    "raw_text": "Soft tissue sarcoma in children and young people\n1.11.6 Consider a very urgent, direct access ultrasound scan (to be done within\n48 hours) to assess for soft tissue sarcoma in children and young people with an\nunexplained lump that is increasing in size. [2015]\n1.11.7 Consider a very urgent referral (for an appointment within 48 hours) for children\nand young people if they have ultrasound scan findings that are suggestive of\nsoft tissue sarcoma or if ultrasound findings are uncertain and clinical concern\npersists. [2015]\n1.12 Childhood cancers\nNICE has published a guideline on babies, children and young people's experience of\nhealthcare.\nNeuroblastoma\n1.12.1 Consider very urgent referral (for an appointment within 48 hours) for specialist\nassessment for neuroblastoma in children with a palpable abdominal mass or\nunexplained enlarged abdominal organ. [2015]\nRetinoblastoma\n1.12.2 Consider referral for ophthalmological assessment using a suspected cancer\npathway referral for retinoblastoma in children with an absent fundal ('red') reflex.\nIf there is new-onset squint that occurs together with an absent fundal ('red')\nreflex, see the recommendation on new-onset squint with loss of fundal 'red'\nreflex in NICE's guideline on suspected neurological conditions. [2015]\nWilms' tumour\n1.12.3 Consider very urgent referral (for an appointment within 48 hours) for specialist"
  },
  {
    "element_id": "page_31_seq_0",
    "page_number": 31,
    "element_type": "text",
    "markdown": "assessment for Wilms' tumour in children with any of the following:\n\u2022 a palpable abdominal mass\n\u2022 an unexplained enlarged abdominal organ\n\u2022 unexplained visible haematuria. [2015]\n1.13 Non-site-specific symptoms\nSome symptoms or symptom combinations may be features of several different cancers.\nFor some of these symptoms, the risk for each individual cancer may be low but the total\nrisk of cancer of any type may be higher. This section includes recommendations for these\nsymptoms.\nSymptoms of concern in children and young people\n1.13.1 Take into account the insight and knowledge of parents and carers when\nconsidering making a referral for suspected cancer in a child or young person.\nConsider referral for children if their parent or carer has persistent concern or\nanxiety about the child's symptoms, even if the symptoms are most likely to have\na benign cause. [2015]\nSymptoms of concern in adults\n1.13.2 For people with unexplained weight loss, which is a symptom of several cancers\nincluding colorectal, gastro-oesophageal, lung, prostate, pancreatic and\nurological cancer:\n\u2022 carry out an assessment for additional symptoms, signs or findings that may\nhelp to clarify which cancer is most likely and\n\u2022 offer urgent investigation or a suspected cancer pathway referral. [2015]\n1.13.3 For people with unexplained appetite loss, which is a symptom of several cancers\nincluding lung, oesophageal, stomach, colorectal, pancreatic, bladder and renal",
    "raw_text": "assessment for Wilms' tumour in children with any of the following:\n\u2022 a palpable abdominal mass\n\u2022 an unexplained enlarged abdominal organ\n\u2022 unexplained visible haematuria. [2015]\n1.13 Non-site-specific symptoms\nSome symptoms or symptom combinations may be features of several different cancers.\nFor some of these symptoms, the risk for each individual cancer may be low but the total\nrisk of cancer of any type may be higher. This section includes recommendations for these\nsymptoms.\nSymptoms of concern in children and young people\n1.13.1 Take into account the insight and knowledge of parents and carers when\nconsidering making a referral for suspected cancer in a child or young person.\nConsider referral for children if their parent or carer has persistent concern or\nanxiety about the child's symptoms, even if the symptoms are most likely to have\na benign cause. [2015]\nSymptoms of concern in adults\n1.13.2 For people with unexplained weight loss, which is a symptom of several cancers\nincluding colorectal, gastro-oesophageal, lung, prostate, pancreatic and\nurological cancer:\n\u2022 carry out an assessment for additional symptoms, signs or findings that may\nhelp to clarify which cancer is most likely and\n\u2022 offer urgent investigation or a suspected cancer pathway referral. [2015]\n1.13.3 For people with unexplained appetite loss, which is a symptom of several cancers\nincluding lung, oesophageal, stomach, colorectal, pancreatic, bladder and renal"
  },
  {
    "element_id": "page_32_seq_0",
    "page_number": 32,
    "element_type": "text",
    "markdown": "cancer:\n\u2022 carry out an assessment for additional symptoms, signs or findings that may\nhelp to clarify which cancer is most likely and\n\u2022 offer urgent investigation or a suspected cancer pathway referral. [2015]\n1.13.4 For people with deep vein thrombosis, which is associated with several cancers\nincluding urogenital, breast, colorectal and lung cancer:\n\u2022 carry out an assessment for additional symptoms, signs or findings that may\nhelp to clarify which cancer is most likely and\n\u2022 consider urgent investigation or a suspected cancer pathway referral. [2015]",
    "raw_text": "cancer:\n\u2022 carry out an assessment for additional symptoms, signs or findings that may\nhelp to clarify which cancer is most likely and\n\u2022 offer urgent investigation or a suspected cancer pathway referral. [2015]\n1.13.4 For people with deep vein thrombosis, which is associated with several cancers\nincluding urogenital, breast, colorectal and lung cancer:\n\u2022 carry out an assessment for additional symptoms, signs or findings that may\nhelp to clarify which cancer is most likely and\n\u2022 consider urgent investigation or a suspected cancer pathway referral. [2015]"
  },
  {
    "element_id": "page_33_seq_0",
    "page_number": 33,
    "element_type": "text",
    "markdown": "Recommendations on patient support,\nsafety netting and the diagnostic process\nUse this guideline to guide referrals. If still uncertain about whether a referral is\nneeded, consider contacting a specialist (see the recommendations on the diagnostic\nprocess). Consider a review for people with any symptom associated with increased\ncancer risk who do not meet the criteria for referral or investigative action (see the\nrecommendations on safety netting).\n1.14 Patient information and support\n1.14.1 Discuss with people with suspected cancer (and their carers, as appropriate,\ntaking account of the need for confidentiality) their preferences for being\ninvolved in decision-making about referral options and further investigations\nincluding their potential risks and benefits. [2015]\n1.14.2 When cancer is suspected in a child, discuss the referral decision and information\nto be given to the child with the parents or carers (and the child if appropriate).\n[2015]\n1.14.3 Explain to people who are being referred with suspected cancer that they are\nbeing referred to a cancer service. Reassure them, as appropriate, that most\npeople referred will not have a diagnosis of cancer, and discuss alternative\ndiagnoses with them. [2015]\n1.14.4 Give the person information on the possible diagnosis (both benign and\nmalignant) in accordance with their wishes for information (see also NICE's\nguideline on patient experience in adult NHS services). [2015]\n1.14.5 The information given to people with suspected cancer and their families and/or\ncarers should cover, among other issues:\n\u2022 where the person is being referred to",
    "raw_text": "Recommendations on patient support,\nsafety netting and the diagnostic process\nUse this guideline to guide referrals. If still uncertain about whether a referral is\nneeded, consider contacting a specialist (see the recommendations on the diagnostic\nprocess). Consider a review for people with any symptom associated with increased\ncancer risk who do not meet the criteria for referral or investigative action (see the\nrecommendations on safety netting).\n1.14 Patient information and support\n1.14.1 Discuss with people with suspected cancer (and their carers, as appropriate,\ntaking account of the need for confidentiality) their preferences for being\ninvolved in decision-making about referral options and further investigations\nincluding their potential risks and benefits. [2015]\n1.14.2 When cancer is suspected in a child, discuss the referral decision and information\nto be given to the child with the parents or carers (and the child if appropriate).\n[2015]\n1.14.3 Explain to people who are being referred with suspected cancer that they are\nbeing referred to a cancer service. Reassure them, as appropriate, that most\npeople referred will not have a diagnosis of cancer, and discuss alternative\ndiagnoses with them. [2015]\n1.14.4 Give the person information on the possible diagnosis (both benign and\nmalignant) in accordance with their wishes for information (see also NICE's\nguideline on patient experience in adult NHS services). [2015]\n1.14.5 The information given to people with suspected cancer and their families and/or\ncarers should cover, among other issues:\n\u2022 where the person is being referred to"
  },
  {
    "element_id": "page_34_seq_0",
    "page_number": 34,
    "element_type": "text",
    "markdown": "\u2022 how long they will have to wait for the appointment\n\u2022 how to obtain further information about the type of cancer suspected or help\nbefore the specialist appointment\n\u2022 what to expect from the service the person will be attending\n\u2022 what type of tests may be carried out, and what will happen during\ndiagnostic procedures\n\u2022 how long it will take to get a diagnosis or test results\n\u2022 whether they can take someone with them to the appointment\n\u2022 who to contact if they do not receive confirmation of an appointment\n\u2022 other sources of support. [2015]\n1.14.6 Provide information that is appropriate for the person in terms of language, ability\nand culture, recognising the potential for different cultural meanings associated\nwith the possibility of cancer. [2015]\n1.14.7 Have information available in a variety of formats on both local and national\nsources of information and support for people who are being referred with\nsuspected cancer. For more information on information sharing, see the section\non enabling patients to actively participate in their care in NICE's guideline on\npatient experience in adult NHS services. [2015]\n1.14.8 Reassure people in the safety netting group (see recommendation 1.15.2) who are\nconcerned that they may have cancer that with their current symptoms their risk\nof having cancer is low. [2015]\n1.14.9 Explain to people who are being offered safety netting (see\nrecommendation 1.15.2) which symptoms to look out for and when they should\nreturn for re-evaluation. It may be appropriate to provide written information.\n[2015]\n1.14.10 When referring a person with suspected cancer to a specialist service, assess\ntheir need for continuing support while waiting for their referral appointment. This",
    "raw_text": "\u2022 how long they will have to wait for the appointment\n\u2022 how to obtain further information about the type of cancer suspected or help\nbefore the specialist appointment\n\u2022 what to expect from the service the person will be attending\n\u2022 what type of tests may be carried out, and what will happen during\ndiagnostic procedures\n\u2022 how long it will take to get a diagnosis or test results\n\u2022 whether they can take someone with them to the appointment\n\u2022 who to contact if they do not receive confirmation of an appointment\n\u2022 other sources of support. [2015]\n1.14.6 Provide information that is appropriate for the person in terms of language, ability\nand culture, recognising the potential for different cultural meanings associated\nwith the possibility of cancer. [2015]\n1.14.7 Have information available in a variety of formats on both local and national\nsources of information and support for people who are being referred with\nsuspected cancer. For more information on information sharing, see the section\non enabling patients to actively participate in their care in NICE's guideline on\npatient experience in adult NHS services. [2015]\n1.14.8 Reassure people in the safety netting group (see recommendation 1.15.2) who are\nconcerned that they may have cancer that with their current symptoms their risk\nof having cancer is low. [2015]\n1.14.9 Explain to people who are being offered safety netting (see\nrecommendation 1.15.2) which symptoms to look out for and when they should\nreturn for re-evaluation. It may be appropriate to provide written information.\n[2015]\n1.14.10 When referring a person with suspected cancer to a specialist service, assess\ntheir need for continuing support while waiting for their referral appointment. This"
  },
  {
    "element_id": "page_35_seq_0",
    "page_number": 35,
    "element_type": "text",
    "markdown": "should include inviting the person to contact their healthcare professional again if\nthey have more concerns or questions before they see a specialist. [2005]\n1.14.11 If the person has additional support needs because of their personal\ncircumstances, inform the specialist (with the person's agreement). [2005]\n1.15 Safety netting\n1.15.1 Ensure that the results of investigations are reviewed and acted upon\nappropriately, with the healthcare professional who ordered the investigation\ntaking or explicitly passing on responsibility for this. Be aware of the possibility of\nfalse-negative results for chest X-rays and tests for occult blood in faeces.\n[2015]\n1.15.2 Consider a review for people with any symptom that is associated with an\nincreased risk of cancer, but who do not meet the criteria for referral or other\ninvestigative action. The review may be:\n\u2022 planned within a time frame agreed with the person or\n\u2022 patient-initiated if new symptoms develop, the person continues to be\nconcerned, or their symptoms recur, persist or worsen. [2015]\n1.16 The diagnostic process\n1.16.1 Take part in continuing education, peer review and other activities to improve and\nmaintain clinical consulting, reasoning and diagnostic skills, in order to identify at\nan early stage people who may have cancer, and to communicate the possibility\nof cancer to the person. [2005]\n1.16.2 Discussion with a specialist (for example, by telephone or email) should be\nconsidered if there is uncertainty about the interpretation of symptoms and signs,\nand whether a referral is needed. This may also enable the primary healthcare\nprofessional to communicate their concerns and a sense of urgency to secondary\nhealthcare professionals when symptoms are not classical. [2005]",
    "raw_text": "should include inviting the person to contact their healthcare professional again if\nthey have more concerns or questions before they see a specialist. [2005]\n1.14.11 If the person has additional support needs because of their personal\ncircumstances, inform the specialist (with the person's agreement). [2005]\n1.15 Safety netting\n1.15.1 Ensure that the results of investigations are reviewed and acted upon\nappropriately, with the healthcare professional who ordered the investigation\ntaking or explicitly passing on responsibility for this. Be aware of the possibility of\nfalse-negative results for chest X-rays and tests for occult blood in faeces.\n[2015]\n1.15.2 Consider a review for people with any symptom that is associated with an\nincreased risk of cancer, but who do not meet the criteria for referral or other\ninvestigative action. The review may be:\n\u2022 planned within a time frame agreed with the person or\n\u2022 patient-initiated if new symptoms develop, the person continues to be\nconcerned, or their symptoms recur, persist or worsen. [2015]\n1.16 The diagnostic process\n1.16.1 Take part in continuing education, peer review and other activities to improve and\nmaintain clinical consulting, reasoning and diagnostic skills, in order to identify at\nan early stage people who may have cancer, and to communicate the possibility\nof cancer to the person. [2005]\n1.16.2 Discussion with a specialist (for example, by telephone or email) should be\nconsidered if there is uncertainty about the interpretation of symptoms and signs,\nand whether a referral is needed. This may also enable the primary healthcare\nprofessional to communicate their concerns and a sense of urgency to secondary\nhealthcare professionals when symptoms are not classical. [2005]"
  },
  {
    "element_id": "page_36_seq_0",
    "page_number": 36,
    "element_type": "text",
    "markdown": "1.16.3 Put in place local arrangements to ensure that letters about non-urgent referrals\nare assessed by the specialist, so that the person can be seen more urgently if\nnecessary. [2005]\n1.16.4 Put in place local arrangements to ensure that there is a maximum waiting period\nfor non-urgent referrals, in accordance with national targets and local\narrangements. [2005]\n1.16.5 Ensure local arrangements are in place to identify people who miss their\nappointments so that they can be followed up. [2005]\n1.16.6 Include all appropriate information in referral correspondence, including whether\nthe referral is urgent or non-urgent. [2005]\n1.16.7 Use local referral proformas if these are in use. [2005]\n1.16.8 Once the decision to refer has been made, make sure that the referral is made\nwithin 1 working day. [2005]",
    "raw_text": "1.16.3 Put in place local arrangements to ensure that letters about non-urgent referrals\nare assessed by the specialist, so that the person can be seen more urgently if\nnecessary. [2005]\n1.16.4 Put in place local arrangements to ensure that there is a maximum waiting period\nfor non-urgent referrals, in accordance with national targets and local\narrangements. [2005]\n1.16.5 Ensure local arrangements are in place to identify people who miss their\nappointments so that they can be followed up. [2005]\n1.16.6 Include all appropriate information in referral correspondence, including whether\nthe referral is urgent or non-urgent. [2005]\n1.16.7 Use local referral proformas if these are in use. [2005]\n1.16.8 Once the decision to refer has been made, make sure that the referral is made\nwithin 1 working day. [2005]"
  },
  {
    "element_id": "page_37_seq_0",
    "page_number": 37,
    "element_type": "text",
    "markdown": "Recommendations organised by symptom\nand findings of primary care\ninvestigations\nThe recommendations in this section are displayed alphabetically by symptom then in\norder of urgency of the action needed, to make sure that the most urgent actions are not\nmissed. Where there are several recommendations relating to the same cancer these have\nbeen grouped for ease of reference. Occasionally the same symptom may suggest more\nthan 1 cancer site. In such instances, the recommendations are displayed together and the\nGP should use their clinical judgement to decide on the most appropriate action.\nUse this guideline to guide referrals. If still uncertain about whether a referral is\nneeded, consider contacting a specialist (see the recommendations on the diagnostic\nprocess). Consider a review for people with any symptom associated with increased\ncancer risk who do not meet the criteria for referral or investigative action (see the\nrecommendations on safety netting).\nAbdominal symptoms\nSee also the section on bleeding for recommendations on rectal bleeding.",
    "raw_text": "Recommendations organised by symptom\nand findings of primary care\ninvestigations\nThe recommendations in this section are displayed alphabetically by symptom then in\norder of urgency of the action needed, to make sure that the most urgent actions are not\nmissed. Where there are several recommendations relating to the same cancer these have\nbeen grouped for ease of reference. Occasionally the same symptom may suggest more\nthan 1 cancer site. In such instances, the recommendations are displayed together and the\nGP should use their clinical judgement to decide on the most appropriate action.\nUse this guideline to guide referrals. If still uncertain about whether a referral is\nneeded, consider contacting a specialist (see the recommendations on the diagnostic\nprocess). Consider a review for people with any symptom associated with increased\ncancer risk who do not meet the criteria for referral or investigative action (see the\nrecommendations on safety netting).\nAbdominal symptoms\nSee also the section on bleeding for recommendations on rectal bleeding."
  },
  {
    "element_id": "page_38_seq_0",
    "page_number": 38,
    "element_type": "text",
    "markdown": "Abdominal distension\nPossible\nSymptom and specific features Recommendation\ncancer\nCarry out tests in primary care\n[1.5.2]\nMeasure serum CA125 in primary\nAbdominal distension (persistent or care [1.5.6]\nfrequent \u2013 particularly more than 12 times See the section on primary care\nOvarian\nper month) in women, especially if 50 and investigations for more\nover information on tests for ovarian\ncancer\nThese recommendations apply\nto women aged 18 and over\nAbdominal examination findings\nPossible\nSymptoms and signs Recommendation\ncancer\nRefer women using a\nsuspected cancer\nAscites and/or a pelvic or abdominal mass\npathway referral [1.5.1]\nidentified by physical examination (which is not Ovarian\nThese recommendations\nobviously uterine fibroids) in women\napply to women aged\n18 and over\nAbdominal, pelvic or rectal mass or enlarged abdominal organ\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nAbdominal or pelvic\nmass identified by Refer women using a suspected cancer\nphysical examination pathway referral [1.5.1]\nOvarian\n(which is not These recommendations apply to women aged\nobviously uterine 18 and over\nfibroids) in women\nOffer quantitative faecal immunochemical\nAbdominal mass Colorectal\ntesting [1.3.1]\nConsider a suspected cancer pathway referral\nRectal mass Colorectal\n[1.3.5]",
    "raw_text": "Abdominal distension\nPossible\nSymptom and specific features Recommendation\ncancer\nCarry out tests in primary care\n[1.5.2]\nMeasure serum CA125 in primary\nAbdominal distension (persistent or care [1.5.6]\nfrequent \u2013 particularly more than 12 times See the section on primary care\nOvarian\nper month) in women, especially if 50 and investigations for more\nover information on tests for ovarian\ncancer\nThese recommendations apply\nto women aged 18 and over\nAbdominal examination findings\nPossible\nSymptoms and signs Recommendation\ncancer\nRefer women using a\nsuspected cancer\nAscites and/or a pelvic or abdominal mass\npathway referral [1.5.1]\nidentified by physical examination (which is not Ovarian\nThese recommendations\nobviously uterine fibroids) in women\napply to women aged\n18 and over\nAbdominal, pelvic or rectal mass or enlarged abdominal organ\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nAbdominal or pelvic\nmass identified by Refer women using a suspected cancer\nphysical examination pathway referral [1.5.1]\nOvarian\n(which is not These recommendations apply to women aged\nobviously uterine 18 and over\nfibroids) in women\nOffer quantitative faecal immunochemical\nAbdominal mass Colorectal\ntesting [1.3.1]\nConsider a suspected cancer pathway referral\nRectal mass Colorectal\n[1.3.5]"
  },
  {
    "element_id": "page_38",
    "page_number": 38,
    "element_type": "table",
    "markdown": "Table 1 on Page 38\n\n| Symptom and specific features              | Possible   | Recommendation                   |\n|                                            | cancer     |                                  |\n|:-------------------------------------------|:-----------|:---------------------------------|\n| Abdominal distension (persistent or        | Ovarian    | Carry out tests in primary care  |\n| frequent \u2013 particularly more than 12 times |            | [1.5.2]                          |\n| per month) in women, especially if 50 and  |            | Measure serum CA125 in primary   |\n| over                                       |            | care [1.5.6]                     |\n|                                            |            | See the section on primary care  |\n|                                            |            | investigations for more          |\n|                                            |            | information on tests for ovarian |\n|                                            |            | cancer                           |\n|                                            |            | These recommendations apply      |\n|                                            |            | to women aged 18 and over        |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nAbdominal distension (persistent or\nfrequent \u2013 particularly more than 12 times\nper month) in women, especially if 50 and\nover\tOvarian\tCarry out tests in primary care\n[1.5.2]\nMeasure serum CA125 in primary\ncare [1.5.6]\nSee the section on primary care\ninvestigations for more\ninformation on tests for ovarian\ncancer\nThese recommendations apply\nto women aged 18 and over"
  },
  {
    "element_id": "page_38",
    "page_number": 38,
    "element_type": "table",
    "markdown": "Table 2 on Page 38\n\n| Symptoms and signs                               | Possible   | Recommendation           |\n|                                                  | cancer     |                          |\n|:-------------------------------------------------|:-----------|:-------------------------|\n| Ascites and/or a pelvic or abdominal mass        | Ovarian    | Refer women using a      |\n| identified by physical examination (which is not |            | suspected cancer         |\n| obviously uterine fibroids) in women             |            | pathway referral [1.5.1] |\n|                                                  |            | These recommendations    |\n|                                                  |            | apply to women aged      |\n|                                                  |            | 18 and over              |",
    "raw_text": "Symptoms and signs\tPossible\ncancer\tRecommendation\nAscites and/or a pelvic or abdominal mass\nidentified by physical examination (which is not\nobviously uterine fibroids) in women\tOvarian\tRefer women using a\nsuspected cancer\npathway referral [1.5.1]\nThese recommendations\napply to women aged\n18 and over"
  },
  {
    "element_id": "page_38",
    "page_number": 38,
    "element_type": "table",
    "markdown": "Table 3 on Page 38\n\n| Symptom and specific   | Possible cancer   | Recommendation                               |\n| features               |                   |                                              |\n|:-----------------------|:------------------|:---------------------------------------------|\n| Abdominal or pelvic    | Ovarian           | Refer women using a suspected cancer         |\n| mass identified by     |                   | pathway referral [1.5.1]                     |\n| physical examination   |                   | These recommendations apply to women aged    |\n| (which is not          |                   | 18 and over                                  |\n| obviously uterine      |                   |                                              |\n| fibroids) in women     |                   |                                              |\n| Abdominal mass         | Colorectal        | Offer quantitative faecal immunochemical     |\n|                        |                   | testing [1.3.1]                              |\n| Rectal mass            | Colorectal        | Consider a suspected cancer pathway referral |\n|                        |                   | [1.3.5]                                      |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nAbdominal or pelvic\nmass identified by\nphysical examination\n(which is not\nobviously uterine\nfibroids) in women\tOvarian\tRefer women using a suspected cancer\npathway referral [1.5.1]\nThese recommendations apply to women aged\n18 and over\nAbdominal mass\tColorectal\tOffer quantitative faecal immunochemical\ntesting [1.3.1]\nRectal mass\tColorectal\tConsider a suspected cancer pathway referral\n[1.3.5]"
  },
  {
    "element_id": "page_39_seq_0",
    "page_number": 39,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account\nany associated symptoms, particularly fever,\nnight sweats, shortness of breath, pruritus or\nSplenomegaly weight loss [1.10.6]\nNon-Hodgkin's\n(unexplained) in Separate recommendations have been made for\nlymphoma\nadults adults and for children and young people to\nreflect that there are different referral\npathways. In practice young people (aged 16 to\n24) may be referred using either pathway\ndepending on their age and local arrangements\nUpper abdominal\nConsider a suspected cancer pathway referral\nmassconsistent with Stomach\n[1.2.6]\nstomach cancer\nUpper abdominal\nmassconsistent with Consider an urgent direct access ultrasound\nGall bladder\nan enlarged gall scan (to be done within 2 weeks) [1.2.10]\nbladder\nUpper abdominal\nConsider an urgent direct access ultrasound\nmassconsistent with Liver\nscan (to be done within 2 weeks) [1.2.11]\nan enlarged liver\nConsider a very urgent full blood count (within\nHepatosplenomegaly Leukaemia\n48 hours) [1.10.1]\nAbdominal or pelvic pain\nSymptom and specific features Possible cancer Recommendation\nAbdominal pain with weight loss Offer quantitative faecal\nColorectal\n(unexplained), 40 and over immunochemical testing [1.3.1]\nAbdominal pain (unexplained)\nOffer quantitative faecal\nwith rectal bleeding in adults Colorectal\nimmunochemical testing [1.3.1]\nunder 50\nAbdominal pain (unexplained), Offer quantitative faecal\nColorectal\n50 and over immunochemical testing [1.3.1]",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account\nany associated symptoms, particularly fever,\nnight sweats, shortness of breath, pruritus or\nSplenomegaly weight loss [1.10.6]\nNon-Hodgkin's\n(unexplained) in Separate recommendations have been made for\nlymphoma\nadults adults and for children and young people to\nreflect that there are different referral\npathways. In practice young people (aged 16 to\n24) may be referred using either pathway\ndepending on their age and local arrangements\nUpper abdominal\nConsider a suspected cancer pathway referral\nmassconsistent with Stomach\n[1.2.6]\nstomach cancer\nUpper abdominal\nmassconsistent with Consider an urgent direct access ultrasound\nGall bladder\nan enlarged gall scan (to be done within 2 weeks) [1.2.10]\nbladder\nUpper abdominal\nConsider an urgent direct access ultrasound\nmassconsistent with Liver\nscan (to be done within 2 weeks) [1.2.11]\nan enlarged liver\nConsider a very urgent full blood count (within\nHepatosplenomegaly Leukaemia\n48 hours) [1.10.1]\nAbdominal or pelvic pain\nSymptom and specific features Possible cancer Recommendation\nAbdominal pain with weight loss Offer quantitative faecal\nColorectal\n(unexplained), 40 and over immunochemical testing [1.3.1]\nAbdominal pain (unexplained)\nOffer quantitative faecal\nwith rectal bleeding in adults Colorectal\nimmunochemical testing [1.3.1]\nunder 50\nAbdominal pain (unexplained), Offer quantitative faecal\nColorectal\n50 and over immunochemical testing [1.3.1]"
  },
  {
    "element_id": "page_39",
    "page_number": 39,
    "element_type": "table",
    "markdown": "Table 1 on Page 39\n\n| Symptom and specific   | Possible cancer   | Recommendation                                  |\n| features               |                   |                                                 |\n|:-----------------------|:------------------|:------------------------------------------------|\n| Splenomegaly           | Non-Hodgkin's     | Consider a suspected cancer pathway referral.   |\n| (unexplained) in       | lymphoma          | When considering referral, take into account    |\n| adults                 |                   | any associated symptoms, particularly fever,    |\n|                        |                   | night sweats, shortness of breath, pruritus or  |\n|                        |                   | weight loss [1.10.6]                            |\n|                        |                   | Separate recommendations have been made for     |\n|                        |                   | adults and for children and young people to     |\n|                        |                   | reflect that there are different referral       |\n|                        |                   | pathways. In practice young people (aged 16 to  |\n|                        |                   | 24) may be referred using either pathway        |\n|                        |                   | depending on their age and local arrangements   |\n| Upper abdominal        | Stomach           | Consider a suspected cancer pathway referral    |\n| massconsistent with    |                   | [1.2.6]                                         |\n| stomach cancer         |                   |                                                 |\n| Upper abdominal        | Gall bladder      | Consider an urgent direct access ultrasound     |\n| massconsistent with    |                   | scan (to be done within 2 weeks) [1.2.10]       |\n| an enlarged gall       |                   |                                                 |\n| bladder                |                   |                                                 |\n| Upper abdominal        | Liver             | Consider an urgent direct access ultrasound     |\n| massconsistent with    |                   | scan (to be done within 2 weeks) [1.2.11]       |\n| an enlarged liver      |                   |                                                 |\n| Hepatosplenomegaly     | Leukaemia         | Consider a very urgent full blood count (within |\n|                        |                   | 48 hours) [1.10.1]                              |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nSplenomegaly\n(unexplained) in\nadults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account\nany associated symptoms, particularly fever,\nnight sweats, shortness of breath, pruritus or\nweight loss [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to\nreflect that there are different referral\npathways. In practice young people (aged 16 to\n24) may be referred using either pathway\ndepending on their age and local arrangements\nUpper abdominal\nmassconsistent with\nstomach cancer\tStomach\tConsider a suspected cancer pathway referral\n[1.2.6]\nUpper abdominal\nmassconsistent with\nan enlarged gall\nbladder\tGall bladder\tConsider an urgent direct access ultrasound\nscan (to be done within 2 weeks) [1.2.10]\nUpper abdominal\nmassconsistent with\nan enlarged liver\tLiver\tConsider an urgent direct access ultrasound\nscan (to be done within 2 weeks) [1.2.11]\nHepatosplenomegaly\tLeukaemia\tConsider a very urgent full blood count (within\n48 hours) [1.10.1]"
  },
  {
    "element_id": "page_39",
    "page_number": 39,
    "element_type": "table",
    "markdown": "Table 2 on Page 39\n\n| Symptom and specific features   | Possible cancer   | Recommendation                 |\n|:--------------------------------|:------------------|:-------------------------------|\n| Abdominal pain with weight loss | Colorectal        | Offer quantitative faecal      |\n| (unexplained), 40 and over      |                   | immunochemical testing [1.3.1] |\n| Abdominal pain (unexplained)    | Colorectal        | Offer quantitative faecal      |\n| with rectal bleeding in adults  |                   | immunochemical testing [1.3.1] |\n| under 50                        |                   |                                |\n| Abdominal pain (unexplained),   | Colorectal        | Offer quantitative faecal      |\n| 50 and over                     |                   | immunochemical testing [1.3.1] |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nAbdominal pain with weight loss\n(unexplained), 40 and over\tColorectal\tOffer quantitative faecal\nimmunochemical testing [1.3.1]\nAbdominal pain (unexplained)\nwith rectal bleeding in adults\nunder 50\tColorectal\tOffer quantitative faecal\nimmunochemical testing [1.3.1]\nAbdominal pain (unexplained),\n50 and over\tColorectal\tOffer quantitative faecal\nimmunochemical testing [1.3.1]"
  },
  {
    "element_id": "page_40_seq_0",
    "page_number": 40,
    "element_type": "text",
    "markdown": "Symptom and specific features Possible cancer Recommendation\nUpper abdominal pain with Oesophageal Refer using a suspected cancer\nweight loss, 55 and over or stomach pathway referral [1.2.1] [1.2.7]\nUpper abdominal pain with low\nConsider non-urgent, direct access\nhaemoglobin levels or raised Oesophageal\nupper gastrointestinal endoscopy\nplatelet count or nausea or or stomach\n[1.2.3] [1.2.9]\nvomiting, 55 and over\nCarry out tests in primary care [1.5.2]\nMeasure serum CA125 in primary\nAbdominal or pelvic pain\ncare [1.5.6]\n(persistent or frequent \u2013\nSee the section on primary care\nparticularly more than 12 times Ovarian\ninvestigations for more information\nper month) in women, especially if\non tests for ovarian cancer\n50 and over\nThese recommendations apply to\nwomen aged 18 and over\nConsider an urgent, direct access CT\nAbdominal pain with weight loss, scan (to be done within 2 weeks), or\nPancreatic\n60 and over an urgent ultrasound scan if CT is not\navailable [1.2.5]\nCarry out appropriate tests for\novarian cancer, because irritable\nbowel syndrome rarely presents for\nthe first time in women of this age\n[1.5.5]\nMeasure serum CA125 in primary\nIrritable bowel syndrome\ncare [1.5.6]\nsymptoms within the last Ovarian\nSee the section on primary care\n12 months in women 50 and over\ninvestigations for more information\non tests for ovarian cancer\nThese recommendations apply to\nwomen aged 18 and over\nAlso see the NICE guideline on\nirritable bowel syndrome in adults.",
    "raw_text": "Symptom and specific features Possible cancer Recommendation\nUpper abdominal pain with Oesophageal Refer using a suspected cancer\nweight loss, 55 and over or stomach pathway referral [1.2.1] [1.2.7]\nUpper abdominal pain with low\nConsider non-urgent, direct access\nhaemoglobin levels or raised Oesophageal\nupper gastrointestinal endoscopy\nplatelet count or nausea or or stomach\n[1.2.3] [1.2.9]\nvomiting, 55 and over\nCarry out tests in primary care [1.5.2]\nMeasure serum CA125 in primary\nAbdominal or pelvic pain\ncare [1.5.6]\n(persistent or frequent \u2013\nSee the section on primary care\nparticularly more than 12 times Ovarian\ninvestigations for more information\nper month) in women, especially if\non tests for ovarian cancer\n50 and over\nThese recommendations apply to\nwomen aged 18 and over\nConsider an urgent, direct access CT\nAbdominal pain with weight loss, scan (to be done within 2 weeks), or\nPancreatic\n60 and over an urgent ultrasound scan if CT is not\navailable [1.2.5]\nCarry out appropriate tests for\novarian cancer, because irritable\nbowel syndrome rarely presents for\nthe first time in women of this age\n[1.5.5]\nMeasure serum CA125 in primary\nIrritable bowel syndrome\ncare [1.5.6]\nsymptoms within the last Ovarian\nSee the section on primary care\n12 months in women 50 and over\ninvestigations for more information\non tests for ovarian cancer\nThese recommendations apply to\nwomen aged 18 and over\nAlso see the NICE guideline on\nirritable bowel syndrome in adults."
  },
  {
    "element_id": "page_40",
    "page_number": 40,
    "element_type": "table",
    "markdown": "Table 1 on Page 40\n\n| Symptom and specific features      | Possible cancer   | Recommendation                          |\n|:-----------------------------------|:------------------|:----------------------------------------|\n| Upper abdominal pain with          | Oesophageal       | Refer using a suspected cancer          |\n| weight loss, 55 and over           | or stomach        | pathway referral [1.2.1] [1.2.7]        |\n| Upper abdominal pain with low      | Oesophageal       | Consider non-urgent, direct access      |\n| haemoglobin levels or raised       | or stomach        | upper gastrointestinal endoscopy        |\n| platelet count or nausea or        |                   | [1.2.3] [1.2.9]                         |\n| vomiting, 55 and over              |                   |                                         |\n| Abdominal or pelvic pain           | Ovarian           | Carry out tests in primary care [1.5.2] |\n| (persistent or frequent \u2013          |                   | Measure serum CA125 in primary          |\n| particularly more than 12 times    |                   | care [1.5.6]                            |\n| per month) in women, especially if |                   | See the section on primary care         |\n| 50 and over                        |                   | investigations for more information     |\n|                                    |                   | on tests for ovarian cancer             |\n|                                    |                   | These recommendations apply to          |\n|                                    |                   | women aged 18 and over                  |\n| Abdominal pain with weight loss,   | Pancreatic        | Consider an urgent, direct access CT    |\n| 60 and over                        |                   | scan (to be done within 2 weeks), or    |\n|                                    |                   | an urgent ultrasound scan if CT is not  |\n|                                    |                   | available [1.2.5]                       |\n| Irritable bowel syndrome           | Ovarian           | Carry out appropriate tests for         |\n| symptoms within the last           |                   | ovarian cancer, because irritable       |\n| 12 months in women 50 and over     |                   | bowel syndrome rarely presents for      |\n|                                    |                   | the first time in women of this age     |\n|                                    |                   | [1.5.5]                                 |\n|                                    |                   | Measure serum CA125 in primary          |\n|                                    |                   | care [1.5.6]                            |\n|                                    |                   | See the section on primary care         |\n|                                    |                   | investigations for more information     |\n|                                    |                   | on tests for ovarian cancer             |\n|                                    |                   | These recommendations apply to          |\n|                                    |                   | women aged 18 and over                  |\n|                                    |                   | Also see the NICE guideline on          |\n|                                    |                   | irritable bowel syndrome in adults.     |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nUpper abdominal pain with\nweight loss, 55 and over\tOesophageal\nor stomach\tRefer using a suspected cancer\npathway referral [1.2.1] [1.2.7]\nUpper abdominal pain with low\nhaemoglobin levels or raised\nplatelet count or nausea or\nvomiting, 55 and over\tOesophageal\nor stomach\tConsider non-urgent, direct access\nupper gastrointestinal endoscopy\n[1.2.3] [1.2.9]\nAbdominal or pelvic pain\n(persistent or frequent \u2013\nparticularly more than 12 times\nper month) in women, especially if\n50 and over\tOvarian\tCarry out tests in primary care [1.5.2]\nMeasure serum CA125 in primary\ncare [1.5.6]\nSee the section on primary care\ninvestigations for more information\non tests for ovarian cancer\nThese recommendations apply to\nwomen aged 18 and over\nAbdominal pain with weight loss,\n60 and over\tPancreatic\tConsider an urgent, direct access CT\nscan (to be done within 2 weeks), or\nan urgent ultrasound scan if CT is not\navailable [1.2.5]\nIrritable bowel syndrome\nsymptoms within the last\n12 months in women 50 and over\tOvarian\tCarry out appropriate tests for\novarian cancer, because irritable\nbowel syndrome rarely presents for\nthe first time in women of this age\n[1.5.5]\nMeasure serum CA125 in primary\ncare [1.5.6]\nSee the section on primary care\ninvestigations for more information\non tests for ovarian cancer\nThese recommendations apply to\nwomen aged 18 and over\nAlso see the NICE guideline on\nirritable bowel syndrome in adults."
  },
  {
    "element_id": "page_41_seq_0",
    "page_number": 41,
    "element_type": "text",
    "markdown": "Change in bowel habit\nPossible\nSymptom and specific features Recommendation\ncancer\nOffer quantitative faecal immunochemical\nChange in bowel habit Colorectal\ntesting [1.3.1]\nConsider carrying out tests in primary care\n[1.5.3]\nMeasure serum CA125 in primary care [1.5.6]\nChange in bowel habit\nOvarian See the section on primary care investigations\n(unexplained) in women\nfor information on tests for ovarian cancer\nThese recommendations apply to women\naged 18 and over\nDiarrhoea or constipation Consider an urgent, direct access CT scan (to\nwith weight loss, 60 and Pancreatic be done within 2 weeks), or an urgent\nover ultrasound scan if CT is not available [1.2.5]\nCarry out appropriate tests for ovarian cancer,\nbecause irritable bowel syndrome rarely\npresents for the first time in women of this\nage [1.5.5]\nMeasure serum CA125 in primary care [1.5.6]\nIrritable bowel syndrome\nsymptoms within the last See the section on primary care investigations\nOvarian\n12 months, in women for more information about tests for ovarian\n50 and over cancer\nThese recommendations apply to women\naged 18 and over\nAlso see the NICE guideline on irritable bowel\nsyndrome in adults\nDyspepsia\nSymptom and specific features Possible cancer Recommendation\nConsider non-urgent, direct access\nDyspepsia (treatment-resistant), Oesophageal\nupper gastrointestinal endoscopy\n55 and over or stomach\n[1.2.3] [1.2.9]",
    "raw_text": "Change in bowel habit\nPossible\nSymptom and specific features Recommendation\ncancer\nOffer quantitative faecal immunochemical\nChange in bowel habit Colorectal\ntesting [1.3.1]\nConsider carrying out tests in primary care\n[1.5.3]\nMeasure serum CA125 in primary care [1.5.6]\nChange in bowel habit\nOvarian See the section on primary care investigations\n(unexplained) in women\nfor information on tests for ovarian cancer\nThese recommendations apply to women\naged 18 and over\nDiarrhoea or constipation Consider an urgent, direct access CT scan (to\nwith weight loss, 60 and Pancreatic be done within 2 weeks), or an urgent\nover ultrasound scan if CT is not available [1.2.5]\nCarry out appropriate tests for ovarian cancer,\nbecause irritable bowel syndrome rarely\npresents for the first time in women of this\nage [1.5.5]\nMeasure serum CA125 in primary care [1.5.6]\nIrritable bowel syndrome\nsymptoms within the last See the section on primary care investigations\nOvarian\n12 months, in women for more information about tests for ovarian\n50 and over cancer\nThese recommendations apply to women\naged 18 and over\nAlso see the NICE guideline on irritable bowel\nsyndrome in adults\nDyspepsia\nSymptom and specific features Possible cancer Recommendation\nConsider non-urgent, direct access\nDyspepsia (treatment-resistant), Oesophageal\nupper gastrointestinal endoscopy\n55 and over or stomach\n[1.2.3] [1.2.9]"
  },
  {
    "element_id": "page_41",
    "page_number": 41,
    "element_type": "table",
    "markdown": "Table 1 on Page 41\n\n| Symptom and specific features   | Possible   | Recommendation                                  |\n|                                 | cancer     |                                                 |\n|:--------------------------------|:-----------|:------------------------------------------------|\n| Change in bowel habit           | Colorectal | Offer quantitative faecal immunochemical        |\n|                                 |            | testing [1.3.1]                                 |\n| Change in bowel habit           | Ovarian    | Consider carrying out tests in primary care     |\n| (unexplained) in women          |            | [1.5.3]                                         |\n|                                 |            | Measure serum CA125 in primary care [1.5.6]     |\n|                                 |            | See the section on primary care investigations  |\n|                                 |            | for information on tests for ovarian cancer     |\n|                                 |            | These recommendations apply to women            |\n|                                 |            | aged 18 and over                                |\n| Diarrhoea or constipation       | Pancreatic | Consider an urgent, direct access CT scan (to   |\n| with weight loss, 60 and        |            | be done within 2 weeks), or an urgent           |\n| over                            |            | ultrasound scan if CT is not available [1.2.5]  |\n| Irritable bowel syndrome        | Ovarian    | Carry out appropriate tests for ovarian cancer, |\n| symptoms within the last        |            | because irritable bowel syndrome rarely         |\n| 12 months, in women             |            | presents for the first time in women of this    |\n| 50 and over                     |            | age [1.5.5]                                     |\n|                                 |            | Measure serum CA125 in primary care [1.5.6]     |\n|                                 |            | See the section on primary care investigations  |\n|                                 |            | for more information about tests for ovarian    |\n|                                 |            | cancer                                          |\n|                                 |            | These recommendations apply to women            |\n|                                 |            | aged 18 and over                                |\n|                                 |            | Also see the NICE guideline on irritable bowel  |\n|                                 |            | syndrome in adults                              |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nChange in bowel habit\tColorectal\tOffer quantitative faecal immunochemical\ntesting [1.3.1]\nChange in bowel habit\n(unexplained) in women\tOvarian\tConsider carrying out tests in primary care\n[1.5.3]\nMeasure serum CA125 in primary care [1.5.6]\nSee the section on primary care investigations\nfor information on tests for ovarian cancer\nThese recommendations apply to women\naged 18 and over\nDiarrhoea or constipation\nwith weight loss, 60 and\nover\tPancreatic\tConsider an urgent, direct access CT scan (to\nbe done within 2 weeks), or an urgent\nultrasound scan if CT is not available [1.2.5]\nIrritable bowel syndrome\nsymptoms within the last\n12 months, in women\n50 and over\tOvarian\tCarry out appropriate tests for ovarian cancer,\nbecause irritable bowel syndrome rarely\npresents for the first time in women of this\nage [1.5.5]\nMeasure serum CA125 in primary care [1.5.6]\nSee the section on primary care investigations\nfor more information about tests for ovarian\ncancer\nThese recommendations apply to women\naged 18 and over\nAlso see the NICE guideline on irritable bowel\nsyndrome in adults"
  },
  {
    "element_id": "page_41",
    "page_number": 41,
    "element_type": "table",
    "markdown": "Table 2 on Page 41\n\n| Symptom and specific features    | Possible cancer   | Recommendation                     |\n|:---------------------------------|:------------------|:-----------------------------------|\n| Dyspepsia (treatment-resistant), | Oesophageal       | Consider non-urgent, direct access |\n| 55 and over                      | or stomach        | upper gastrointestinal endoscopy   |\n|                                  |                   | [1.2.3] [1.2.9]                    |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nDyspepsia (treatment-resistant),\n55 and over\tOesophageal\nor stomach\tConsider non-urgent, direct access\nupper gastrointestinal endoscopy\n[1.2.3] [1.2.9]"
  },
  {
    "element_id": "page_42_seq_0",
    "page_number": 42,
    "element_type": "text",
    "markdown": "Symptom and specific features Possible cancer Recommendation\nDyspepsia\nOesophageal Refer using a suspected cancer\nDyspepsia with weight loss,\nor stomach pathway referral [1.2.1] [1.2.7]\n55 and over\nDyspepsia with raised platelet Consider non-urgent, direct access\nOesophageal\ncount or nausea or vomiting, upper gastrointestinal endoscopy\nor stomach\n55 and over [1.2.3] [1.2.9]\nDysphagia\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nOesophageal or Refer using a suspected cancer pathway\nDysphagia\nstomach referral [1.2.1] [1.2.7]\nNausea or vomiting\nSymptom and specific features Possible cancer Recommendation\nConsider an urgent, direct access\nNausea or vomiting with weight CT scan (to be done within\nPancreatic\nloss, 60 and over 2 weeks), or an urgent ultrasound\nscan if CT is not available [1.2.5]\nNausea or vomiting with raised\nConsider non-urgent, direct access\nplatelet count or weight loss or Oesophageal\nupper gastrointestinal endoscopy\nreflux or dyspepsia or upper or stomach\n[1.2.3] [1.2.9]\nabdominal pain, 55 and over\nRectal examination findings\nPossible\nSymptom and signs Recommendation\ncancer\nProstate feels malignant on digital Refer men using a suspected cancer\nProstate\nrectal examination, in men pathway referral [1.6.1]\nAnal mass or anal ulceration Consider a suspected cancer\nAnal\n(unexplained) pathway referral [1.3.6]\nConsider a suspected cancer\nRectalmass Colorectal\npathway referral [1.3.5]",
    "raw_text": "Symptom and specific features Possible cancer Recommendation\nDyspepsia\nOesophageal Refer using a suspected cancer\nDyspepsia with weight loss,\nor stomach pathway referral [1.2.1] [1.2.7]\n55 and over\nDyspepsia with raised platelet Consider non-urgent, direct access\nOesophageal\ncount or nausea or vomiting, upper gastrointestinal endoscopy\nor stomach\n55 and over [1.2.3] [1.2.9]\nDysphagia\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nOesophageal or Refer using a suspected cancer pathway\nDysphagia\nstomach referral [1.2.1] [1.2.7]\nNausea or vomiting\nSymptom and specific features Possible cancer Recommendation\nConsider an urgent, direct access\nNausea or vomiting with weight CT scan (to be done within\nPancreatic\nloss, 60 and over 2 weeks), or an urgent ultrasound\nscan if CT is not available [1.2.5]\nNausea or vomiting with raised\nConsider non-urgent, direct access\nplatelet count or weight loss or Oesophageal\nupper gastrointestinal endoscopy\nreflux or dyspepsia or upper or stomach\n[1.2.3] [1.2.9]\nabdominal pain, 55 and over\nRectal examination findings\nPossible\nSymptom and signs Recommendation\ncancer\nProstate feels malignant on digital Refer men using a suspected cancer\nProstate\nrectal examination, in men pathway referral [1.6.1]\nAnal mass or anal ulceration Consider a suspected cancer\nAnal\n(unexplained) pathway referral [1.3.6]\nConsider a suspected cancer\nRectalmass Colorectal\npathway referral [1.3.5]"
  },
  {
    "element_id": "page_42",
    "page_number": 42,
    "element_type": "table",
    "markdown": "Table 1 on Page 42\n\n| Symptom and specific features   | Possible cancer   | Recommendation                     |\n|:--------------------------------|:------------------|:-----------------------------------|\n| Dyspepsia                       | Oesophageal       | Refer using a suspected cancer     |\n| Dyspepsia with weight loss,     | or stomach        | pathway referral [1.2.1] [1.2.7]   |\n| 55 and over                     |                   |                                    |\n| Dyspepsia with raised platelet  | Oesophageal       | Consider non-urgent, direct access |\n| count or nausea or vomiting,    | or stomach        | upper gastrointestinal endoscopy   |\n| 55 and over                     |                   | [1.2.3] [1.2.9]                    |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nDyspepsia\nDyspepsia with weight loss,\n55 and over\tOesophageal\nor stomach\tRefer using a suspected cancer\npathway referral [1.2.1] [1.2.7]\nDyspepsia with raised platelet\ncount or nausea or vomiting,\n55 and over\tOesophageal\nor stomach\tConsider non-urgent, direct access\nupper gastrointestinal endoscopy\n[1.2.3] [1.2.9]"
  },
  {
    "element_id": "page_42",
    "page_number": 42,
    "element_type": "table",
    "markdown": "Table 2 on Page 42\n\n| Symptom and specific   | Possible cancer   | Recommendation                         |\n| features               |                   |                                        |\n|:-----------------------|:------------------|:---------------------------------------|\n| Dysphagia              | Oesophageal or    | Refer using a suspected cancer pathway |\n|                        | stomach           | referral [1.2.1] [1.2.7]               |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nDysphagia\tOesophageal or\nstomach\tRefer using a suspected cancer pathway\nreferral [1.2.1] [1.2.7]"
  },
  {
    "element_id": "page_42",
    "page_number": 42,
    "element_type": "table",
    "markdown": "Table 3 on Page 42\n\n| Symptom and specific features    | Possible cancer   | Recommendation                      |\n|:---------------------------------|:------------------|:------------------------------------|\n| Nausea or vomiting with weight   | Pancreatic        | Consider an urgent, direct access   |\n| loss, 60 and over                |                   | CT scan (to be done within          |\n|                                  |                   | 2 weeks), or an urgent ultrasound   |\n|                                  |                   | scan if CT is not available [1.2.5] |\n| Nausea or vomiting with raised   | Oesophageal       | Consider non-urgent, direct access  |\n| platelet count or weight loss or | or stomach        | upper gastrointestinal endoscopy    |\n| reflux or dyspepsia or upper     |                   | [1.2.3] [1.2.9]                     |\n| abdominal pain, 55 and over      |                   |                                     |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nNausea or vomiting with weight\nloss, 60 and over\tPancreatic\tConsider an urgent, direct access\nCT scan (to be done within\n2 weeks), or an urgent ultrasound\nscan if CT is not available [1.2.5]\nNausea or vomiting with raised\nplatelet count or weight loss or\nreflux or dyspepsia or upper\nabdominal pain, 55 and over\tOesophageal\nor stomach\tConsider non-urgent, direct access\nupper gastrointestinal endoscopy\n[1.2.3] [1.2.9]"
  },
  {
    "element_id": "page_42",
    "page_number": 42,
    "element_type": "table",
    "markdown": "Table 4 on Page 42\n\n| Symptom and signs                   | Possible   | Recommendation                     |\n|                                     | cancer     |                                    |\n|:------------------------------------|:-----------|:-----------------------------------|\n| Prostate feels malignant on digital | Prostate   | Refer men using a suspected cancer |\n| rectal examination, in men          |            | pathway referral [1.6.1]           |\n| Anal mass or anal ulceration        | Anal       | Consider a suspected cancer        |\n| (unexplained)                       |            | pathway referral [1.3.6]           |\n| Rectalmass                          | Colorectal | Consider a suspected cancer        |\n|                                     |            | pathway referral [1.3.5]           |",
    "raw_text": "Symptom and signs\tPossible\ncancer\tRecommendation\nProstate feels malignant on digital\nrectal examination, in men\tProstate\tRefer men using a suspected cancer\npathway referral [1.6.1]\nAnal mass or anal ulceration\n(unexplained)\tAnal\tConsider a suspected cancer\npathway referral [1.3.6]\nRectalmass\tColorectal\tConsider a suspected cancer\npathway referral [1.3.5]"
  },
  {
    "element_id": "page_43_seq_0",
    "page_number": 43,
    "element_type": "text",
    "markdown": "Reflux\nSymptom and specific features Possible cancer Recommendation\nReflux with weight loss, 55 and Oesophageal Refer using a suspected cancer\nover or stomach pathway referral [1.2.1] [1.2.7]\nReflux with raised platelet Consider non-urgent, direct access\nOesophageal\ncount or nausea or vomiting, upper gastrointestinal endoscopy\nor stomach\n55 and over [1.2.3] [1.2.9]\nBleeding\nSee also:\n\u2022 the section on urological symptoms for haematuria\n\u2022 the section on primary care investigations for faecal occult blood.\nBleeding, bruising or petechiae\nPossible\nSymptom and specific features Recommendation\ncancer\nBleeding, bruising or Consider a very urgent full blood count\nLeukaemia\npetechiae (unexplained) (within 48 hours) [1.10.1]\nHaematemesis\nSymptom and\nPossible cancer Recommendation\nspecific features\nOesophageal or Consider non-urgent, direct access upper\nHaematemesis\nstomach gastrointestinal endoscopy [1.2.2] [1.2.8]\nHaemoptysis\nPossible\nSymptom and specific features Recommendation\ncancer\nHaemoptysis (unexplained), Refer people using a suspected cancer\nLung\n40 and over pathway referral [1.1.1]",
    "raw_text": "Reflux\nSymptom and specific features Possible cancer Recommendation\nReflux with weight loss, 55 and Oesophageal Refer using a suspected cancer\nover or stomach pathway referral [1.2.1] [1.2.7]\nReflux with raised platelet Consider non-urgent, direct access\nOesophageal\ncount or nausea or vomiting, upper gastrointestinal endoscopy\nor stomach\n55 and over [1.2.3] [1.2.9]\nBleeding\nSee also:\n\u2022 the section on urological symptoms for haematuria\n\u2022 the section on primary care investigations for faecal occult blood.\nBleeding, bruising or petechiae\nPossible\nSymptom and specific features Recommendation\ncancer\nBleeding, bruising or Consider a very urgent full blood count\nLeukaemia\npetechiae (unexplained) (within 48 hours) [1.10.1]\nHaematemesis\nSymptom and\nPossible cancer Recommendation\nspecific features\nOesophageal or Consider non-urgent, direct access upper\nHaematemesis\nstomach gastrointestinal endoscopy [1.2.2] [1.2.8]\nHaemoptysis\nPossible\nSymptom and specific features Recommendation\ncancer\nHaemoptysis (unexplained), Refer people using a suspected cancer\nLung\n40 and over pathway referral [1.1.1]"
  },
  {
    "element_id": "page_43",
    "page_number": 43,
    "element_type": "table",
    "markdown": "Table 1 on Page 43\n\n| Symptom and specific features   | Possible cancer   | Recommendation                     |\n|:--------------------------------|:------------------|:-----------------------------------|\n| Reflux with weight loss, 55 and | Oesophageal       | Refer using a suspected cancer     |\n| over                            | or stomach        | pathway referral [1.2.1] [1.2.7]   |\n| Reflux with raised platelet     | Oesophageal       | Consider non-urgent, direct access |\n| count or nausea or vomiting,    | or stomach        | upper gastrointestinal endoscopy   |\n| 55 and over                     |                   | [1.2.3] [1.2.9]                    |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nReflux with weight loss, 55 and\nover\tOesophageal\nor stomach\tRefer using a suspected cancer\npathway referral [1.2.1] [1.2.7]\nReflux with raised platelet\ncount or nausea or vomiting,\n55 and over\tOesophageal\nor stomach\tConsider non-urgent, direct access\nupper gastrointestinal endoscopy\n[1.2.3] [1.2.9]"
  },
  {
    "element_id": "page_43",
    "page_number": 43,
    "element_type": "table",
    "markdown": "Table 2 on Page 43\n\n| Symptom and specific features   | Possible   | Recommendation                          |\n|                                 | cancer     |                                         |\n|:--------------------------------|:-----------|:----------------------------------------|\n| Bleeding, bruising or           | Leukaemia  | Consider a very urgent full blood count |\n| petechiae (unexplained)         |            | (within 48 hours) [1.10.1]              |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nBleeding, bruising or\npetechiae (unexplained)\tLeukaemia\tConsider a very urgent full blood count\n(within 48 hours) [1.10.1]"
  },
  {
    "element_id": "page_43",
    "page_number": 43,
    "element_type": "table",
    "markdown": "Table 3 on Page 43\n\n| Symptom and         | Possible cancer   | Recommendation                             |\n| specific features   |                   |                                            |\n|:--------------------|:------------------|:-------------------------------------------|\n| Haematemesis        | Oesophageal or    | Consider non-urgent, direct access upper   |\n|                     | stomach           | gastrointestinal endoscopy [1.2.2] [1.2.8] |",
    "raw_text": "Symptom and\nspecific features\tPossible cancer\tRecommendation\nHaematemesis\tOesophageal or\nstomach\tConsider non-urgent, direct access upper\ngastrointestinal endoscopy [1.2.2] [1.2.8]"
  },
  {
    "element_id": "page_43",
    "page_number": 43,
    "element_type": "table",
    "markdown": "Table 4 on Page 43\n\n| Symptom and specific features   | Possible   | Recommendation                        |\n|                                 | cancer     |                                       |\n|:--------------------------------|:-----------|:--------------------------------------|\n| Haemoptysis (unexplained),      | Lung       | Refer people using a suspected cancer |\n| 40 and over                     |            | pathway referral [1.1.1]              |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nHaemoptysis (unexplained),\n40 and over\tLung\tRefer people using a suspected cancer\npathway referral [1.1.1]"
  },
  {
    "element_id": "page_44_seq_0",
    "page_number": 44,
    "element_type": "text",
    "markdown": "Post-menopausal bleeding\nSymptom and specific features Possible cancer Recommendation\nPost-menopausal bleeding in Refer women using a suspected cancer\nEndometrial\nwomen 55 and over pathway referral [1.5.10]\nPost-menopausal bleeding in Consider a suspected cancer pathway\nEndometrial\nwomen under 55 referral [1.5.11]\nPost-menopausal bleeding is unexplained vaginal bleeding more than 12 months after\nmenstruation has stopped because of the menopause.\nRectal bleeding\nPossible\nSymptom and specific features Recommendation\ncancer\nOffer quantitative faecal\nRectal bleeding (unexplained), 50 and over Colorectal immunochemical testing\n[1.3.1]\nOffer quantitative faecal\nRectal bleeding with unexplained abdominal\nColorectal immunochemical testing\npain or weight loss in adults under 50\n[1.3.1]\nVulval bleeding\nPossible\nSymptom and specific features Recommendation\ncancer\nVulval bleeding (unexplained) in Consider a suspected cancer pathway\nVulval\nwomen referral [1.5.14]\nGynaecological symptoms\nSee also the section on bleeding for post-menopausal (vaginal) bleeding\nGynaecological examination findings\nPossible\nSymptom and signs Recommendation\ncancer\nAppearance of cervixconsistent with Consider a suspected cancer pathway\nCervical\ncervical cancer referral [1.5.13]",
    "raw_text": "Post-menopausal bleeding\nSymptom and specific features Possible cancer Recommendation\nPost-menopausal bleeding in Refer women using a suspected cancer\nEndometrial\nwomen 55 and over pathway referral [1.5.10]\nPost-menopausal bleeding in Consider a suspected cancer pathway\nEndometrial\nwomen under 55 referral [1.5.11]\nPost-menopausal bleeding is unexplained vaginal bleeding more than 12 months after\nmenstruation has stopped because of the menopause.\nRectal bleeding\nPossible\nSymptom and specific features Recommendation\ncancer\nOffer quantitative faecal\nRectal bleeding (unexplained), 50 and over Colorectal immunochemical testing\n[1.3.1]\nOffer quantitative faecal\nRectal bleeding with unexplained abdominal\nColorectal immunochemical testing\npain or weight loss in adults under 50\n[1.3.1]\nVulval bleeding\nPossible\nSymptom and specific features Recommendation\ncancer\nVulval bleeding (unexplained) in Consider a suspected cancer pathway\nVulval\nwomen referral [1.5.14]\nGynaecological symptoms\nSee also the section on bleeding for post-menopausal (vaginal) bleeding\nGynaecological examination findings\nPossible\nSymptom and signs Recommendation\ncancer\nAppearance of cervixconsistent with Consider a suspected cancer pathway\nCervical\ncervical cancer referral [1.5.13]"
  },
  {
    "element_id": "page_44",
    "page_number": 44,
    "element_type": "table",
    "markdown": "Table 1 on Page 44\n\n| Symptom and specific features   | Possible cancer   | Recommendation                       |\n|:--------------------------------|:------------------|:-------------------------------------|\n| Post-menopausal bleeding in     | Endometrial       | Refer women using a suspected cancer |\n| women 55 and over               |                   | pathway referral [1.5.10]            |\n| Post-menopausal bleeding in     | Endometrial       | Consider a suspected cancer pathway  |\n| women under 55                  |                   | referral [1.5.11]                    |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nPost-menopausal bleeding in\nwomen 55 and over\tEndometrial\tRefer women using a suspected cancer\npathway referral [1.5.10]\nPost-menopausal bleeding in\nwomen under 55\tEndometrial\tConsider a suspected cancer pathway\nreferral [1.5.11]"
  },
  {
    "element_id": "page_44",
    "page_number": 44,
    "element_type": "table",
    "markdown": "Table 2 on Page 44\n\n| Symptom and specific features              | Possible   | Recommendation            |\n|                                            | cancer     |                           |\n|:-------------------------------------------|:-----------|:--------------------------|\n| Rectal bleeding (unexplained), 50 and over | Colorectal | Offer quantitative faecal |\n|                                            |            | immunochemical testing    |\n|                                            |            | [1.3.1]                   |\n| Rectal bleeding with unexplained abdominal | Colorectal | Offer quantitative faecal |\n| pain or weight loss in adults under 50     |            | immunochemical testing    |\n|                                            |            | [1.3.1]                   |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nRectal bleeding (unexplained), 50 and over\tColorectal\tOffer quantitative faecal\nimmunochemical testing\n[1.3.1]\nRectal bleeding with unexplained abdominal\npain or weight loss in adults under 50\tColorectal\tOffer quantitative faecal\nimmunochemical testing\n[1.3.1]"
  },
  {
    "element_id": "page_44",
    "page_number": 44,
    "element_type": "table",
    "markdown": "Table 3 on Page 44\n\n| Symptom and specific features    | Possible   | Recommendation                      |\n|                                  | cancer     |                                     |\n|:---------------------------------|:-----------|:------------------------------------|\n| Vulval bleeding (unexplained) in | Vulval     | Consider a suspected cancer pathway |\n| women                            |            | referral [1.5.14]                   |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nVulval bleeding (unexplained) in\nwomen\tVulval\tConsider a suspected cancer pathway\nreferral [1.5.14]"
  },
  {
    "element_id": "page_44",
    "page_number": 44,
    "element_type": "table",
    "markdown": "Table 4 on Page 44\n\n| Symptom and signs                   | Possible   | Recommendation                      |\n|                                     | cancer     |                                     |\n|:------------------------------------|:-----------|:------------------------------------|\n| Appearance of cervixconsistent with | Cervical   | Consider a suspected cancer pathway |\n| cervical cancer                     |            | referral [1.5.13]                   |",
    "raw_text": "Symptom and signs\tPossible\ncancer\tRecommendation\nAppearance of cervixconsistent with\ncervical cancer\tCervical\tConsider a suspected cancer pathway\nreferral [1.5.13]"
  },
  {
    "element_id": "page_45_seq_0",
    "page_number": 45,
    "element_type": "text",
    "markdown": "Vaginal symptoms\nSymptom and specific features Possible cancer Recommendation\nVaginal discharge (unexplained) either at first Consider a direct\npresentation or with thrombocytosis or with Endometrial access ultrasound\nhaematuria, in women 55 and over scan [1.5.12]\nConsider a\nVaginal mass (unexplained and palpable) in or at suspected cancer\nVaginal\nthe entrance to the vagina pathway referral\n[1.5.15]\nVulval symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nConsider a suspected cancer pathway\nVulval bleeding (unexplained) Vulval\nreferral [1.5.14]\nVulval lump or ulceration Consider a suspected cancer pathway\nVulval\n(unexplained) referral [1.5.14]\nLumps or masses\nLumps and masses\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nAnal mass\nAnal Consider a suspected cancer pathway referral 1.3.6]\n(unexplained)\nAxillary lump\n(unexplained), Breast Consider a suspected cancer pathway referral [1.4.2]\n30 and over\nBreast lump\n(unexplained) Refer people using a suspected cancer pathway referral\nBreast\nwith or without [1.4.1]\npain, 30 and over",
    "raw_text": "Vaginal symptoms\nSymptom and specific features Possible cancer Recommendation\nVaginal discharge (unexplained) either at first Consider a direct\npresentation or with thrombocytosis or with Endometrial access ultrasound\nhaematuria, in women 55 and over scan [1.5.12]\nConsider a\nVaginal mass (unexplained and palpable) in or at suspected cancer\nVaginal\nthe entrance to the vagina pathway referral\n[1.5.15]\nVulval symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nConsider a suspected cancer pathway\nVulval bleeding (unexplained) Vulval\nreferral [1.5.14]\nVulval lump or ulceration Consider a suspected cancer pathway\nVulval\n(unexplained) referral [1.5.14]\nLumps or masses\nLumps and masses\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nAnal mass\nAnal Consider a suspected cancer pathway referral 1.3.6]\n(unexplained)\nAxillary lump\n(unexplained), Breast Consider a suspected cancer pathway referral [1.4.2]\n30 and over\nBreast lump\n(unexplained) Refer people using a suspected cancer pathway referral\nBreast\nwith or without [1.4.1]\npain, 30 and over"
  },
  {
    "element_id": "page_45",
    "page_number": 45,
    "element_type": "table",
    "markdown": "Table 1 on Page 45\n\n| Symptom and specific features                    | Possible cancer   | Recommendation    |\n|:-------------------------------------------------|:------------------|:------------------|\n| Vaginal discharge (unexplained) either at first  | Endometrial       | Consider a direct |\n| presentation or with thrombocytosis or with      |                   | access ultrasound |\n| haematuria, in women 55 and over                 |                   | scan [1.5.12]     |\n| Vaginal mass (unexplained and palpable) in or at | Vaginal           | Consider a        |\n| the entrance to the vagina                       |                   | suspected cancer  |\n|                                                  |                   | pathway referral  |\n|                                                  |                   | [1.5.15]          |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nVaginal discharge (unexplained) either at first\npresentation or with thrombocytosis or with\nhaematuria, in women 55 and over\tEndometrial\tConsider a direct\naccess ultrasound\nscan [1.5.12]\nVaginal mass (unexplained and palpable) in or at\nthe entrance to the vagina\tVaginal\tConsider a\nsuspected cancer\npathway referral\n[1.5.15]"
  },
  {
    "element_id": "page_45",
    "page_number": 45,
    "element_type": "table",
    "markdown": "Table 2 on Page 45\n\n| Symptom and specific features   | Possible   | Recommendation                      |\n|                                 | cancer     |                                     |\n|:--------------------------------|:-----------|:------------------------------------|\n| Vulval bleeding (unexplained)   | Vulval     | Consider a suspected cancer pathway |\n|                                 |            | referral [1.5.14]                   |\n| Vulval lump or ulceration       | Vulval     | Consider a suspected cancer pathway |\n| (unexplained)                   |            | referral [1.5.14]                   |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nVulval bleeding (unexplained)\tVulval\tConsider a suspected cancer pathway\nreferral [1.5.14]\nVulval lump or ulceration\n(unexplained)\tVulval\tConsider a suspected cancer pathway\nreferral [1.5.14]"
  },
  {
    "element_id": "page_45",
    "page_number": 45,
    "element_type": "table",
    "markdown": "Table 3 on Page 45\n\n| Symptom and specific   | Possible   | Recommendation                                         |\n| features               | cancer     |                                                        |\n|:-----------------------|:-----------|:-------------------------------------------------------|\n| Anal mass              | Anal       | Consider a suspected cancer pathway referral 1.3.6]    |\n| (unexplained)          |            |                                                        |\n| Axillary lump          | Breast     | Consider a suspected cancer pathway referral [1.4.2]   |\n| (unexplained),         |            |                                                        |\n| 30 and over            |            |                                                        |\n| Breast lump            | Breast     | Refer people using a suspected cancer pathway referral |\n| (unexplained)          |            | [1.4.1]                                                |\n| with or without        |            |                                                        |\n| pain, 30 and over      |            |                                                        |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nAnal mass\n(unexplained)\tAnal\tConsider a suspected cancer pathway referral 1.3.6]\nAxillary lump\n(unexplained),\n30 and over\tBreast\tConsider a suspected cancer pathway referral [1.4.2]\nBreast lump\n(unexplained)\nwith or without\npain, 30 and over\tBreast\tRefer people using a suspected cancer pathway referral\n[1.4.1]"
  },
  {
    "element_id": "page_46_seq_0",
    "page_number": 46,
    "element_type": "text",
    "markdown": "Symptom and specific Possible\nRecommendation\nfeatures cancer\nBreast lump\nConsider non-urgent referral\n(unexplained)\nBreast See also recommendations 1.16.2 and 1.16.3 for\nwith or without\ninformation about seeking specialist advice [1.4.3]\npain, under 30\nConsider an urgent referral (for an appointment within\n2 weeks) for assessment by a dentist [1.8.3]\nLip or oral Consider a suspected cancer pathway referral by the\nOral\ncavitylump dentist in people when assessed by a dentist as having a\nlump on the lip or in the oral cavity consistent with oral\ncancer [1.8.4]\nConsider an urgent, direct access ultrasound scan (to be\ndone within 2 weeks) [1.11.4]\nLump\nSoft Separate recommendations have been made for adults\n(unexplained)\ntissue and for children and young people to reflect that there\nthat is increasing\nsarcoma are different referral pathways. In practice young people\nin size in adults\n(aged 16 to 24) may be referred using either pathway\ndepending on their age and local arrangements\nNeck lump\n(unexplained), Laryngeal Consider a suspected cancer pathway referral [1.8.1]\n45 and over\nNeck lump\n(persistent and Oral Consider a suspected cancer pathway referral [1.8.2]\nunexplained)\nPenile mass (and\nsexually\ntransmitted\nPenile Consider a suspected cancer pathway referral [1.6.9]\ninfection has\nbeen excluded as\na cause) in men\nThyroid lump\nThyroid Consider a suspected cancer pathway referral [1.8.5]\n(unexplained)",
    "raw_text": "Symptom and specific Possible\nRecommendation\nfeatures cancer\nBreast lump\nConsider non-urgent referral\n(unexplained)\nBreast See also recommendations 1.16.2 and 1.16.3 for\nwith or without\ninformation about seeking specialist advice [1.4.3]\npain, under 30\nConsider an urgent referral (for an appointment within\n2 weeks) for assessment by a dentist [1.8.3]\nLip or oral Consider a suspected cancer pathway referral by the\nOral\ncavitylump dentist in people when assessed by a dentist as having a\nlump on the lip or in the oral cavity consistent with oral\ncancer [1.8.4]\nConsider an urgent, direct access ultrasound scan (to be\ndone within 2 weeks) [1.11.4]\nLump\nSoft Separate recommendations have been made for adults\n(unexplained)\ntissue and for children and young people to reflect that there\nthat is increasing\nsarcoma are different referral pathways. In practice young people\nin size in adults\n(aged 16 to 24) may be referred using either pathway\ndepending on their age and local arrangements\nNeck lump\n(unexplained), Laryngeal Consider a suspected cancer pathway referral [1.8.1]\n45 and over\nNeck lump\n(persistent and Oral Consider a suspected cancer pathway referral [1.8.2]\nunexplained)\nPenile mass (and\nsexually\ntransmitted\nPenile Consider a suspected cancer pathway referral [1.6.9]\ninfection has\nbeen excluded as\na cause) in men\nThyroid lump\nThyroid Consider a suspected cancer pathway referral [1.8.5]\n(unexplained)"
  },
  {
    "element_id": "page_46",
    "page_number": 46,
    "element_type": "table",
    "markdown": "Table 1 on Page 46\n\n| Symptom and specific   | Possible   | Recommendation                                             |\n| features               | cancer     |                                                            |\n|:-----------------------|:-----------|:-----------------------------------------------------------|\n| Breast lump            | Breast     | Consider non-urgent referral                               |\n| (unexplained)          |            | See also recommendations 1.16.2 and 1.16.3 for             |\n| with or without        |            | information about seeking specialist advice [1.4.3]        |\n| pain, under 30         |            |                                                            |\n| Lip or oral            | Oral       | Consider an urgent referral (for an appointment within     |\n| cavitylump             |            | 2 weeks) for assessment by a dentist [1.8.3]               |\n|                        |            | Consider a suspected cancer pathway referral by the        |\n|                        |            | dentist in people when assessed by a dentist as having a   |\n|                        |            | lump on the lip or in the oral cavity consistent with oral |\n|                        |            | cancer [1.8.4]                                             |\n| Lump                   | Soft       | Consider an urgent, direct access ultrasound scan (to be   |\n| (unexplained)          | tissue     | done within 2 weeks) [1.11.4]                              |\n| that is increasing     | sarcoma    | Separate recommendations have been made for adults         |\n| in size in adults      |            | and for children and young people to reflect that there    |\n|                        |            | are different referral pathways. In practice young people  |\n|                        |            | (aged 16 to 24) may be referred using either pathway       |\n|                        |            | depending on their age and local arrangements              |\n| Neck lump              | Laryngeal  | Consider a suspected cancer pathway referral [1.8.1]       |\n| (unexplained),         |            |                                                            |\n| 45 and over            |            |                                                            |\n| Neck lump              | Oral       | Consider a suspected cancer pathway referral [1.8.2]       |\n| (persistent and        |            |                                                            |\n| unexplained)           |            |                                                            |\n| Penile mass (and       | Penile     | Consider a suspected cancer pathway referral [1.6.9]       |\n| sexually               |            |                                                            |\n| transmitted            |            |                                                            |\n| infection has          |            |                                                            |\n| been excluded as       |            |                                                            |\n| a cause) in men        |            |                                                            |\n| Thyroid lump           | Thyroid    | Consider a suspected cancer pathway referral [1.8.5]       |\n| (unexplained)          |            |                                                            |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nBreast lump\n(unexplained)\nwith or without\npain, under 30\tBreast\tConsider non-urgent referral\nSee also recommendations 1.16.2 and 1.16.3 for\ninformation about seeking specialist advice [1.4.3]\nLip or oral\ncavitylump\tOral\tConsider an urgent referral (for an appointment within\n2 weeks) for assessment by a dentist [1.8.3]\nConsider a suspected cancer pathway referral by the\ndentist in people when assessed by a dentist as having a\nlump on the lip or in the oral cavity consistent with oral\ncancer [1.8.4]\nLump\n(unexplained)\nthat is increasing\nin size in adults\tSoft\ntissue\nsarcoma\tConsider an urgent, direct access ultrasound scan (to be\ndone within 2 weeks) [1.11.4]\nSeparate recommendations have been made for adults\nand for children and young people to reflect that there\nare different referral pathways. In practice young people\n(aged 16 to 24) may be referred using either pathway\ndepending on their age and local arrangements\nNeck lump\n(unexplained),\n45 and over\tLaryngeal\tConsider a suspected cancer pathway referral [1.8.1]\nNeck lump\n(persistent and\nunexplained)\tOral\tConsider a suspected cancer pathway referral [1.8.2]\nPenile mass (and\nsexually\ntransmitted\ninfection has\nbeen excluded as\na cause) in men\tPenile\tConsider a suspected cancer pathway referral [1.6.9]\nThyroid lump\n(unexplained)\tThyroid\tConsider a suspected cancer pathway referral [1.8.5]"
  },
  {
    "element_id": "page_47_seq_0",
    "page_number": 47,
    "element_type": "text",
    "markdown": "Symptom and specific Possible\nRecommendation\nfeatures cancer\nVaginal mass\n(unexplained and\npalpable) in or at\nVaginal Consider a suspected cancer pathway referral [1.5.15]\nthe entrance to\nthe vagina in\nwomen\nVulval lump\n(unexplained) in Vulval Consider a suspected cancer pathway referral [1.5.14]\nwomen\nSee also the section on abdominal symptoms for abdominal, anal, pelvic and rectal lumps\nor masses.\nLymphadenopathy\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral\nWhen considering referral for Hodgkin's\nlymphoma, take into account any associated\nsymptoms, particularly fever, night sweats,\nshortness of breath, pruritus, weight loss or\nalcohol-induced lymph node pain [1.10.8]\nNon-Hodgkin's When considering referral for non-Hodgkin's\nLymphadenopathy\nlymphoma or lymphoma, take into account any associated\n(unexplained) in\nHodgkin's symptoms, particularly fever, night sweats,\nadults\nlymphoma shortness of breath, pruritus or weight loss [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Symptom and specific Possible\nRecommendation\nfeatures cancer\nVaginal mass\n(unexplained and\npalpable) in or at\nVaginal Consider a suspected cancer pathway referral [1.5.15]\nthe entrance to\nthe vagina in\nwomen\nVulval lump\n(unexplained) in Vulval Consider a suspected cancer pathway referral [1.5.14]\nwomen\nSee also the section on abdominal symptoms for abdominal, anal, pelvic and rectal lumps\nor masses.\nLymphadenopathy\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral\nWhen considering referral for Hodgkin's\nlymphoma, take into account any associated\nsymptoms, particularly fever, night sweats,\nshortness of breath, pruritus, weight loss or\nalcohol-induced lymph node pain [1.10.8]\nNon-Hodgkin's When considering referral for non-Hodgkin's\nLymphadenopathy\nlymphoma or lymphoma, take into account any associated\n(unexplained) in\nHodgkin's symptoms, particularly fever, night sweats,\nadults\nlymphoma shortness of breath, pruritus or weight loss [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_47",
    "page_number": 47,
    "element_type": "table",
    "markdown": "Table 1 on Page 47\n\n| Symptom and specific   | Possible   | Recommendation                                        |\n| features               | cancer     |                                                       |\n|:-----------------------|:-----------|:------------------------------------------------------|\n| Vaginal mass           | Vaginal    | Consider a suspected cancer pathway referral [1.5.15] |\n| (unexplained and       |            |                                                       |\n| palpable) in or at     |            |                                                       |\n| the entrance to        |            |                                                       |\n| the vagina in          |            |                                                       |\n| women                  |            |                                                       |\n| Vulval lump            | Vulval     | Consider a suspected cancer pathway referral [1.5.14] |\n| (unexplained) in       |            |                                                       |\n| women                  |            |                                                       |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nVaginal mass\n(unexplained and\npalpable) in or at\nthe entrance to\nthe vagina in\nwomen\tVaginal\tConsider a suspected cancer pathway referral [1.5.15]\nVulval lump\n(unexplained) in\nwomen\tVulval\tConsider a suspected cancer pathway referral [1.5.14]"
  },
  {
    "element_id": "page_47",
    "page_number": 47,
    "element_type": "table",
    "markdown": "Table 2 on Page 47\n\n| Symptom and specific   | Possible cancer   | Recommendation                                        |\n| features               |                   |                                                       |\n|:-----------------------|:------------------|:------------------------------------------------------|\n| Lymphadenopathy        | Non-Hodgkin's     | Consider a suspected cancer pathway referral          |\n| (unexplained) in       | lymphoma or       | When considering referral for Hodgkin's               |\n| adults                 | Hodgkin's         | lymphoma, take into account any associated            |\n|                        | lymphoma          | symptoms, particularly fever, night sweats,           |\n|                        |                   | shortness of breath, pruritus, weight loss or         |\n|                        |                   | alcohol-induced lymph node pain [1.10.8]              |\n|                        |                   | When considering referral for non-Hodgkin's           |\n|                        |                   | lymphoma, take into account any associated            |\n|                        |                   | symptoms, particularly fever, night sweats,           |\n|                        |                   | shortness of breath, pruritus or weight loss [1.10.6] |\n|                        |                   | Separate recommendations have been made for           |\n|                        |                   | adults and for children and young people to reflect   |\n|                        |                   | that there are different referral pathways. In        |\n|                        |                   | practice young people (aged 16 to 24) may be          |\n|                        |                   | referred using either pathway depending on their      |\n|                        |                   | age and local arrangements                            |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nLymphadenopathy\n(unexplained) in\nadults\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a suspected cancer pathway referral\nWhen considering referral for Hodgkin's\nlymphoma, take into account any associated\nsymptoms, particularly fever, night sweats,\nshortness of breath, pruritus, weight loss or\nalcohol-induced lymph node pain [1.10.8]\nWhen considering referral for non-Hodgkin's\nlymphoma, take into account any associated\nsymptoms, particularly fever, night sweats,\nshortness of breath, pruritus or weight loss [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_48_seq_0",
    "page_number": 48,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nLymphadenopathy\n(supraclavicular or\nConsider an urgent chest X-ray (to be done within\npersistent Lung\n2 weeks) [1.1.3]\ncervical), 40 and\nover\nLymphadenopathy\nConsider a very urgent full blood count (within\n(generalised) in Leukaemia\n48 hours) [1.10.1]\nadults\nOral lesions\nPossible\nSymptom and specific features Recommendation\ncancer\nUlceration in the oral\ncavity (unexplained\nOral Consider a suspected cancer pathway referral [1.8.2]\nand lasting for more\nthan 3 weeks)\nConsider an urgent referral (for an appointment within\n2 weeks) for assessment by a dentist [1.8.3]\nConsider a suspected cancer pathway referral by the\nLip or oral cavity lump Oral\ndentist in people when assessed by a dentist as having\na lump on the lip or in the oral cavity consistent with\noral cancer [1.8.4]\nNeurological symptoms in adults\nNeurological symptoms in adults\nSymptom and specific features Possible cancer Recommendation\nLoss of central Brain or\nConsider an urgent, direct access MRI scan of\nneurological function central\nthe brain (or CT scan if MRI is contraindicated;\n(progressive, sub-acute) nervous\nto be done within 2 weeks) [1.9.1]\nin adults system",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nLymphadenopathy\n(supraclavicular or\nConsider an urgent chest X-ray (to be done within\npersistent Lung\n2 weeks) [1.1.3]\ncervical), 40 and\nover\nLymphadenopathy\nConsider a very urgent full blood count (within\n(generalised) in Leukaemia\n48 hours) [1.10.1]\nadults\nOral lesions\nPossible\nSymptom and specific features Recommendation\ncancer\nUlceration in the oral\ncavity (unexplained\nOral Consider a suspected cancer pathway referral [1.8.2]\nand lasting for more\nthan 3 weeks)\nConsider an urgent referral (for an appointment within\n2 weeks) for assessment by a dentist [1.8.3]\nConsider a suspected cancer pathway referral by the\nLip or oral cavity lump Oral\ndentist in people when assessed by a dentist as having\na lump on the lip or in the oral cavity consistent with\noral cancer [1.8.4]\nNeurological symptoms in adults\nNeurological symptoms in adults\nSymptom and specific features Possible cancer Recommendation\nLoss of central Brain or\nConsider an urgent, direct access MRI scan of\nneurological function central\nthe brain (or CT scan if MRI is contraindicated;\n(progressive, sub-acute) nervous\nto be done within 2 weeks) [1.9.1]\nin adults system"
  },
  {
    "element_id": "page_48",
    "page_number": 48,
    "element_type": "table",
    "markdown": "Table 1 on Page 48\n\n| Symptom and specific   | Possible cancer   | Recommendation                                    |\n| features               |                   |                                                   |\n|:-----------------------|:------------------|:--------------------------------------------------|\n| Lymphadenopathy        | Lung              | Consider an urgent chest X-ray (to be done within |\n| (supraclavicular or    |                   | 2 weeks) [1.1.3]                                  |\n| persistent             |                   |                                                   |\n| cervical), 40 and      |                   |                                                   |\n| over                   |                   |                                                   |\n| Lymphadenopathy        | Leukaemia         | Consider a very urgent full blood count (within   |\n| (generalised) in       |                   | 48 hours) [1.10.1]                                |\n| adults                 |                   |                                                   |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nLymphadenopathy\n(supraclavicular or\npersistent\ncervical), 40 and\nover\tLung\tConsider an urgent chest X-ray (to be done within\n2 weeks) [1.1.3]\nLymphadenopathy\n(generalised) in\nadults\tLeukaemia\tConsider a very urgent full blood count (within\n48 hours) [1.10.1]"
  },
  {
    "element_id": "page_48",
    "page_number": 48,
    "element_type": "table",
    "markdown": "Table 2 on Page 48\n\n| Symptom and specific features   | Possible   | Recommendation                                          |\n|                                 | cancer     |                                                         |\n|:--------------------------------|:-----------|:--------------------------------------------------------|\n| Ulceration in the oral          | Oral       | Consider a suspected cancer pathway referral [1.8.2]    |\n| cavity (unexplained             |            |                                                         |\n| and lasting for more            |            |                                                         |\n| than 3 weeks)                   |            |                                                         |\n| Lip or oral cavity lump         | Oral       | Consider an urgent referral (for an appointment within  |\n|                                 |            | 2 weeks) for assessment by a dentist [1.8.3]            |\n|                                 |            | Consider a suspected cancer pathway referral by the     |\n|                                 |            | dentist in people when assessed by a dentist as having  |\n|                                 |            | a lump on the lip or in the oral cavity consistent with |\n|                                 |            | oral cancer [1.8.4]                                     |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nUlceration in the oral\ncavity (unexplained\nand lasting for more\nthan 3 weeks)\tOral\tConsider a suspected cancer pathway referral [1.8.2]\nLip or oral cavity lump\tOral\tConsider an urgent referral (for an appointment within\n2 weeks) for assessment by a dentist [1.8.3]\nConsider a suspected cancer pathway referral by the\ndentist in people when assessed by a dentist as having\na lump on the lip or in the oral cavity consistent with\noral cancer [1.8.4]"
  },
  {
    "element_id": "page_48",
    "page_number": 48,
    "element_type": "table",
    "markdown": "Table 3 on Page 48\n\n| Symptom and specific features   | Possible cancer   | Recommendation                                   |\n|:--------------------------------|:------------------|:-------------------------------------------------|\n| Loss of central                 | Brain or          | Consider an urgent, direct access MRI scan of    |\n| neurological function           | central           | the brain (or CT scan if MRI is contraindicated; |\n| (progressive, sub-acute)        | nervous           | to be done within 2 weeks) [1.9.1]               |\n| in adults                       | system            |                                                  |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nLoss of central\nneurological function\n(progressive, sub-acute)\nin adults\tBrain or\ncentral\nnervous\nsystem\tConsider an urgent, direct access MRI scan of\nthe brain (or CT scan if MRI is contraindicated;\nto be done within 2 weeks) [1.9.1]"
  },
  {
    "element_id": "page_49_seq_0",
    "page_number": 49,
    "element_type": "text",
    "markdown": "Pain\nSee also the section on abdominal symptoms for abdominal or pelvic pain.\nPain\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nAlcohol-induced associated symptoms [1.10.8]\nlymph node pain with Separate recommendations have been made for\nHodgkin's\nunexplained adults and for children and young people to\nlymphoma\nlymphadenopathy in reflect that there are different referral pathways.\nadults In practice young people (aged 16 to 24) may be\nreferred using either pathway depending on\ntheir age and local arrangements\nConsider an urgent, direct access CT scan (to\nBack pain with weight\nPancreatic be done within 2 weeks), or an urgent\nloss, 60 and over\nultrasound scan if CT is not available [1.2.5]\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte\nsedimentation rate\nBack pain\n\u2022 paraprotein, using serum protein\n(persistent), 60 and Myeloma\nelectrophoresis\nover\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available,\nuse a Bence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations\nfor more information on tests for myeloma",
    "raw_text": "Pain\nSee also the section on abdominal symptoms for abdominal or pelvic pain.\nPain\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nAlcohol-induced associated symptoms [1.10.8]\nlymph node pain with Separate recommendations have been made for\nHodgkin's\nunexplained adults and for children and young people to\nlymphoma\nlymphadenopathy in reflect that there are different referral pathways.\nadults In practice young people (aged 16 to 24) may be\nreferred using either pathway depending on\ntheir age and local arrangements\nConsider an urgent, direct access CT scan (to\nBack pain with weight\nPancreatic be done within 2 weeks), or an urgent\nloss, 60 and over\nultrasound scan if CT is not available [1.2.5]\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte\nsedimentation rate\nBack pain\n\u2022 paraprotein, using serum protein\n(persistent), 60 and Myeloma\nelectrophoresis\nover\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available,\nuse a Bence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations\nfor more information on tests for myeloma"
  },
  {
    "element_id": "page_49",
    "page_number": 49,
    "element_type": "table",
    "markdown": "Table 1 on Page 49\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Alcohol-induced        | Hodgkin's         | Consider a suspected cancer pathway referral.       |\n| lymph node pain with   | lymphoma          | When considering referral, take into account any    |\n| unexplained            |                   | associated symptoms [1.10.8]                        |\n| lymphadenopathy in     |                   | Separate recommendations have been made for         |\n| adults                 |                   | adults and for children and young people to         |\n|                        |                   | reflect that there are different referral pathways. |\n|                        |                   | In practice young people (aged 16 to 24) may be     |\n|                        |                   | referred using either pathway depending on          |\n|                        |                   | their age and local arrangements                    |\n| Back pain with weight  | Pancreatic        | Consider an urgent, direct access CT scan (to       |\n| loss, 60 and over      |                   | be done within 2 weeks), or an urgent               |\n|                        |                   | ultrasound scan if CT is not available [1.2.5]      |\n| Back pain              | Myeloma           | Offer a full blood count and blood tests for:       |\n| (persistent), 60 and   |                   | \u2022 calcium                                           |\n| over                   |                   | \u2022 plasma viscosity or erythrocyte                   |\n|                        |                   | sedimentation rate                                  |\n|                        |                   | \u2022 paraprotein, using serum protein                  |\n|                        |                   | electrophoresis                                     |\n|                        |                   | \u2022 free light chains contained in serum.             |\n|                        |                   | If serum free light chain testing is not available, |\n|                        |                   | use a Bence\u2013Jones protein urine test. [1.10.4]      |\n|                        |                   | See the section on primary care investigations      |\n|                        |                   | for more information on tests for myeloma           |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nAlcohol-induced\nlymph node pain with\nunexplained\nlymphadenopathy in\nadults\tHodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nSeparate recommendations have been made for\nadults and for children and young people to\nreflect that there are different referral pathways.\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on\ntheir age and local arrangements\nBack pain with weight\nloss, 60 and over\tPancreatic\tConsider an urgent, direct access CT scan (to\nbe done within 2 weeks), or an urgent\nultrasound scan if CT is not available [1.2.5]\nBack pain\n(persistent), 60 and\nover\tMyeloma\tOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte\nsedimentation rate\n\u2022 paraprotein, using serum protein\nelectrophoresis\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available,\nuse a Bence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations\nfor more information on tests for myeloma"
  },
  {
    "element_id": "page_50_seq_0",
    "page_number": 50,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte\nsedimentation rate\nBone pain\n\u2022 paraprotein, using serum protein\n(persistent), 60 and Myeloma\nelectrophoresis\nover\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available,\nuse a Bence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations\nfor more information on tests for myeloma\nChest pain\nLung or Offer an urgent chest X-ray (to be done within\n(unexplained), 40 and\nmesothelioma 2 weeks) [1.1.2] [1.1.5]\nover, ever smoked\nChest pain\n(unexplained), 40 and Offer an urgent chest X-ray (to be done within\nMesothelioma\nover, exposed to 2 weeks) [1.1.5]\nasbestos\nChest pain\n(unexplained) with\ncough or fatigue or\nshortness of breath or Lung or Offer an urgent chest X-ray (to be done within\nweight loss or mesothelioma 2 weeks) [1.1.2] [1.1.5]\nappetite loss\n(unexplained), 40 and\nover",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte\nsedimentation rate\nBone pain\n\u2022 paraprotein, using serum protein\n(persistent), 60 and Myeloma\nelectrophoresis\nover\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available,\nuse a Bence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations\nfor more information on tests for myeloma\nChest pain\nLung or Offer an urgent chest X-ray (to be done within\n(unexplained), 40 and\nmesothelioma 2 weeks) [1.1.2] [1.1.5]\nover, ever smoked\nChest pain\n(unexplained), 40 and Offer an urgent chest X-ray (to be done within\nMesothelioma\nover, exposed to 2 weeks) [1.1.5]\nasbestos\nChest pain\n(unexplained) with\ncough or fatigue or\nshortness of breath or Lung or Offer an urgent chest X-ray (to be done within\nweight loss or mesothelioma 2 weeks) [1.1.2] [1.1.5]\nappetite loss\n(unexplained), 40 and\nover"
  },
  {
    "element_id": "page_50",
    "page_number": 50,
    "element_type": "table",
    "markdown": "Table 1 on Page 50\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Bone pain              | Myeloma           | Offer a full blood count and blood tests for:       |\n| (persistent), 60 and   |                   | \u2022 calcium                                           |\n| over                   |                   | \u2022 plasma viscosity or erythrocyte                   |\n|                        |                   | sedimentation rate                                  |\n|                        |                   | \u2022 paraprotein, using serum protein                  |\n|                        |                   | electrophoresis                                     |\n|                        |                   | \u2022 free light chains contained in serum.             |\n|                        |                   | If serum free light chain testing is not available, |\n|                        |                   | use a Bence\u2013Jones protein urine test. [1.10.4]      |\n|                        |                   | See the section on primary care investigations      |\n|                        |                   | for more information on tests for myeloma           |\n| Chest pain             | Lung or           | Offer an urgent chest X-ray (to be done within      |\n| (unexplained), 40 and  | mesothelioma      | 2 weeks) [1.1.2] [1.1.5]                            |\n| over, ever smoked      |                   |                                                     |\n| Chest pain             | Mesothelioma      | Offer an urgent chest X-ray (to be done within      |\n| (unexplained), 40 and  |                   | 2 weeks) [1.1.5]                                    |\n| over, exposed to       |                   |                                                     |\n| asbestos               |                   |                                                     |\n| Chest pain             | Lung or           | Offer an urgent chest X-ray (to be done within      |\n| (unexplained) with     | mesothelioma      | 2 weeks) [1.1.2] [1.1.5]                            |\n| cough or fatigue or    |                   |                                                     |\n| shortness of breath or |                   |                                                     |\n| weight loss or         |                   |                                                     |\n| appetite loss          |                   |                                                     |\n| (unexplained), 40 and  |                   |                                                     |\n| over                   |                   |                                                     |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nBone pain\n(persistent), 60 and\nover\tMyeloma\tOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte\nsedimentation rate\n\u2022 paraprotein, using serum protein\nelectrophoresis\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available,\nuse a Bence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations\nfor more information on tests for myeloma\nChest pain\n(unexplained), 40 and\nover, ever smoked\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]\nChest pain\n(unexplained), 40 and\nover, exposed to\nasbestos\tMesothelioma\tOffer an urgent chest X-ray (to be done within\n2 weeks) [1.1.5]\nChest pain\n(unexplained) with\ncough or fatigue or\nshortness of breath or\nweight loss or\nappetite loss\n(unexplained), 40 and\nover\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]"
  },
  {
    "element_id": "page_51_seq_0",
    "page_number": 51,
    "element_type": "text",
    "markdown": "Respiratory symptoms\nChest infection\nPossible\nSymptom and specific features Recommendation\ncancer\nChest infection (persistent or Consider an urgent chest X-ray (to be\nLung\nrecurrent), 40 and over done within 2 weeks) [1.1.3]\nChest pain\nSymptom and specific features Possible cancer Recommendation\nOffer an urgent chest\nChest pain (unexplained), 40 and over, ever Lung or\nX-ray (to be done within\nsmoked mesothelioma\n2 weeks) [1.1.2] [1.1.5]\nOffer an urgent chest\nChest pain (unexplained), 40 and over,\nMesothelioma X-ray (to be done within\nexposed to asbestos\n2 weeks) [1.1.5]\nChest pain (unexplained) with cough or Offer an urgent chest\nLung or\nfatigue or shortness of breath or weight loss X-ray (to be done within\nmesothelioma\nor appetite loss (unexplained), 40 and over 2 weeks) [1.1.2] [1.1.5]\nCough\nSymptom and specific features Possible cancer Recommendation\nOffer an urgent chest\nCough (unexplained), 40 and over, ever Lung or\nX-ray (to be done within\nsmoked mesothelioma\n2 weeks) [1.1.2] [1.1.5]\nOffer an urgent chest\nCough (unexplained), 40 and over, exposed to\nMesothelioma X-ray (to be done within\nasbestos\n2 weeks) [1.1.5]\nCough (unexplained) with fatigue or shortness Offer an urgent chest\nLung or\nof breath or chest pain or weight loss or X-ray (to be done within\nmesothelioma\nappetite loss (unexplained), 40 and over 2 weeks) [1.1.2] [1.1.5]",
    "raw_text": "Respiratory symptoms\nChest infection\nPossible\nSymptom and specific features Recommendation\ncancer\nChest infection (persistent or Consider an urgent chest X-ray (to be\nLung\nrecurrent), 40 and over done within 2 weeks) [1.1.3]\nChest pain\nSymptom and specific features Possible cancer Recommendation\nOffer an urgent chest\nChest pain (unexplained), 40 and over, ever Lung or\nX-ray (to be done within\nsmoked mesothelioma\n2 weeks) [1.1.2] [1.1.5]\nOffer an urgent chest\nChest pain (unexplained), 40 and over,\nMesothelioma X-ray (to be done within\nexposed to asbestos\n2 weeks) [1.1.5]\nChest pain (unexplained) with cough or Offer an urgent chest\nLung or\nfatigue or shortness of breath or weight loss X-ray (to be done within\nmesothelioma\nor appetite loss (unexplained), 40 and over 2 weeks) [1.1.2] [1.1.5]\nCough\nSymptom and specific features Possible cancer Recommendation\nOffer an urgent chest\nCough (unexplained), 40 and over, ever Lung or\nX-ray (to be done within\nsmoked mesothelioma\n2 weeks) [1.1.2] [1.1.5]\nOffer an urgent chest\nCough (unexplained), 40 and over, exposed to\nMesothelioma X-ray (to be done within\nasbestos\n2 weeks) [1.1.5]\nCough (unexplained) with fatigue or shortness Offer an urgent chest\nLung or\nof breath or chest pain or weight loss or X-ray (to be done within\nmesothelioma\nappetite loss (unexplained), 40 and over 2 weeks) [1.1.2] [1.1.5]"
  },
  {
    "element_id": "page_51",
    "page_number": 51,
    "element_type": "table",
    "markdown": "Table 1 on Page 51\n\n| Symptom and specific features   | Possible   | Recommendation                        |\n|                                 | cancer     |                                       |\n|:--------------------------------|:-----------|:--------------------------------------|\n| Chest infection (persistent or  | Lung       | Consider an urgent chest X-ray (to be |\n| recurrent), 40 and over         |            | done within 2 weeks) [1.1.3]          |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nChest infection (persistent or\nrecurrent), 40 and over\tLung\tConsider an urgent chest X-ray (to be\ndone within 2 weeks) [1.1.3]"
  },
  {
    "element_id": "page_51",
    "page_number": 51,
    "element_type": "table",
    "markdown": "Table 2 on Page 51\n\n| Symptom and specific features                 | Possible cancer   | Recommendation           |\n|:----------------------------------------------|:------------------|:-------------------------|\n| Chest pain (unexplained), 40 and over, ever   | Lung or           | Offer an urgent chest    |\n| smoked                                        | mesothelioma      | X-ray (to be done within |\n|                                               |                   | 2 weeks) [1.1.2] [1.1.5] |\n| Chest pain (unexplained), 40 and over,        | Mesothelioma      | Offer an urgent chest    |\n| exposed to asbestos                           |                   | X-ray (to be done within |\n|                                               |                   | 2 weeks) [1.1.5]         |\n| Chest pain (unexplained) with cough or        | Lung or           | Offer an urgent chest    |\n| fatigue or shortness of breath or weight loss | mesothelioma      | X-ray (to be done within |\n| or appetite loss (unexplained), 40 and over   |                   | 2 weeks) [1.1.2] [1.1.5] |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nChest pain (unexplained), 40 and over, ever\nsmoked\tLung or\nmesothelioma\tOffer an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]\nChest pain (unexplained), 40 and over,\nexposed to asbestos\tMesothelioma\tOffer an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.5]\nChest pain (unexplained) with cough or\nfatigue or shortness of breath or weight loss\nor appetite loss (unexplained), 40 and over\tLung or\nmesothelioma\tOffer an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]"
  },
  {
    "element_id": "page_51",
    "page_number": 51,
    "element_type": "table",
    "markdown": "Table 3 on Page 51\n\n| Symptom and specific features                 | Possible cancer   | Recommendation           |\n|:----------------------------------------------|:------------------|:-------------------------|\n| Cough (unexplained), 40 and over, ever        | Lung or           | Offer an urgent chest    |\n| smoked                                        | mesothelioma      | X-ray (to be done within |\n|                                               |                   | 2 weeks) [1.1.2] [1.1.5] |\n| Cough (unexplained), 40 and over, exposed to  | Mesothelioma      | Offer an urgent chest    |\n| asbestos                                      |                   | X-ray (to be done within |\n|                                               |                   | 2 weeks) [1.1.5]         |\n| Cough (unexplained) with fatigue or shortness | Lung or           | Offer an urgent chest    |\n| of breath or chest pain or weight loss or     | mesothelioma      | X-ray (to be done within |\n| appetite loss (unexplained), 40 and over      |                   | 2 weeks) [1.1.2] [1.1.5] |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nCough (unexplained), 40 and over, ever\nsmoked\tLung or\nmesothelioma\tOffer an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]\nCough (unexplained), 40 and over, exposed to\nasbestos\tMesothelioma\tOffer an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.5]\nCough (unexplained) with fatigue or shortness\nof breath or chest pain or weight loss or\nappetite loss (unexplained), 40 and over\tLung or\nmesothelioma\tOffer an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]"
  },
  {
    "element_id": "page_52_seq_0",
    "page_number": 52,
    "element_type": "text",
    "markdown": "Hoarseness\nPossible\nSymptom and specific features Recommendation\ncancer\nHoarseness (persistent and Consider a suspected cancer\nLaryngeal\nunexplained), 45 and over pathway referral [1.8.1]\nRespiratory examination findings\nSymptom and signs Possible cancer Recommendation\nChest signsconsistent with Consider an urgent chest X-ray (to be\nLung\nlung cancer, 40 and over done within 2 weeks) [1.1.3]\nChest signs compatible with Consider an urgent chest X-ray (to be\nMesothelioma\npleural disease, 40 and over done within 2 weeks) [1.1.6]\nLung or Consider an urgent chest X-ray (to be\nFinger clubbing, 40 and over\nmesothelioma done within 2 weeks) [1.1.3] [1.1.6]\nShortness of breath\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nShortness of breath\n(unexplained), Lung or Offer an urgent chest X-ray (to be done within\n40 and over, ever mesothelioma 2 weeks) [1.1.2] [1.1.5]\nsmoked\nShortness of breath\n(unexplained),\nOffer an urgent chest X-ray (to be done within\n40 and over, and Mesothelioma\n2 weeks) [1.1.5]\nexposed to\nasbestos\nShortness of breath\nwith cough or\nfatigue or chest\nLung or Offer an urgent chest X-ray (to be done within\npain or weight loss\nmesothelioma 2 weeks) [1.1.2] [1.1.5]\nor appetite loss\n(unexplained),\n40 and over",
    "raw_text": "Hoarseness\nPossible\nSymptom and specific features Recommendation\ncancer\nHoarseness (persistent and Consider a suspected cancer\nLaryngeal\nunexplained), 45 and over pathway referral [1.8.1]\nRespiratory examination findings\nSymptom and signs Possible cancer Recommendation\nChest signsconsistent with Consider an urgent chest X-ray (to be\nLung\nlung cancer, 40 and over done within 2 weeks) [1.1.3]\nChest signs compatible with Consider an urgent chest X-ray (to be\nMesothelioma\npleural disease, 40 and over done within 2 weeks) [1.1.6]\nLung or Consider an urgent chest X-ray (to be\nFinger clubbing, 40 and over\nmesothelioma done within 2 weeks) [1.1.3] [1.1.6]\nShortness of breath\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nShortness of breath\n(unexplained), Lung or Offer an urgent chest X-ray (to be done within\n40 and over, ever mesothelioma 2 weeks) [1.1.2] [1.1.5]\nsmoked\nShortness of breath\n(unexplained),\nOffer an urgent chest X-ray (to be done within\n40 and over, and Mesothelioma\n2 weeks) [1.1.5]\nexposed to\nasbestos\nShortness of breath\nwith cough or\nfatigue or chest\nLung or Offer an urgent chest X-ray (to be done within\npain or weight loss\nmesothelioma 2 weeks) [1.1.2] [1.1.5]\nor appetite loss\n(unexplained),\n40 and over"
  },
  {
    "element_id": "page_52",
    "page_number": 52,
    "element_type": "table",
    "markdown": "Table 1 on Page 52\n\n| Symptom and specific features   | Possible   | Recommendation              |\n|                                 | cancer     |                             |\n|:--------------------------------|:-----------|:----------------------------|\n| Hoarseness (persistent and      | Laryngeal  | Consider a suspected cancer |\n| unexplained), 45 and over       |            | pathway referral [1.8.1]    |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nHoarseness (persistent and\nunexplained), 45 and over\tLaryngeal\tConsider a suspected cancer\npathway referral [1.8.1]"
  },
  {
    "element_id": "page_52",
    "page_number": 52,
    "element_type": "table",
    "markdown": "Table 2 on Page 52\n\n| Symptom and signs            | Possible cancer   | Recommendation                        |\n|:-----------------------------|:------------------|:--------------------------------------|\n| Chest signsconsistent with   | Lung              | Consider an urgent chest X-ray (to be |\n| lung cancer, 40 and over     |                   | done within 2 weeks) [1.1.3]          |\n| Chest signs compatible with  | Mesothelioma      | Consider an urgent chest X-ray (to be |\n| pleural disease, 40 and over |                   | done within 2 weeks) [1.1.6]          |\n| Finger clubbing, 40 and over | Lung or           | Consider an urgent chest X-ray (to be |\n|                              | mesothelioma      | done within 2 weeks) [1.1.3] [1.1.6]  |",
    "raw_text": "Symptom and signs\tPossible cancer\tRecommendation\nChest signsconsistent with\nlung cancer, 40 and over\tLung\tConsider an urgent chest X-ray (to be\ndone within 2 weeks) [1.1.3]\nChest signs compatible with\npleural disease, 40 and over\tMesothelioma\tConsider an urgent chest X-ray (to be\ndone within 2 weeks) [1.1.6]\nFinger clubbing, 40 and over\tLung or\nmesothelioma\tConsider an urgent chest X-ray (to be\ndone within 2 weeks) [1.1.3] [1.1.6]"
  },
  {
    "element_id": "page_52",
    "page_number": 52,
    "element_type": "table",
    "markdown": "Table 3 on Page 52\n\n| Symptom and specific   | Possible cancer   | Recommendation                                 |\n| features               |                   |                                                |\n|:-----------------------|:------------------|:-----------------------------------------------|\n| Shortness of breath    | Lung or           | Offer an urgent chest X-ray (to be done within |\n| (unexplained),         | mesothelioma      | 2 weeks) [1.1.2] [1.1.5]                       |\n| 40 and over, ever      |                   |                                                |\n| smoked                 |                   |                                                |\n| Shortness of breath    | Mesothelioma      | Offer an urgent chest X-ray (to be done within |\n| (unexplained),         |                   | 2 weeks) [1.1.5]                               |\n| 40 and over, and       |                   |                                                |\n| exposed to             |                   |                                                |\n| asbestos               |                   |                                                |\n| Shortness of breath    | Lung or           | Offer an urgent chest X-ray (to be done within |\n| with cough or          | mesothelioma      | 2 weeks) [1.1.2] [1.1.5]                       |\n| fatigue or chest       |                   |                                                |\n| pain or weight loss    |                   |                                                |\n| or appetite loss       |                   |                                                |\n| (unexplained),         |                   |                                                |\n| 40 and over            |                   |                                                |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nShortness of breath\n(unexplained),\n40 and over, ever\nsmoked\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]\nShortness of breath\n(unexplained),\n40 and over, and\nexposed to\nasbestos\tMesothelioma\tOffer an urgent chest X-ray (to be done within\n2 weeks) [1.1.5]\nShortness of breath\nwith cough or\nfatigue or chest\npain or weight loss\nor appetite loss\n(unexplained),\n40 and over\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to be done within\n2 weeks) [1.1.2] [1.1.5]"
  },
  {
    "element_id": "page_53_seq_0",
    "page_number": 53,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nShortness of breath Non-Hodgkin's\nSeparate recommendations have been made for\nwith unexplained lymphoma or\nadults and for children and young people to\nlymphadenopathy in Hodgkin's\nreflect that there are different referral pathways.\nadults lymphoma\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nShortness of breath\nSeparate recommendations have been made for\nwith unexplained Non-Hodgkin's\nadults and for children and young people to\nsplenomegaly in lymphoma\nreflect that there are different referral pathways.\nadults\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nSkeletal symptoms\nBack pain\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nBack pain with Consider an urgent, direct access CT scan (to be done\nweight loss, Pancreatic within 2 weeks), or an urgent ultrasound scan if CT is not\n60 and over available [1.2.5]",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nShortness of breath Non-Hodgkin's\nSeparate recommendations have been made for\nwith unexplained lymphoma or\nadults and for children and young people to\nlymphadenopathy in Hodgkin's\nreflect that there are different referral pathways.\nadults lymphoma\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nShortness of breath\nSeparate recommendations have been made for\nwith unexplained Non-Hodgkin's\nadults and for children and young people to\nsplenomegaly in lymphoma\nreflect that there are different referral pathways.\nadults\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nSkeletal symptoms\nBack pain\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nBack pain with Consider an urgent, direct access CT scan (to be done\nweight loss, Pancreatic within 2 weeks), or an urgent ultrasound scan if CT is not\n60 and over available [1.2.5]"
  },
  {
    "element_id": "page_53",
    "page_number": 53,
    "element_type": "table",
    "markdown": "Table 1 on Page 53\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Shortness of breath    | Non-Hodgkin's     | Consider a suspected cancer pathway referral.       |\n| with unexplained       | lymphoma or       | When considering referral, take into account any    |\n| lymphadenopathy in     | Hodgkin's         | associated symptoms [1.10.6]                        |\n| adults                 | lymphoma          | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to         |\n|                        |                   | reflect that there are different referral pathways. |\n|                        |                   | In practice young people (aged 16 to 24) may be     |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Shortness of breath    | Non-Hodgkin's     | Consider a suspected cancer pathway referral.       |\n| with unexplained       | lymphoma          | When considering referral, take into account any    |\n| splenomegaly in        |                   | associated symptoms [1.10.6]                        |\n| adults                 |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to         |\n|                        |                   | reflect that there are different referral pathways. |\n|                        |                   | In practice young people (aged 16 to 24) may be     |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nShortness of breath\nwith unexplained\nlymphadenopathy in\nadults\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to\nreflect that there are different referral pathways.\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nShortness of breath\nwith unexplained\nsplenomegaly in\nadults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to\nreflect that there are different referral pathways.\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_53",
    "page_number": 53,
    "element_type": "table",
    "markdown": "Table 2 on Page 53\n\n| Symptom and specific   | Possible   | Recommendation                                             |\n| features               | cancer     |                                                            |\n|:-----------------------|:-----------|:-----------------------------------------------------------|\n| Back pain with         | Pancreatic | Consider an urgent, direct access CT scan (to be done      |\n| weight loss,           |            | within 2 weeks), or an urgent ultrasound scan if CT is not |\n| 60 and over            |            | available [1.2.5]                                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nBack pain with\nweight loss,\n60 and over\tPancreatic\tConsider an urgent, direct access CT scan (to be done\nwithin 2 weeks), or an urgent ultrasound scan if CT is not\navailable [1.2.5]"
  },
  {
    "element_id": "page_54_seq_0",
    "page_number": 54,
    "element_type": "text",
    "markdown": "Symptom and specific Possible\nRecommendation\nfeatures cancer\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\nBack pain\n\u2022 paraprotein, using serum protein electrophoresis\n(persistent), Myeloma\n60 and over \u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for more\ninformation on tests for myeloma\nBone pain\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\nBone pain\n\u2022 paraprotein, using serum protein electrophoresis\n(persistent), 60 and Myeloma\nover \u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for\nmore information on tests for myeloma",
    "raw_text": "Symptom and specific Possible\nRecommendation\nfeatures cancer\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\nBack pain\n\u2022 paraprotein, using serum protein electrophoresis\n(persistent), Myeloma\n60 and over \u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for more\ninformation on tests for myeloma\nBone pain\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\nBone pain\n\u2022 paraprotein, using serum protein electrophoresis\n(persistent), 60 and Myeloma\nover \u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for\nmore information on tests for myeloma"
  },
  {
    "element_id": "page_54",
    "page_number": 54,
    "element_type": "table",
    "markdown": "Table 1 on Page 54\n\n| Symptom and specific   | Possible   | Recommendation                                            |\n| features               | cancer     |                                                           |\n|:-----------------------|:-----------|:----------------------------------------------------------|\n| Back pain              | Myeloma    | Offer a full blood count and blood tests for:             |\n| (persistent),          |            | \u2022 calcium                                                 |\n| 60 and over            |            | \u2022 plasma viscosity or erythrocyte sedimentation rate      |\n|                        |            | \u2022 paraprotein, using serum protein electrophoresis        |\n|                        |            | \u2022 free light chains contained in serum.                   |\n|                        |            | If serum free light chain testing is not available, use a |\n|                        |            | Bence\u2013Jones protein urine test. [1.10.4]                  |\n|                        |            | See the section on primary care investigations for more   |\n|                        |            | information on tests for myeloma                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nBack pain\n(persistent),\n60 and over\tMyeloma\tOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\n\u2022 paraprotein, using serum protein electrophoresis\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for more\ninformation on tests for myeloma"
  },
  {
    "element_id": "page_54",
    "page_number": 54,
    "element_type": "table",
    "markdown": "Table 2 on Page 54\n\n| Symptom and specific   | Possible   | Recommendation                                            |\n| features               | cancer     |                                                           |\n|:-----------------------|:-----------|:----------------------------------------------------------|\n| Bone pain              | Myeloma    | Offer a full blood count and blood tests for:             |\n| (persistent), 60 and   |            | \u2022 calcium                                                 |\n| over                   |            | \u2022 plasma viscosity or erythrocyte sedimentation rate      |\n|                        |            | \u2022 paraprotein, using serum protein electrophoresis        |\n|                        |            | \u2022 free light chains contained in serum.                   |\n|                        |            | If serum free light chain testing is not available, use a |\n|                        |            | Bence\u2013Jones protein urine test. [1.10.4]                  |\n|                        |            | See the section on primary care investigations for        |\n|                        |            | more information on tests for myeloma                     |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nBone pain\n(persistent), 60 and\nover\tMyeloma\tOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\n\u2022 paraprotein, using serum protein electrophoresis\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for\nmore information on tests for myeloma"
  },
  {
    "element_id": "page_55_seq_0",
    "page_number": 55,
    "element_type": "text",
    "markdown": "Fracture\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\nFracture\n\u2022 paraprotein, using serum protein electrophoresis\n(unexplained), Myeloma\n60 and over \u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for\nmore information on tests for myeloma\nSkin or surface symptoms\nSee also the section on lumps or masses for oral lesions.\nSkin or surface symptoms\nSymptoms and signs Possible cancer Recommendation\nAnal ulceration Consider a suspected cancer pathway\nAnal\n(unexplained) referral [1.3.6]\nBruising (unexplained) in Consider a very urgent full blood count\nLeukaemia\nadults (within 48 hours) [1.10.1]\nNipple changes of\nconcern (in one nipple\nRefer people using a suspected cancer\nonly) including discharge Breast\npathway referral [1.4.1]\nand retraction, 50 and\nover",
    "raw_text": "Fracture\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\nFracture\n\u2022 paraprotein, using serum protein electrophoresis\n(unexplained), Myeloma\n60 and over \u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for\nmore information on tests for myeloma\nSkin or surface symptoms\nSee also the section on lumps or masses for oral lesions.\nSkin or surface symptoms\nSymptoms and signs Possible cancer Recommendation\nAnal ulceration Consider a suspected cancer pathway\nAnal\n(unexplained) referral [1.3.6]\nBruising (unexplained) in Consider a very urgent full blood count\nLeukaemia\nadults (within 48 hours) [1.10.1]\nNipple changes of\nconcern (in one nipple\nRefer people using a suspected cancer\nonly) including discharge Breast\npathway referral [1.4.1]\nand retraction, 50 and\nover"
  },
  {
    "element_id": "page_55",
    "page_number": 55,
    "element_type": "table",
    "markdown": "Table 1 on Page 55\n\n| Symptom and specific   | Possible   | Recommendation                                            |\n| features               | cancer     |                                                           |\n|:-----------------------|:-----------|:----------------------------------------------------------|\n| Fracture               | Myeloma    | Offer a full blood count and blood tests for:             |\n| (unexplained),         |            | \u2022 calcium                                                 |\n| 60 and over            |            | \u2022 plasma viscosity or erythrocyte sedimentation rate      |\n|                        |            | \u2022 paraprotein, using serum protein electrophoresis        |\n|                        |            | \u2022 free light chains contained in serum.                   |\n|                        |            | If serum free light chain testing is not available, use a |\n|                        |            | Bence\u2013Jones protein urine test. [1.10.4]                  |\n|                        |            | See the section on primary care investigations for        |\n|                        |            | more information on tests for myeloma                     |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nFracture\n(unexplained),\n60 and over\tMyeloma\tOffer a full blood count and blood tests for:\n\u2022 calcium\n\u2022 plasma viscosity or erythrocyte sedimentation rate\n\u2022 paraprotein, using serum protein electrophoresis\n\u2022 free light chains contained in serum.\nIf serum free light chain testing is not available, use a\nBence\u2013Jones protein urine test. [1.10.4]\nSee the section on primary care investigations for\nmore information on tests for myeloma"
  },
  {
    "element_id": "page_55",
    "page_number": 55,
    "element_type": "table",
    "markdown": "Table 2 on Page 55\n\n| Symptoms and signs        | Possible cancer   | Recommendation                          |\n|:--------------------------|:------------------|:----------------------------------------|\n| Anal ulceration           | Anal              | Consider a suspected cancer pathway     |\n| (unexplained)             |                   | referral [1.3.6]                        |\n| Bruising (unexplained) in | Leukaemia         | Consider a very urgent full blood count |\n| adults                    |                   | (within 48 hours) [1.10.1]              |\n| Nipple changes of         | Breast            | Refer people using a suspected cancer   |\n| concern (in one nipple    |                   | pathway referral [1.4.1]                |\n| only) including discharge |                   |                                         |\n| and retraction, 50 and    |                   |                                         |\n| over                      |                   |                                         |",
    "raw_text": "Symptoms and signs\tPossible cancer\tRecommendation\nAnal ulceration\n(unexplained)\tAnal\tConsider a suspected cancer pathway\nreferral [1.3.6]\nBruising (unexplained) in\nadults\tLeukaemia\tConsider a very urgent full blood count\n(within 48 hours) [1.10.1]\nNipple changes of\nconcern (in one nipple\nonly) including discharge\nand retraction, 50 and\nover\tBreast\tRefer people using a suspected cancer\npathway referral [1.4.1]"
  },
  {
    "element_id": "page_56_seq_0",
    "page_number": 56,
    "element_type": "text",
    "markdown": "Symptoms and signs Possible cancer Recommendation\nConsider urgent referral (for an\nappointment within 2 weeks) for\nassessment by a dentist [1.8.3]\nOral cavity red or red and\nConsider a suspected cancer pathway\nwhite patchconsistent\nOral referral by the dentist for people when\nwith erythroplakia or\nassessed by a dentist as having a red or\nerythroleukoplakia\nred and white patch in the oral cavity\nconsistent with erythroplakia or\nerythroleukoplakia [1.8.4]\nConsider a very urgent full blood count\nPallor Leukaemia\n(within 48 hours) [1.10.1]\nPenile lesion (ulcerated\nand sexually transmitted\ninfection has been\nexcluded, or persistent Consider a suspected cancer pathway\nPenile\nafter treatment for a referral [1.6.9]\nsexually transmitted\ninfection has been\ncompleted) in men\nPenile mass (and sexually\ntransmitted infection has Consider a suspected cancer pathway\nPenile\nbeen excluded as a cause) referral [1.6.9]\nin men\nPenile symptomsaffecting\nthe foreskin or glans Consider a suspected cancer pathway\nPenile\n(unexplained or persistent) referral [1.6.10]\nin men\nPetechiae (unexplained) in Consider a very urgent full blood count\nLeukaemia\nadults (within 48 hours) [1.10.1]",
    "raw_text": "Symptoms and signs Possible cancer Recommendation\nConsider urgent referral (for an\nappointment within 2 weeks) for\nassessment by a dentist [1.8.3]\nOral cavity red or red and\nConsider a suspected cancer pathway\nwhite patchconsistent\nOral referral by the dentist for people when\nwith erythroplakia or\nassessed by a dentist as having a red or\nerythroleukoplakia\nred and white patch in the oral cavity\nconsistent with erythroplakia or\nerythroleukoplakia [1.8.4]\nConsider a very urgent full blood count\nPallor Leukaemia\n(within 48 hours) [1.10.1]\nPenile lesion (ulcerated\nand sexually transmitted\ninfection has been\nexcluded, or persistent Consider a suspected cancer pathway\nPenile\nafter treatment for a referral [1.6.9]\nsexually transmitted\ninfection has been\ncompleted) in men\nPenile mass (and sexually\ntransmitted infection has Consider a suspected cancer pathway\nPenile\nbeen excluded as a cause) referral [1.6.9]\nin men\nPenile symptomsaffecting\nthe foreskin or glans Consider a suspected cancer pathway\nPenile\n(unexplained or persistent) referral [1.6.10]\nin men\nPetechiae (unexplained) in Consider a very urgent full blood count\nLeukaemia\nadults (within 48 hours) [1.10.1]"
  },
  {
    "element_id": "page_56",
    "page_number": 56,
    "element_type": "table",
    "markdown": "Table 1 on Page 56\n\n| Symptoms and signs          | Possible cancer   | Recommendation                           |\n|:----------------------------|:------------------|:-----------------------------------------|\n| Oral cavity red or red and  | Oral              | Consider urgent referral (for an         |\n| white patchconsistent       |                   | appointment within 2 weeks) for          |\n| with erythroplakia or       |                   | assessment by a dentist [1.8.3]          |\n| erythroleukoplakia          |                   | Consider a suspected cancer pathway      |\n|                             |                   | referral by the dentist for people when  |\n|                             |                   | assessed by a dentist as having a red or |\n|                             |                   | red and white patch in the oral cavity   |\n|                             |                   | consistent with erythroplakia or         |\n|                             |                   | erythroleukoplakia [1.8.4]               |\n| Pallor                      | Leukaemia         | Consider a very urgent full blood count  |\n|                             |                   | (within 48 hours) [1.10.1]               |\n| Penile lesion (ulcerated    | Penile            | Consider a suspected cancer pathway      |\n| and sexually transmitted    |                   | referral [1.6.9]                         |\n| infection has been          |                   |                                          |\n| excluded, or persistent     |                   |                                          |\n| after treatment for a       |                   |                                          |\n| sexually transmitted        |                   |                                          |\n| infection has been          |                   |                                          |\n| completed) in men           |                   |                                          |\n| Penile mass (and sexually   | Penile            | Consider a suspected cancer pathway      |\n| transmitted infection has   |                   | referral [1.6.9]                         |\n| been excluded as a cause)   |                   |                                          |\n| in men                      |                   |                                          |\n| Penile symptomsaffecting    | Penile            | Consider a suspected cancer pathway      |\n| the foreskin or glans       |                   | referral [1.6.10]                        |\n| (unexplained or persistent) |                   |                                          |\n| in men                      |                   |                                          |\n| Petechiae (unexplained) in  | Leukaemia         | Consider a very urgent full blood count  |\n| adults                      |                   | (within 48 hours) [1.10.1]               |",
    "raw_text": "Symptoms and signs\tPossible cancer\tRecommendation\nOral cavity red or red and\nwhite patchconsistent\nwith erythroplakia or\nerythroleukoplakia\tOral\tConsider urgent referral (for an\nappointment within 2 weeks) for\nassessment by a dentist [1.8.3]\nConsider a suspected cancer pathway\nreferral by the dentist for people when\nassessed by a dentist as having a red or\nred and white patch in the oral cavity\nconsistent with erythroplakia or\nerythroleukoplakia [1.8.4]\nPallor\tLeukaemia\tConsider a very urgent full blood count\n(within 48 hours) [1.10.1]\nPenile lesion (ulcerated\nand sexually transmitted\ninfection has been\nexcluded, or persistent\nafter treatment for a\nsexually transmitted\ninfection has been\ncompleted) in men\tPenile\tConsider a suspected cancer pathway\nreferral [1.6.9]\nPenile mass (and sexually\ntransmitted infection has\nbeen excluded as a cause)\nin men\tPenile\tConsider a suspected cancer pathway\nreferral [1.6.9]\nPenile symptomsaffecting\nthe foreskin or glans\n(unexplained or persistent)\nin men\tPenile\tConsider a suspected cancer pathway\nreferral [1.6.10]\nPetechiae (unexplained) in\nadults\tLeukaemia\tConsider a very urgent full blood count\n(within 48 hours) [1.10.1]"
  },
  {
    "element_id": "page_57_seq_0",
    "page_number": 57,
    "element_type": "text",
    "markdown": "Symptoms and signs Possible cancer Recommendation\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6]\nSeparate recommendations have been\nPruritus with unexplained Non-Hodgkin's\nmade for adults and for children and young\nsplenomegaly in adults lymphoma\npeople to reflect that there are different\nreferral pathways. In practice young\npeople (aged 16 to 24) may be referred\nusing either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.8]\nHodgkin's\nSeparate recommendations have been\nPruritus with unexplained lymphoma or\nmade for adults and for children and young\nlymphadenopathy in adults non-Hodgkin's\npeople to reflect that there are different\nlymphoma\nreferral pathways. In practice young\npeople (aged 16 to 24) may be referred\nusing either pathway depending on their\nage and local arrangements\nSkin changes that Consider a suspected cancer pathway\nBreast\nsuggest breast cancer referral [1.4.2]\nSkin lesion (pigmented\nand suspicious) with a Refer people using a suspected cancer\nMelanoma\nweighted 7-point checklist pathway referral [1.7.1]\nscore of 3 or more\nSkin lesion (pigmented or\nnon-pigmented) that Consider a suspected cancer pathway\nMelanoma\nsuggests nodular referral [1.7.3]\nmelanoma",
    "raw_text": "Symptoms and signs Possible cancer Recommendation\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6]\nSeparate recommendations have been\nPruritus with unexplained Non-Hodgkin's\nmade for adults and for children and young\nsplenomegaly in adults lymphoma\npeople to reflect that there are different\nreferral pathways. In practice young\npeople (aged 16 to 24) may be referred\nusing either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.8]\nHodgkin's\nSeparate recommendations have been\nPruritus with unexplained lymphoma or\nmade for adults and for children and young\nlymphadenopathy in adults non-Hodgkin's\npeople to reflect that there are different\nlymphoma\nreferral pathways. In practice young\npeople (aged 16 to 24) may be referred\nusing either pathway depending on their\nage and local arrangements\nSkin changes that Consider a suspected cancer pathway\nBreast\nsuggest breast cancer referral [1.4.2]\nSkin lesion (pigmented\nand suspicious) with a Refer people using a suspected cancer\nMelanoma\nweighted 7-point checklist pathway referral [1.7.1]\nscore of 3 or more\nSkin lesion (pigmented or\nnon-pigmented) that Consider a suspected cancer pathway\nMelanoma\nsuggests nodular referral [1.7.3]\nmelanoma"
  },
  {
    "element_id": "page_57",
    "page_number": 57,
    "element_type": "table",
    "markdown": "Table 1 on Page 57\n\n| Symptoms and signs         | Possible cancer   | Recommendation                             |\n|:---------------------------|:------------------|:-------------------------------------------|\n| Pruritus with unexplained  | Non-Hodgkin's     | Consider a suspected cancer pathway        |\n| splenomegaly in adults     | lymphoma          | referral. When considering referral, take  |\n|                            |                   | into account any associated symptoms       |\n|                            |                   | [1.10.6]                                   |\n|                            |                   | Separate recommendations have been         |\n|                            |                   | made for adults and for children and young |\n|                            |                   | people to reflect that there are different |\n|                            |                   | referral pathways. In practice young       |\n|                            |                   | people (aged 16 to 24) may be referred     |\n|                            |                   | using either pathway depending on their    |\n|                            |                   | age and local arrangements                 |\n| Pruritus with unexplained  | Hodgkin's         | Consider a suspected cancer pathway        |\n| lymphadenopathy in adults  | lymphoma or       | referral. When considering referral, take  |\n|                            | non-Hodgkin's     | into account any associated symptoms       |\n|                            | lymphoma          | [1.10.8]                                   |\n|                            |                   | Separate recommendations have been         |\n|                            |                   | made for adults and for children and young |\n|                            |                   | people to reflect that there are different |\n|                            |                   | referral pathways. In practice young       |\n|                            |                   | people (aged 16 to 24) may be referred     |\n|                            |                   | using either pathway depending on their    |\n|                            |                   | age and local arrangements                 |\n| Skin changes that          | Breast            | Consider a suspected cancer pathway        |\n| suggest breast cancer      |                   | referral [1.4.2]                           |\n| Skin lesion (pigmented     | Melanoma          | Refer people using a suspected cancer      |\n| and suspicious) with a     |                   | pathway referral [1.7.1]                   |\n| weighted 7-point checklist |                   |                                            |\n| score of 3 or more         |                   |                                            |\n| Skin lesion (pigmented or  | Melanoma          | Consider a suspected cancer pathway        |\n| non-pigmented) that        |                   | referral [1.7.3]                           |\n| suggests nodular           |                   |                                            |\n| melanoma                   |                   |                                            |",
    "raw_text": "Symptoms and signs\tPossible cancer\tRecommendation\nPruritus with unexplained\nsplenomegaly in adults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6]\nSeparate recommendations have been\nmade for adults and for children and young\npeople to reflect that there are different\nreferral pathways. In practice young\npeople (aged 16 to 24) may be referred\nusing either pathway depending on their\nage and local arrangements\nPruritus with unexplained\nlymphadenopathy in adults\tHodgkin's\nlymphoma or\nnon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.8]\nSeparate recommendations have been\nmade for adults and for children and young\npeople to reflect that there are different\nreferral pathways. In practice young\npeople (aged 16 to 24) may be referred\nusing either pathway depending on their\nage and local arrangements\nSkin changes that\nsuggest breast cancer\tBreast\tConsider a suspected cancer pathway\nreferral [1.4.2]\nSkin lesion (pigmented\nand suspicious) with a\nweighted 7-point checklist\nscore of 3 or more\tMelanoma\tRefer people using a suspected cancer\npathway referral [1.7.1]\nSkin lesion (pigmented or\nnon-pigmented) that\nsuggests nodular\nmelanoma\tMelanoma\tConsider a suspected cancer pathway\nreferral [1.7.3]"
  },
  {
    "element_id": "page_58_seq_0",
    "page_number": 58,
    "element_type": "text",
    "markdown": "Symptoms and signs Possible cancer Recommendation\nSkin lesion that raises the\nSquamous cell Consider a suspected cancer pathway\nsuspicion of a squamous\ncarcinoma referral [1.7.4]\ncell carcinoma\nConsider routine referral [1.7.5]\nOnly consider a suspected cancer\npathway referral if there is particular\nconcern that a delay may have a\nSkin lesion that raises the significant impact, because of factors such\nBasal cell\nsuspicion of a basal cell as lesion site or size [1.7.6]\ncarcinoma\ncarcinoma\nTypical features of basal cell carcinoma\ninclude: an ulcer with a raised rolled edge;\nprominent fine blood vessels around a\nlesion; or a nodule on the skin (particularly\npearly or waxy nodules)\nVulval lump or ulceration Consider a suspected cancer pathway\nVulval\n(unexplained) in women referral [1.5.14]\nUrological symptoms\nDysuria\nPossible\nSymptom and specific features Recommendation\ncancer\nDysuria with unexplained non-visible Refer people using a suspected\nBladder\nhaematuria, 60 and over cancer pathway referral [1.6.4]\nErectile dysfunction\nSymptom and Possible\nRecommendation\nspecific features cancer\nConsider a prostate-specific antigen (PSA) test and digital\nErectile\nrectal examination [1.6.2]\ndysfunction in Prostate\nSee the section on primary care investigations for more\nmen\ninformation on PSA tests and digital rectal examination",
    "raw_text": "Symptoms and signs Possible cancer Recommendation\nSkin lesion that raises the\nSquamous cell Consider a suspected cancer pathway\nsuspicion of a squamous\ncarcinoma referral [1.7.4]\ncell carcinoma\nConsider routine referral [1.7.5]\nOnly consider a suspected cancer\npathway referral if there is particular\nconcern that a delay may have a\nSkin lesion that raises the significant impact, because of factors such\nBasal cell\nsuspicion of a basal cell as lesion site or size [1.7.6]\ncarcinoma\ncarcinoma\nTypical features of basal cell carcinoma\ninclude: an ulcer with a raised rolled edge;\nprominent fine blood vessels around a\nlesion; or a nodule on the skin (particularly\npearly or waxy nodules)\nVulval lump or ulceration Consider a suspected cancer pathway\nVulval\n(unexplained) in women referral [1.5.14]\nUrological symptoms\nDysuria\nPossible\nSymptom and specific features Recommendation\ncancer\nDysuria with unexplained non-visible Refer people using a suspected\nBladder\nhaematuria, 60 and over cancer pathway referral [1.6.4]\nErectile dysfunction\nSymptom and Possible\nRecommendation\nspecific features cancer\nConsider a prostate-specific antigen (PSA) test and digital\nErectile\nrectal examination [1.6.2]\ndysfunction in Prostate\nSee the section on primary care investigations for more\nmen\ninformation on PSA tests and digital rectal examination"
  },
  {
    "element_id": "page_58",
    "page_number": 58,
    "element_type": "table",
    "markdown": "Table 1 on Page 58\n\n| Symptoms and signs          | Possible cancer   | Recommendation                                |\n|:----------------------------|:------------------|:----------------------------------------------|\n| Skin lesion that raises the | Squamous cell     | Consider a suspected cancer pathway           |\n| suspicion of a squamous     | carcinoma         | referral [1.7.4]                              |\n| cell carcinoma              |                   |                                               |\n| Skin lesion that raises the | Basal cell        | Consider routine referral [1.7.5]             |\n| suspicion of a basal cell   | carcinoma         | Only consider a suspected cancer              |\n| carcinoma                   |                   | pathway referral if there is particular       |\n|                             |                   | concern that a delay may have a               |\n|                             |                   | significant impact, because of factors such   |\n|                             |                   | as lesion site or size [1.7.6]                |\n|                             |                   | Typical features of basal cell carcinoma      |\n|                             |                   | include: an ulcer with a raised rolled edge;  |\n|                             |                   | prominent fine blood vessels around a         |\n|                             |                   | lesion; or a nodule on the skin (particularly |\n|                             |                   | pearly or waxy nodules)                       |\n| Vulval lump or ulceration   | Vulval            | Consider a suspected cancer pathway           |\n| (unexplained) in women      |                   | referral [1.5.14]                             |",
    "raw_text": "Symptoms and signs\tPossible cancer\tRecommendation\nSkin lesion that raises the\nsuspicion of a squamous\ncell carcinoma\tSquamous cell\ncarcinoma\tConsider a suspected cancer pathway\nreferral [1.7.4]\nSkin lesion that raises the\nsuspicion of a basal cell\ncarcinoma\tBasal cell\ncarcinoma\tConsider routine referral [1.7.5]\nOnly consider a suspected cancer\npathway referral if there is particular\nconcern that a delay may have a\nsignificant impact, because of factors such\nas lesion site or size [1.7.6]\nTypical features of basal cell carcinoma\ninclude: an ulcer with a raised rolled edge;\nprominent fine blood vessels around a\nlesion; or a nodule on the skin (particularly\npearly or waxy nodules)\nVulval lump or ulceration\n(unexplained) in women\tVulval\tConsider a suspected cancer pathway\nreferral [1.5.14]"
  },
  {
    "element_id": "page_58",
    "page_number": 58,
    "element_type": "table",
    "markdown": "Table 2 on Page 58\n\n| Symptom and specific features        | Possible   | Recommendation                  |\n|                                      | cancer     |                                 |\n|:-------------------------------------|:-----------|:--------------------------------|\n| Dysuria with unexplained non-visible | Bladder    | Refer people using a suspected  |\n| haematuria, 60 and over              |            | cancer pathway referral [1.6.4] |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nDysuria with unexplained non-visible\nhaematuria, 60 and over\tBladder\tRefer people using a suspected\ncancer pathway referral [1.6.4]"
  },
  {
    "element_id": "page_58",
    "page_number": 58,
    "element_type": "table",
    "markdown": "Table 3 on Page 58\n\n| Symptom and         | Possible   | Recommendation                                              |\n| specific features   | cancer     |                                                             |\n|:--------------------|:-----------|:------------------------------------------------------------|\n| Erectile            | Prostate   | Consider a prostate-specific antigen (PSA) test and digital |\n| dysfunction in      |            | rectal examination [1.6.2]                                  |\n| men                 |            | See the section on primary care investigations for more     |\n|                     |            | information on PSA tests and digital rectal examination     |",
    "raw_text": "Symptom and\nspecific features\tPossible\ncancer\tRecommendation\nErectile\ndysfunction in\nmen\tProstate\tConsider a prostate-specific antigen (PSA) test and digital\nrectal examination [1.6.2]\nSee the section on primary care investigations for more\ninformation on PSA tests and digital rectal examination"
  },
  {
    "element_id": "page_59_seq_0",
    "page_number": 59,
    "element_type": "text",
    "markdown": "Haematuria\nSymptom and specific features Possible cancer Recommendation\nHaematuria (visible and unexplained) either\nwithout urinary tract infection or that Refer people using a\nBladder or\npersists or recurs after successful suspected cancer pathway\nrenal\ntreatment of urinary tract infection, 45 and referral [1.6.4] [1.6.6]\nover\nHaematuria (non-visible and unexplained) Refer people using a\nwith dysuria or raised white cell count on a Bladder suspected cancer pathway\nblood test, 60 and over referral [1.6.4]\nHaematuria (visible) with low haemoglobin\nlevels or thrombocytosis or high blood Consider a direct access\nEndometrial\nglucose levels or unexplained vaginal ultrasound scan [1.5.12]\ndischarge in women 55 and over\nConsider a prostate-specific\nantigen (PSA) test and digital\nrectal examination [1.6.2]\nHaematuria (visible) in men Prostate See the section on primary\ncare investigations for more\ninformation on PSA tests and\ndigital rectal examination\nTesticular symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nTestis enlargement or change in shape or Consider a suspected cancer\nTesticular\ntexture (non-painful) in men pathway referral [1.6.7]\nTesticular symptoms (unexplained or Consider a direct access\nTesticular\npersistent) in men ultrasound scan [1.6.8]",
    "raw_text": "Haematuria\nSymptom and specific features Possible cancer Recommendation\nHaematuria (visible and unexplained) either\nwithout urinary tract infection or that Refer people using a\nBladder or\npersists or recurs after successful suspected cancer pathway\nrenal\ntreatment of urinary tract infection, 45 and referral [1.6.4] [1.6.6]\nover\nHaematuria (non-visible and unexplained) Refer people using a\nwith dysuria or raised white cell count on a Bladder suspected cancer pathway\nblood test, 60 and over referral [1.6.4]\nHaematuria (visible) with low haemoglobin\nlevels or thrombocytosis or high blood Consider a direct access\nEndometrial\nglucose levels or unexplained vaginal ultrasound scan [1.5.12]\ndischarge in women 55 and over\nConsider a prostate-specific\nantigen (PSA) test and digital\nrectal examination [1.6.2]\nHaematuria (visible) in men Prostate See the section on primary\ncare investigations for more\ninformation on PSA tests and\ndigital rectal examination\nTesticular symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nTestis enlargement or change in shape or Consider a suspected cancer\nTesticular\ntexture (non-painful) in men pathway referral [1.6.7]\nTesticular symptoms (unexplained or Consider a direct access\nTesticular\npersistent) in men ultrasound scan [1.6.8]"
  },
  {
    "element_id": "page_59",
    "page_number": 59,
    "element_type": "table",
    "markdown": "Table 1 on Page 59\n\n| Symptom and specific features                | Possible cancer   | Recommendation                 |\n|:---------------------------------------------|:------------------|:-------------------------------|\n| Haematuria (visible and unexplained) either  | Bladder or        | Refer people using a           |\n| without urinary tract infection or that      | renal             | suspected cancer pathway       |\n| persists or recurs after successful          |                   | referral [1.6.4] [1.6.6]       |\n| treatment of urinary tract infection, 45 and |                   |                                |\n| over                                         |                   |                                |\n| Haematuria (non-visible and unexplained)     | Bladder           | Refer people using a           |\n| with dysuria or raised white cell count on a |                   | suspected cancer pathway       |\n| blood test, 60 and over                      |                   | referral [1.6.4]               |\n| Haematuria (visible) with low haemoglobin    | Endometrial       | Consider a direct access       |\n| levels or thrombocytosis or high blood       |                   | ultrasound scan [1.5.12]       |\n| glucose levels or unexplained vaginal        |                   |                                |\n| discharge in women 55 and over               |                   |                                |\n| Haematuria (visible) in men                  | Prostate          | Consider a prostate-specific   |\n|                                              |                   | antigen (PSA) test and digital |\n|                                              |                   | rectal examination [1.6.2]     |\n|                                              |                   | See the section on primary     |\n|                                              |                   | care investigations for more   |\n|                                              |                   | information on PSA tests and   |\n|                                              |                   | digital rectal examination     |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nHaematuria (visible and unexplained) either\nwithout urinary tract infection or that\npersists or recurs after successful\ntreatment of urinary tract infection, 45 and\nover\tBladder or\nrenal\tRefer people using a\nsuspected cancer pathway\nreferral [1.6.4] [1.6.6]\nHaematuria (non-visible and unexplained)\nwith dysuria or raised white cell count on a\nblood test, 60 and over\tBladder\tRefer people using a\nsuspected cancer pathway\nreferral [1.6.4]\nHaematuria (visible) with low haemoglobin\nlevels or thrombocytosis or high blood\nglucose levels or unexplained vaginal\ndischarge in women 55 and over\tEndometrial\tConsider a direct access\nultrasound scan [1.5.12]\nHaematuria (visible) in men\tProstate\tConsider a prostate-specific\nantigen (PSA) test and digital\nrectal examination [1.6.2]\nSee the section on primary\ncare investigations for more\ninformation on PSA tests and\ndigital rectal examination"
  },
  {
    "element_id": "page_59",
    "page_number": 59,
    "element_type": "table",
    "markdown": "Table 2 on Page 59\n\n| Symptom and specific features            | Possible   | Recommendation              |\n|                                          | cancer     |                             |\n|:-----------------------------------------|:-----------|:----------------------------|\n| Testis enlargement or change in shape or | Testicular | Consider a suspected cancer |\n| texture (non-painful) in men             |            | pathway referral [1.6.7]    |\n| Testicular symptoms (unexplained or      | Testicular | Consider a direct access    |\n| persistent) in men                       |            | ultrasound scan [1.6.8]     |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nTestis enlargement or change in shape or\ntexture (non-painful) in men\tTesticular\tConsider a suspected cancer\npathway referral [1.6.7]\nTesticular symptoms (unexplained or\npersistent) in men\tTesticular\tConsider a direct access\nultrasound scan [1.6.8]"
  },
  {
    "element_id": "page_60_seq_0",
    "page_number": 60,
    "element_type": "text",
    "markdown": "Other urinary tract symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nConsider non-urgent referral for\nUrinary tract infection (unexplained bladder cancer in people aged\nand recurrent or persistent), 60 and Bladder 60 and over with recurrent or\nover persistent unexplained urinary tract\ninfection [1.6.5]\nConsider a prostate-specific antigen\n(PSA) test and digital rectal\nLower urinary tract symptoms, such examination [1.6.2]\nas nocturia, urinary frequency, Prostate See the section on primary care\nhesitancy, urgency or retention in men investigations for more information\non PSA tests and digital rectal\nexamination\nCarry out tests in primary care [1.5.2]\nMeasure serum CA125 in primary\nUrinary urgency or frequency\ncare [1.5.6]\n(increased and persistent or frequent\nSee the section on primary care\n\u2013 particularly more than 12 times per Ovarian\ninvestigations for information on tests\nmonth) in women, especially if 50 and\nfor ovarian cancer\nover\nThese recommendations apply to\nwomen aged 18 and over",
    "raw_text": "Other urinary tract symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nConsider non-urgent referral for\nUrinary tract infection (unexplained bladder cancer in people aged\nand recurrent or persistent), 60 and Bladder 60 and over with recurrent or\nover persistent unexplained urinary tract\ninfection [1.6.5]\nConsider a prostate-specific antigen\n(PSA) test and digital rectal\nLower urinary tract symptoms, such examination [1.6.2]\nas nocturia, urinary frequency, Prostate See the section on primary care\nhesitancy, urgency or retention in men investigations for more information\non PSA tests and digital rectal\nexamination\nCarry out tests in primary care [1.5.2]\nMeasure serum CA125 in primary\nUrinary urgency or frequency\ncare [1.5.6]\n(increased and persistent or frequent\nSee the section on primary care\n\u2013 particularly more than 12 times per Ovarian\ninvestigations for information on tests\nmonth) in women, especially if 50 and\nfor ovarian cancer\nover\nThese recommendations apply to\nwomen aged 18 and over"
  },
  {
    "element_id": "page_60",
    "page_number": 60,
    "element_type": "table",
    "markdown": "Table 1 on Page 60\n\n| Symptom and specific features          | Possible   | Recommendation                          |\n|                                        | cancer     |                                         |\n|:---------------------------------------|:-----------|:----------------------------------------|\n| Urinary tract infection (unexplained   | Bladder    | Consider non-urgent referral for        |\n| and recurrent or persistent), 60 and   |            | bladder cancer in people aged           |\n| over                                   |            | 60 and over with recurrent or           |\n|                                        |            | persistent unexplained urinary tract    |\n|                                        |            | infection [1.6.5]                       |\n| Lower urinary tract symptoms, such     | Prostate   | Consider a prostate-specific antigen    |\n| as nocturia, urinary frequency,        |            | (PSA) test and digital rectal           |\n| hesitancy, urgency or retention in men |            | examination [1.6.2]                     |\n|                                        |            | See the section on primary care         |\n|                                        |            | investigations for more information     |\n|                                        |            | on PSA tests and digital rectal         |\n|                                        |            | examination                             |\n| Urinary urgency or frequency           | Ovarian    | Carry out tests in primary care [1.5.2] |\n| (increased and persistent or frequent  |            | Measure serum CA125 in primary          |\n| \u2013 particularly more than 12 times per  |            | care [1.5.6]                            |\n| month) in women, especially if 50 and  |            | See the section on primary care         |\n| over                                   |            | investigations for information on tests |\n|                                        |            | for ovarian cancer                      |\n|                                        |            | These recommendations apply to          |\n|                                        |            | women aged 18 and over                  |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nUrinary tract infection (unexplained\nand recurrent or persistent), 60 and\nover\tBladder\tConsider non-urgent referral for\nbladder cancer in people aged\n60 and over with recurrent or\npersistent unexplained urinary tract\ninfection [1.6.5]\nLower urinary tract symptoms, such\nas nocturia, urinary frequency,\nhesitancy, urgency or retention in men\tProstate\tConsider a prostate-specific antigen\n(PSA) test and digital rectal\nexamination [1.6.2]\nSee the section on primary care\ninvestigations for more information\non PSA tests and digital rectal\nexamination\nUrinary urgency or frequency\n(increased and persistent or frequent\n\u2013 particularly more than 12 times per\nmonth) in women, especially if 50 and\nover\tOvarian\tCarry out tests in primary care [1.5.2]\nMeasure serum CA125 in primary\ncare [1.5.6]\nSee the section on primary care\ninvestigations for information on tests\nfor ovarian cancer\nThese recommendations apply to\nwomen aged 18 and over"
  },
  {
    "element_id": "page_61_seq_0",
    "page_number": 61,
    "element_type": "text",
    "markdown": "Non-specific features of cancer\nAppetite loss or early satiety\nSymptom and specific features Possible cancer Recommendation\nCarry out an assessment for\nadditional symptoms, signs or\nSeveral, including\nfindings that may help to\nlung, oesophageal,\nclarify which cancer is most\nAppetite loss (unexplained) stomach, colorectal,\nlikely\npancreatic, bladder\nOffer urgent investigation or\nor renal\na suspected cancer pathway\nreferral [1.13.3]\nOffer an urgent chest X-ray\nAppetite loss (unexplained), Lung or\n(to be done within 2 weeks)\n40 and over, ever smoked mesothelioma\n[1.1.2] [1.1.5]\nAppetite loss (unexplained), Offer an urgent chest X-ray\n40 and over, exposed to Mesothelioma (to be done within 2 weeks)\nasbestos [1.1.5]\nAppetite loss (unexplained) with\nOffer an urgent chest X-ray\ncough or fatigue or shortness of Lung or\n(to be done within 2 weeks)\nbreath or chest pain or weight mesothelioma\n[1.1.2] [1.1.5]\nloss (unexplained), 40 and over\nCarry out tests in primary\ncare [1.5.2]\nMeasure serum CA125 in\nAppetite loss or early satiety primary care [1.5.6]\n(persistent or frequent \u2013 See the section on primary\nparticularly more than 12 times Ovarian care investigations for\nper month) in women, especially information on tests for\nif 50 and over ovarian cancer\nThese recommendations\napply to women aged 18 and\nover",
    "raw_text": "Non-specific features of cancer\nAppetite loss or early satiety\nSymptom and specific features Possible cancer Recommendation\nCarry out an assessment for\nadditional symptoms, signs or\nSeveral, including\nfindings that may help to\nlung, oesophageal,\nclarify which cancer is most\nAppetite loss (unexplained) stomach, colorectal,\nlikely\npancreatic, bladder\nOffer urgent investigation or\nor renal\na suspected cancer pathway\nreferral [1.13.3]\nOffer an urgent chest X-ray\nAppetite loss (unexplained), Lung or\n(to be done within 2 weeks)\n40 and over, ever smoked mesothelioma\n[1.1.2] [1.1.5]\nAppetite loss (unexplained), Offer an urgent chest X-ray\n40 and over, exposed to Mesothelioma (to be done within 2 weeks)\nasbestos [1.1.5]\nAppetite loss (unexplained) with\nOffer an urgent chest X-ray\ncough or fatigue or shortness of Lung or\n(to be done within 2 weeks)\nbreath or chest pain or weight mesothelioma\n[1.1.2] [1.1.5]\nloss (unexplained), 40 and over\nCarry out tests in primary\ncare [1.5.2]\nMeasure serum CA125 in\nAppetite loss or early satiety primary care [1.5.6]\n(persistent or frequent \u2013 See the section on primary\nparticularly more than 12 times Ovarian care investigations for\nper month) in women, especially information on tests for\nif 50 and over ovarian cancer\nThese recommendations\napply to women aged 18 and\nover"
  },
  {
    "element_id": "page_61",
    "page_number": 61,
    "element_type": "table",
    "markdown": "Table 1 on Page 61\n\n| Symptom and specific features    | Possible cancer      | Recommendation                |\n|:---------------------------------|:---------------------|:------------------------------|\n| Appetite loss (unexplained)      | Several, including   | Carry out an assessment for   |\n|                                  | lung, oesophageal,   | additional symptoms, signs or |\n|                                  | stomach, colorectal, | findings that may help to     |\n|                                  | pancreatic, bladder  | clarify which cancer is most  |\n|                                  | or renal             | likely                        |\n|                                  |                      | Offer urgent investigation or |\n|                                  |                      | a suspected cancer pathway    |\n|                                  |                      | referral [1.13.3]             |\n| Appetite loss (unexplained),     | Lung or              | Offer an urgent chest X-ray   |\n| 40 and over, ever smoked         | mesothelioma         | (to be done within 2 weeks)   |\n|                                  |                      | [1.1.2] [1.1.5]               |\n| Appetite loss (unexplained),     | Mesothelioma         | Offer an urgent chest X-ray   |\n| 40 and over, exposed to          |                      | (to be done within 2 weeks)   |\n| asbestos                         |                      | [1.1.5]                       |\n| Appetite loss (unexplained) with | Lung or              | Offer an urgent chest X-ray   |\n| cough or fatigue or shortness of | mesothelioma         | (to be done within 2 weeks)   |\n| breath or chest pain or weight   |                      | [1.1.2] [1.1.5]               |\n| loss (unexplained), 40 and over  |                      |                               |\n| Appetite loss or early satiety   | Ovarian              | Carry out tests in primary    |\n| (persistent or frequent \u2013        |                      | care [1.5.2]                  |\n| particularly more than 12 times  |                      | Measure serum CA125 in        |\n| per month) in women, especially  |                      | primary care [1.5.6]          |\n| if 50 and over                   |                      | See the section on primary    |\n|                                  |                      | care investigations for       |\n|                                  |                      | information on tests for      |\n|                                  |                      | ovarian cancer                |\n|                                  |                      | These recommendations         |\n|                                  |                      | apply to women aged 18 and    |\n|                                  |                      | over                          |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nAppetite loss (unexplained)\tSeveral, including\nlung, oesophageal,\nstomach, colorectal,\npancreatic, bladder\nor renal\tCarry out an assessment for\nadditional symptoms, signs or\nfindings that may help to\nclarify which cancer is most\nlikely\nOffer urgent investigation or\na suspected cancer pathway\nreferral [1.13.3]\nAppetite loss (unexplained),\n40 and over, ever smoked\tLung or\nmesothelioma\tOffer an urgent chest X-ray\n(to be done within 2 weeks)\n[1.1.2] [1.1.5]\nAppetite loss (unexplained),\n40 and over, exposed to\nasbestos\tMesothelioma\tOffer an urgent chest X-ray\n(to be done within 2 weeks)\n[1.1.5]\nAppetite loss (unexplained) with\ncough or fatigue or shortness of\nbreath or chest pain or weight\nloss (unexplained), 40 and over\tLung or\nmesothelioma\tOffer an urgent chest X-ray\n(to be done within 2 weeks)\n[1.1.2] [1.1.5]\nAppetite loss or early satiety\n(persistent or frequent \u2013\nparticularly more than 12 times\nper month) in women, especially\nif 50 and over\tOvarian\tCarry out tests in primary\ncare [1.5.2]\nMeasure serum CA125 in\nprimary care [1.5.6]\nSee the section on primary\ncare investigations for\ninformation on tests for\novarian cancer\nThese recommendations\napply to women aged 18 and\nover"
  },
  {
    "element_id": "page_62_seq_0",
    "page_number": 62,
    "element_type": "text",
    "markdown": "Deep vein thrombosis\nSymptom and\nPossible cancer Recommendation\nspecific features\nCarry out an assessment for additional\nSeveral, including symptoms, signs or findings that may help to\nDeep vein\nurogenital, breast, clarify which cancer is most likely\nthrombosis\ncolorectal and lung Consider urgent investigation or a suspected\ncancer pathway referral [1.13.4]\nDiabetes\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nDiabetes (new Consider an urgent, direct access CT scan (to be\nonset) with weight Pancreatic done within 2 weeks), or urgent ultrasound scan if\nloss, 60 and over CT is not available [1.2.5]\nFatigue\nSymptom and specific features Possible cancer Recommendation\nOffer an urgent chest X-ray (to\nFatigue (unexplained), 40 and over, Lung or\nbe done within 2 weeks) [1.1.2]\never smoked mesothelioma\n[1.1.5]\nFatigue (unexplained), 40 and over, Offer an urgent chest X-ray (to\nMesothelioma\nexposed to asbestos be done within 2 weeks) [1.1.5]\nFatigue with cough or shortness of\nOffer an urgent chest X-ray (to\nbreath or chest pain or weight loss or Lung or\nbe done within 2 weeks) [1.1.2]\nappetite loss (unexplained), 40 and mesothelioma\n[1.1.5]\nover\nConsider a very urgent full\nFatigue (persistent) in adults Leukaemia blood count (within 48 hours)\n[1.10.1]",
    "raw_text": "Deep vein thrombosis\nSymptom and\nPossible cancer Recommendation\nspecific features\nCarry out an assessment for additional\nSeveral, including symptoms, signs or findings that may help to\nDeep vein\nurogenital, breast, clarify which cancer is most likely\nthrombosis\ncolorectal and lung Consider urgent investigation or a suspected\ncancer pathway referral [1.13.4]\nDiabetes\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nDiabetes (new Consider an urgent, direct access CT scan (to be\nonset) with weight Pancreatic done within 2 weeks), or urgent ultrasound scan if\nloss, 60 and over CT is not available [1.2.5]\nFatigue\nSymptom and specific features Possible cancer Recommendation\nOffer an urgent chest X-ray (to\nFatigue (unexplained), 40 and over, Lung or\nbe done within 2 weeks) [1.1.2]\never smoked mesothelioma\n[1.1.5]\nFatigue (unexplained), 40 and over, Offer an urgent chest X-ray (to\nMesothelioma\nexposed to asbestos be done within 2 weeks) [1.1.5]\nFatigue with cough or shortness of\nOffer an urgent chest X-ray (to\nbreath or chest pain or weight loss or Lung or\nbe done within 2 weeks) [1.1.2]\nappetite loss (unexplained), 40 and mesothelioma\n[1.1.5]\nover\nConsider a very urgent full\nFatigue (persistent) in adults Leukaemia blood count (within 48 hours)\n[1.10.1]"
  },
  {
    "element_id": "page_62",
    "page_number": 62,
    "element_type": "table",
    "markdown": "Table 1 on Page 62\n\n| Symptom and         | Possible cancer     | Recommendation                               |\n| specific features   |                     |                                              |\n|:--------------------|:--------------------|:---------------------------------------------|\n| Deep vein           | Several, including  | Carry out an assessment for additional       |\n| thrombosis          | urogenital, breast, | symptoms, signs or findings that may help to |\n|                     | colorectal and lung | clarify which cancer is most likely          |\n|                     |                     | Consider urgent investigation or a suspected |\n|                     |                     | cancer pathway referral [1.13.4]             |",
    "raw_text": "Symptom and\nspecific features\tPossible cancer\tRecommendation\nDeep vein\nthrombosis\tSeveral, including\nurogenital, breast,\ncolorectal and lung\tCarry out an assessment for additional\nsymptoms, signs or findings that may help to\nclarify which cancer is most likely\nConsider urgent investigation or a suspected\ncancer pathway referral [1.13.4]"
  },
  {
    "element_id": "page_62",
    "page_number": 62,
    "element_type": "table",
    "markdown": "Table 2 on Page 62\n\n| Symptom and specific   | Possible   | Recommendation                                     |\n| features               | cancer     |                                                    |\n|:-----------------------|:-----------|:---------------------------------------------------|\n| Diabetes (new          | Pancreatic | Consider an urgent, direct access CT scan (to be   |\n| onset) with weight     |            | done within 2 weeks), or urgent ultrasound scan if |\n| loss, 60 and over      |            | CT is not available [1.2.5]                        |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nDiabetes (new\nonset) with weight\nloss, 60 and over\tPancreatic\tConsider an urgent, direct access CT scan (to be\ndone within 2 weeks), or urgent ultrasound scan if\nCT is not available [1.2.5]"
  },
  {
    "element_id": "page_62",
    "page_number": 62,
    "element_type": "table",
    "markdown": "Table 3 on Page 62\n\n| Symptom and specific features          | Possible cancer   | Recommendation                  |\n|:---------------------------------------|:------------------|:--------------------------------|\n| Fatigue (unexplained), 40 and over,    | Lung or           | Offer an urgent chest X-ray (to |\n| ever smoked                            | mesothelioma      | be done within 2 weeks) [1.1.2] |\n|                                        |                   | [1.1.5]                         |\n| Fatigue (unexplained), 40 and over,    | Mesothelioma      | Offer an urgent chest X-ray (to |\n| exposed to asbestos                    |                   | be done within 2 weeks) [1.1.5] |\n| Fatigue with cough or shortness of     | Lung or           | Offer an urgent chest X-ray (to |\n| breath or chest pain or weight loss or | mesothelioma      | be done within 2 weeks) [1.1.2] |\n| appetite loss (unexplained), 40 and    |                   | [1.1.5]                         |\n| over                                   |                   |                                 |\n| Fatigue (persistent) in adults         | Leukaemia         | Consider a very urgent full     |\n|                                        |                   | blood count (within 48 hours)   |\n|                                        |                   | [1.10.1]                        |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nFatigue (unexplained), 40 and over,\never smoked\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to\nbe done within 2 weeks) [1.1.2]\n[1.1.5]\nFatigue (unexplained), 40 and over,\nexposed to asbestos\tMesothelioma\tOffer an urgent chest X-ray (to\nbe done within 2 weeks) [1.1.5]\nFatigue with cough or shortness of\nbreath or chest pain or weight loss or\nappetite loss (unexplained), 40 and\nover\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to\nbe done within 2 weeks) [1.1.2]\n[1.1.5]\nFatigue (persistent) in adults\tLeukaemia\tConsider a very urgent full\nblood count (within 48 hours)\n[1.10.1]"
  },
  {
    "element_id": "page_63_seq_0",
    "page_number": 63,
    "element_type": "text",
    "markdown": "Symptom and specific features Possible cancer Recommendation\nCarry out tests in primary care\n[1.5.2]\nMeasure serum CA125 in\nprimary care [1.5.6]\nSee the section on primary\nFatigue (unexplained) in women Ovarian\ncare investigations for\ninformation on tests for\novarian cancer\nThese recommendations apply\nto women aged 18 and over\nFever\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nFever Consider a very urgent full blood count (within\nLeukaemia\n(unexplained) 48 hours) [1.10.1]\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nFever with\nSeparate recommendations have been made for\nunexplained Non-Hodgkin's\nadults and for children and young people to reflect\nsplenomegaly in lymphoma\nthat there are different referral pathways. In\nadults\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nFever with Hodgkin's\nSeparate recommendations have been made for\nunexplained lymphoma or\nadults and for children and young people to reflect\nlymphadenopathy non-Hodgkin's\nthat there are different referral pathways. In\nin adults lymphoma\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Symptom and specific features Possible cancer Recommendation\nCarry out tests in primary care\n[1.5.2]\nMeasure serum CA125 in\nprimary care [1.5.6]\nSee the section on primary\nFatigue (unexplained) in women Ovarian\ncare investigations for\ninformation on tests for\novarian cancer\nThese recommendations apply\nto women aged 18 and over\nFever\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nFever Consider a very urgent full blood count (within\nLeukaemia\n(unexplained) 48 hours) [1.10.1]\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nFever with\nSeparate recommendations have been made for\nunexplained Non-Hodgkin's\nadults and for children and young people to reflect\nsplenomegaly in lymphoma\nthat there are different referral pathways. In\nadults\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nFever with Hodgkin's\nSeparate recommendations have been made for\nunexplained lymphoma or\nadults and for children and young people to reflect\nlymphadenopathy non-Hodgkin's\nthat there are different referral pathways. In\nin adults lymphoma\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_63",
    "page_number": 63,
    "element_type": "table",
    "markdown": "Table 1 on Page 63\n\n| Symptom and specific features   | Possible cancer   | Recommendation                  |\n|:--------------------------------|:------------------|:--------------------------------|\n| Fatigue (unexplained) in women  | Ovarian           | Carry out tests in primary care |\n|                                 |                   | [1.5.2]                         |\n|                                 |                   | Measure serum CA125 in          |\n|                                 |                   | primary care [1.5.6]            |\n|                                 |                   | See the section on primary      |\n|                                 |                   | care investigations for         |\n|                                 |                   | information on tests for        |\n|                                 |                   | ovarian cancer                  |\n|                                 |                   | These recommendations apply     |\n|                                 |                   | to women aged 18 and over       |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nFatigue (unexplained) in women\tOvarian\tCarry out tests in primary care\n[1.5.2]\nMeasure serum CA125 in\nprimary care [1.5.6]\nSee the section on primary\ncare investigations for\ninformation on tests for\novarian cancer\nThese recommendations apply\nto women aged 18 and over"
  },
  {
    "element_id": "page_63",
    "page_number": 63,
    "element_type": "table",
    "markdown": "Table 2 on Page 63\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Fever                  | Leukaemia         | Consider a very urgent full blood count (within     |\n| (unexplained)          |                   | 48 hours) [1.10.1]                                  |\n| Fever with             | Non-Hodgkin's     | Consider a suspected cancer pathway referral.       |\n| unexplained            | lymphoma          | When considering referral, take into account any    |\n| splenomegaly in        |                   | associated symptoms [1.10.6]                        |\n| adults                 |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Fever with             | Hodgkin's         | Consider a suspected cancer pathway referral.       |\n| unexplained            | lymphoma or       | When considering referral, take into account any    |\n| lymphadenopathy        | non-Hodgkin's     | associated symptoms [1.10.8]                        |\n| in adults              | lymphoma          | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nFever\n(unexplained)\tLeukaemia\tConsider a very urgent full blood count (within\n48 hours) [1.10.1]\nFever with\nunexplained\nsplenomegaly in\nadults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nFever with\nunexplained\nlymphadenopathy\nin adults\tHodgkin's\nlymphoma or\nnon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_64_seq_0",
    "page_number": 64,
    "element_type": "text",
    "markdown": "See also the section on respiratory symptoms for chest infection.\nInfection\nPossible\nSymptom and specific features Recommendation\ncancer\nInfection (unexplained and Consider a very urgent full blood\nLeukaemia\npersistent or recurrent) in adults count (within 48 hours) [1.10.1]\nNight sweats\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nNight sweats\nSeparate recommendations have been made for\nwith unexplained Non-Hodgkin's\nadults and for children and young people to reflect\nsplenomegaly in lymphoma\nthat there are different referral pathways. In\nadults\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nNight sweats Hodgkin's\nSeparate recommendations have been made for\nwith unexplained lymphoma or\nadults and for children and young people to reflect\nlymphadenopathy non-Hodgkin's\nthat there are different referral pathways. In\nin adults lymphoma\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nPallor\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nConsider a very urgent full blood count (within\nPallor Leukaemia\n48 hours) [1.10.1]",
    "raw_text": "See also the section on respiratory symptoms for chest infection.\nInfection\nPossible\nSymptom and specific features Recommendation\ncancer\nInfection (unexplained and Consider a very urgent full blood\nLeukaemia\npersistent or recurrent) in adults count (within 48 hours) [1.10.1]\nNight sweats\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nNight sweats\nSeparate recommendations have been made for\nwith unexplained Non-Hodgkin's\nadults and for children and young people to reflect\nsplenomegaly in lymphoma\nthat there are different referral pathways. In\nadults\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nNight sweats Hodgkin's\nSeparate recommendations have been made for\nwith unexplained lymphoma or\nadults and for children and young people to reflect\nlymphadenopathy non-Hodgkin's\nthat there are different referral pathways. In\nin adults lymphoma\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nPallor\nSymptom and specific Possible\nRecommendation\nfeatures cancer\nConsider a very urgent full blood count (within\nPallor Leukaemia\n48 hours) [1.10.1]"
  },
  {
    "element_id": "page_64",
    "page_number": 64,
    "element_type": "table",
    "markdown": "Table 1 on Page 64\n\n| Symptom and specific features      | Possible   | Recommendation                    |\n|                                    | cancer     |                                   |\n|:-----------------------------------|:-----------|:----------------------------------|\n| Infection (unexplained and         | Leukaemia  | Consider a very urgent full blood |\n| persistent or recurrent) in adults |            | count (within 48 hours) [1.10.1]  |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nInfection (unexplained and\npersistent or recurrent) in adults\tLeukaemia\tConsider a very urgent full blood\ncount (within 48 hours) [1.10.1]"
  },
  {
    "element_id": "page_64",
    "page_number": 64,
    "element_type": "table",
    "markdown": "Table 2 on Page 64\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Night sweats           | Non-Hodgkin's     | Consider a suspected cancer pathway referral.       |\n| with unexplained       | lymphoma          | When considering referral, take into account any    |\n| splenomegaly in        |                   | associated symptoms [1.10.6]                        |\n| adults                 |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Night sweats           | Hodgkin's         | Consider a suspected cancer pathway referral.       |\n| with unexplained       | lymphoma or       | When considering referral, take into account any    |\n| lymphadenopathy        | non-Hodgkin's     | associated symptoms [1.10.8]                        |\n| in adults              | lymphoma          | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nNight sweats\nwith unexplained\nsplenomegaly in\nadults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nNight sweats\nwith unexplained\nlymphadenopathy\nin adults\tHodgkin's\nlymphoma or\nnon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_64",
    "page_number": 64,
    "element_type": "table",
    "markdown": "Table 3 on Page 64\n\n| Symptom and specific   | Possible   | Recommendation                                  |\n| features               | cancer     |                                                 |\n|:-----------------------|:-----------|:------------------------------------------------|\n| Pallor                 | Leukaemia  | Consider a very urgent full blood count (within |\n|                        |            | 48 hours) [1.10.1]                              |",
    "raw_text": "Symptom and specific\nfeatures\tPossible\ncancer\tRecommendation\nPallor\tLeukaemia\tConsider a very urgent full blood count (within\n48 hours) [1.10.1]"
  },
  {
    "element_id": "page_65_seq_0",
    "page_number": 65,
    "element_type": "text",
    "markdown": "Pruritus\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nPruritus with\nSeparate recommendations have been made for\nunexplained Non-Hodgkin's\nadults and for children and young people to reflect\nsplenomegaly in lymphoma\nthat there are different referral pathways. In\nadults\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nPruritus with Hodgkin's\nSeparate recommendations have been made for\nunexplained lymphoma or\nadults and for children and young people to reflect\nlymphadenopathy non-Hodgkin's\nthat there are different referral pathways. In\nin adults lymphoma\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nWeight loss\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nSeveral, including\nCarry out an assessment for additional\ncolorectal,\nsymptoms, signs or findings that may help\nWeight loss gastro-oesophageal,\nto clarify which cancer is most likely\n(unexplained) lung, prostate,\nOffer urgent investigation or a suspected\npancreatic or\ncancer pathway referral [1.13.2]\nurological cancer\nWeight loss\n(unexplained) with Offer quantitative faecal immunochemical\nColorectal\nabdominal pain, testing [1.3.1]\n40 and over",
    "raw_text": "Pruritus\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nPruritus with\nSeparate recommendations have been made for\nunexplained Non-Hodgkin's\nadults and for children and young people to reflect\nsplenomegaly in lymphoma\nthat there are different referral pathways. In\nadults\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nPruritus with Hodgkin's\nSeparate recommendations have been made for\nunexplained lymphoma or\nadults and for children and young people to reflect\nlymphadenopathy non-Hodgkin's\nthat there are different referral pathways. In\nin adults lymphoma\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nWeight loss\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nSeveral, including\nCarry out an assessment for additional\ncolorectal,\nsymptoms, signs or findings that may help\nWeight loss gastro-oesophageal,\nto clarify which cancer is most likely\n(unexplained) lung, prostate,\nOffer urgent investigation or a suspected\npancreatic or\ncancer pathway referral [1.13.2]\nurological cancer\nWeight loss\n(unexplained) with Offer quantitative faecal immunochemical\nColorectal\nabdominal pain, testing [1.3.1]\n40 and over"
  },
  {
    "element_id": "page_65",
    "page_number": 65,
    "element_type": "table",
    "markdown": "Table 1 on Page 65\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Pruritus with          | Non-Hodgkin's     | Consider a suspected cancer pathway referral.       |\n| unexplained            | lymphoma          | When considering referral, take into account any    |\n| splenomegaly in        |                   | associated symptoms [1.10.6]                        |\n| adults                 |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Pruritus with          | Hodgkin's         | Consider a suspected cancer pathway referral.       |\n| unexplained            | lymphoma or       | When considering referral, take into account any    |\n| lymphadenopathy        | non-Hodgkin's     | associated symptoms [1.10.8]                        |\n| in adults              | lymphoma          | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nPruritus with\nunexplained\nsplenomegaly in\nadults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.6]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nPruritus with\nunexplained\nlymphadenopathy\nin adults\tHodgkin's\nlymphoma or\nnon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway referral.\nWhen considering referral, take into account any\nassociated symptoms [1.10.8]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_65",
    "page_number": 65,
    "element_type": "table",
    "markdown": "Table 2 on Page 65\n\n| Symptom and specific   | Possible cancer     | Recommendation                            |\n| features               |                     |                                           |\n|:-----------------------|:--------------------|:------------------------------------------|\n| Weight loss            | Several, including  | Carry out an assessment for additional    |\n| (unexplained)          | colorectal,         | symptoms, signs or findings that may help |\n|                        | gastro-oesophageal, | to clarify which cancer is most likely    |\n|                        | lung, prostate,     | Offer urgent investigation or a suspected |\n|                        | pancreatic or       | cancer pathway referral [1.13.2]          |\n|                        | urological cancer   |                                           |\n| Weight loss            | Colorectal          | Offer quantitative faecal immunochemical  |\n| (unexplained) with     |                     | testing [1.3.1]                           |\n| abdominal pain,        |                     |                                           |\n| 40 and over            |                     |                                           |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nWeight loss\n(unexplained)\tSeveral, including\ncolorectal,\ngastro-oesophageal,\nlung, prostate,\npancreatic or\nurological cancer\tCarry out an assessment for additional\nsymptoms, signs or findings that may help\nto clarify which cancer is most likely\nOffer urgent investigation or a suspected\ncancer pathway referral [1.13.2]\nWeight loss\n(unexplained) with\nabdominal pain,\n40 and over\tColorectal\tOffer quantitative faecal immunochemical\ntesting [1.3.1]"
  },
  {
    "element_id": "page_66_seq_0",
    "page_number": 66,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nWeight loss\n(unexplained) with Offer quantitative faecal immunochemical\nColorectal\nrectal bleeding in testing [1.3.1]\nadults under 50\nWeight loss\nOffer quantitative faecal immunochemical\n(unexplained), Colorectal\ntesting [1.3.1]\n50 and over\nWeight loss\n(unexplained), Lung or Offer an urgent chest X-ray (to be done\n40 and over, ever mesothelioma within 2 weeks) [1.1.2] [1.1.5]\nsmoked\nWeight loss\n(unexplained),\nOffer an urgent chest X-ray (to be done\n40 and over, Mesothelioma\nwithin 2 weeks) [1.1.5]\nexposed to\nasbestos\nWeight loss with\ncough or fatigue or\nshortness of breath\nor chest pain or Lung or Offer an urgent chest X-ray (to be done\nappetite loss mesothelioma within 2 weeks) [1.1.2] [1.1.5]\n(unexplained),\n40 and over, never\nsmoked",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nWeight loss\n(unexplained) with Offer quantitative faecal immunochemical\nColorectal\nrectal bleeding in testing [1.3.1]\nadults under 50\nWeight loss\nOffer quantitative faecal immunochemical\n(unexplained), Colorectal\ntesting [1.3.1]\n50 and over\nWeight loss\n(unexplained), Lung or Offer an urgent chest X-ray (to be done\n40 and over, ever mesothelioma within 2 weeks) [1.1.2] [1.1.5]\nsmoked\nWeight loss\n(unexplained),\nOffer an urgent chest X-ray (to be done\n40 and over, Mesothelioma\nwithin 2 weeks) [1.1.5]\nexposed to\nasbestos\nWeight loss with\ncough or fatigue or\nshortness of breath\nor chest pain or Lung or Offer an urgent chest X-ray (to be done\nappetite loss mesothelioma within 2 weeks) [1.1.2] [1.1.5]\n(unexplained),\n40 and over, never\nsmoked"
  },
  {
    "element_id": "page_66",
    "page_number": 66,
    "element_type": "table",
    "markdown": "Table 1 on Page 66\n\n| Symptom and specific   | Possible cancer   | Recommendation                           |\n| features               |                   |                                          |\n|:-----------------------|:------------------|:-----------------------------------------|\n| Weight loss            | Colorectal        | Offer quantitative faecal immunochemical |\n| (unexplained) with     |                   | testing [1.3.1]                          |\n| rectal bleeding in     |                   |                                          |\n| adults under 50        |                   |                                          |\n| Weight loss            | Colorectal        | Offer quantitative faecal immunochemical |\n| (unexplained),         |                   | testing [1.3.1]                          |\n| 50 and over            |                   |                                          |\n| Weight loss            | Lung or           | Offer an urgent chest X-ray (to be done  |\n| (unexplained),         | mesothelioma      | within 2 weeks) [1.1.2] [1.1.5]          |\n| 40 and over, ever      |                   |                                          |\n| smoked                 |                   |                                          |\n| Weight loss            | Mesothelioma      | Offer an urgent chest X-ray (to be done  |\n| (unexplained),         |                   | within 2 weeks) [1.1.5]                  |\n| 40 and over,           |                   |                                          |\n| exposed to             |                   |                                          |\n| asbestos               |                   |                                          |\n| Weight loss with       | Lung or           | Offer an urgent chest X-ray (to be done  |\n| cough or fatigue or    | mesothelioma      | within 2 weeks) [1.1.2] [1.1.5]          |\n| shortness of breath    |                   |                                          |\n| or chest pain or       |                   |                                          |\n| appetite loss          |                   |                                          |\n| (unexplained),         |                   |                                          |\n| 40 and over, never     |                   |                                          |\n| smoked                 |                   |                                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nWeight loss\n(unexplained) with\nrectal bleeding in\nadults under 50\tColorectal\tOffer quantitative faecal immunochemical\ntesting [1.3.1]\nWeight loss\n(unexplained),\n50 and over\tColorectal\tOffer quantitative faecal immunochemical\ntesting [1.3.1]\nWeight loss\n(unexplained),\n40 and over, ever\nsmoked\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to be done\nwithin 2 weeks) [1.1.2] [1.1.5]\nWeight loss\n(unexplained),\n40 and over,\nexposed to\nasbestos\tMesothelioma\tOffer an urgent chest X-ray (to be done\nwithin 2 weeks) [1.1.5]\nWeight loss with\ncough or fatigue or\nshortness of breath\nor chest pain or\nappetite loss\n(unexplained),\n40 and over, never\nsmoked\tLung or\nmesothelioma\tOffer an urgent chest X-ray (to be done\nwithin 2 weeks) [1.1.2] [1.1.5]"
  },
  {
    "element_id": "page_67_seq_0",
    "page_number": 67,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6]\nWeight loss with\nSeparate recommendations have been\nunexplained Non-Hodgkin's\nmade for adults and for children and young\nsplenomegaly in lymphoma\npeople to reflect that there are different\nadults\nreferral pathways. In practice young people\n(aged 16 to 24) may be referred using\neither pathway depending on their age and\nlocal arrangements\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6] [1.10.8]\nWeight loss with Hodgkin's\nSeparate recommendations have been\nunexplained lymphoma or\nmade for adults and for children and young\nlymphadenopathy in non-Hodgkin's\npeople to reflect that there are different\nadults lymphoma\nreferral pathways. In practice young people\n(aged 16 to 24) may be referred using\neither pathway depending on their age and\nlocal arrangements\nWeight loss with\nupper abdominal\nOesophageal or Refer using a suspected cancer pathway\npain or reflux or\nstomach referral [1.2.1] [1.2.7]\ndyspepsia, 55 and\nover",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6]\nWeight loss with\nSeparate recommendations have been\nunexplained Non-Hodgkin's\nmade for adults and for children and young\nsplenomegaly in lymphoma\npeople to reflect that there are different\nadults\nreferral pathways. In practice young people\n(aged 16 to 24) may be referred using\neither pathway depending on their age and\nlocal arrangements\nConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6] [1.10.8]\nWeight loss with Hodgkin's\nSeparate recommendations have been\nunexplained lymphoma or\nmade for adults and for children and young\nlymphadenopathy in non-Hodgkin's\npeople to reflect that there are different\nadults lymphoma\nreferral pathways. In practice young people\n(aged 16 to 24) may be referred using\neither pathway depending on their age and\nlocal arrangements\nWeight loss with\nupper abdominal\nOesophageal or Refer using a suspected cancer pathway\npain or reflux or\nstomach referral [1.2.1] [1.2.7]\ndyspepsia, 55 and\nover"
  },
  {
    "element_id": "page_67",
    "page_number": 67,
    "element_type": "table",
    "markdown": "Table 1 on Page 67\n\n| Symptom and specific   | Possible cancer   | Recommendation                              |\n| features               |                   |                                             |\n|:-----------------------|:------------------|:--------------------------------------------|\n| Weight loss with       | Non-Hodgkin's     | Consider a suspected cancer pathway         |\n| unexplained            | lymphoma          | referral. When considering referral, take   |\n| splenomegaly in        |                   | into account any associated symptoms        |\n| adults                 |                   | [1.10.6]                                    |\n|                        |                   | Separate recommendations have been          |\n|                        |                   | made for adults and for children and young  |\n|                        |                   | people to reflect that there are different  |\n|                        |                   | referral pathways. In practice young people |\n|                        |                   | (aged 16 to 24) may be referred using       |\n|                        |                   | either pathway depending on their age and   |\n|                        |                   | local arrangements                          |\n| Weight loss with       | Hodgkin's         | Consider a suspected cancer pathway         |\n| unexplained            | lymphoma or       | referral. When considering referral, take   |\n| lymphadenopathy in     | non-Hodgkin's     | into account any associated symptoms        |\n| adults                 | lymphoma          | [1.10.6] [1.10.8]                           |\n|                        |                   | Separate recommendations have been          |\n|                        |                   | made for adults and for children and young  |\n|                        |                   | people to reflect that there are different  |\n|                        |                   | referral pathways. In practice young people |\n|                        |                   | (aged 16 to 24) may be referred using       |\n|                        |                   | either pathway depending on their age and   |\n|                        |                   | local arrangements                          |\n| Weight loss with       | Oesophageal or    | Refer using a suspected cancer pathway      |\n| upper abdominal        | stomach           | referral [1.2.1] [1.2.7]                    |\n| pain or reflux or      |                   |                                             |\n| dyspepsia, 55 and      |                   |                                             |\n| over                   |                   |                                             |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nWeight loss with\nunexplained\nsplenomegaly in\nadults\tNon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6]\nSeparate recommendations have been\nmade for adults and for children and young\npeople to reflect that there are different\nreferral pathways. In practice young people\n(aged 16 to 24) may be referred using\neither pathway depending on their age and\nlocal arrangements\nWeight loss with\nunexplained\nlymphadenopathy in\nadults\tHodgkin's\nlymphoma or\nnon-Hodgkin's\nlymphoma\tConsider a suspected cancer pathway\nreferral. When considering referral, take\ninto account any associated symptoms\n[1.10.6] [1.10.8]\nSeparate recommendations have been\nmade for adults and for children and young\npeople to reflect that there are different\nreferral pathways. In practice young people\n(aged 16 to 24) may be referred using\neither pathway depending on their age and\nlocal arrangements\nWeight loss with\nupper abdominal\npain or reflux or\ndyspepsia, 55 and\nover\tOesophageal or\nstomach\tRefer using a suspected cancer pathway\nreferral [1.2.1] [1.2.7]"
  },
  {
    "element_id": "page_68_seq_0",
    "page_number": 68,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider carrying out tests in primary care\n[1.5.3]\nMeasure serum CA125 in primary care\nWeight loss [1.5.6]\n(unexplained) in Ovarian See the section on primary care\nwomen investigations for information on tests for\novarian cancer\nThese recommendations apply to women\naged 18 and over\nWeight loss with\ndiarrhoea or back\npain or abdominal\nConsider an urgent, direct access CT scan\npain or nausea or\nPancreatic (to be done within 2 weeks), or an urgent\nvomiting or\nultrasound scan if CT is not available [1.2.5]\nconstipation or\nnew-onset diabetes,\n60 and over\nWeight loss with\nraised platelet count\nOesophageal or Consider non-urgent, direct access upper\nor nausea or\nstomach gastrointestinal endoscopy [1.2.3] [1.2.9]\nvomiting, 55 and\nover\nPrimary care investigations\nBlood test findings\nInvestigation findings and specific features Possible cancer Recommendation\nOffer quantitative faecal\nAnaemia (iron-deficiency) Colorectal immunochemical testing\n[1.3.1]\nOffer quantitative faecal\nAnaemia (non-iron-deficiency), 60 and over Colorectal immunochemical testing\n[1.3.1]",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider carrying out tests in primary care\n[1.5.3]\nMeasure serum CA125 in primary care\nWeight loss [1.5.6]\n(unexplained) in Ovarian See the section on primary care\nwomen investigations for information on tests for\novarian cancer\nThese recommendations apply to women\naged 18 and over\nWeight loss with\ndiarrhoea or back\npain or abdominal\nConsider an urgent, direct access CT scan\npain or nausea or\nPancreatic (to be done within 2 weeks), or an urgent\nvomiting or\nultrasound scan if CT is not available [1.2.5]\nconstipation or\nnew-onset diabetes,\n60 and over\nWeight loss with\nraised platelet count\nOesophageal or Consider non-urgent, direct access upper\nor nausea or\nstomach gastrointestinal endoscopy [1.2.3] [1.2.9]\nvomiting, 55 and\nover\nPrimary care investigations\nBlood test findings\nInvestigation findings and specific features Possible cancer Recommendation\nOffer quantitative faecal\nAnaemia (iron-deficiency) Colorectal immunochemical testing\n[1.3.1]\nOffer quantitative faecal\nAnaemia (non-iron-deficiency), 60 and over Colorectal immunochemical testing\n[1.3.1]"
  },
  {
    "element_id": "page_68",
    "page_number": 68,
    "element_type": "table",
    "markdown": "Table 1 on Page 68\n\n| Symptom and specific   | Possible cancer   | Recommendation                                 |\n| features               |                   |                                                |\n|:-----------------------|:------------------|:-----------------------------------------------|\n| Weight loss            | Ovarian           | Consider carrying out tests in primary care    |\n| (unexplained) in       |                   | [1.5.3]                                        |\n| women                  |                   | Measure serum CA125 in primary care            |\n|                        |                   | [1.5.6]                                        |\n|                        |                   | See the section on primary care                |\n|                        |                   | investigations for information on tests for    |\n|                        |                   | ovarian cancer                                 |\n|                        |                   | These recommendations apply to women           |\n|                        |                   | aged 18 and over                               |\n| Weight loss with       | Pancreatic        | Consider an urgent, direct access CT scan      |\n| diarrhoea or back      |                   | (to be done within 2 weeks), or an urgent      |\n| pain or abdominal      |                   | ultrasound scan if CT is not available [1.2.5] |\n| pain or nausea or      |                   |                                                |\n| vomiting or            |                   |                                                |\n| constipation or        |                   |                                                |\n| new-onset diabetes,    |                   |                                                |\n| 60 and over            |                   |                                                |\n| Weight loss with       | Oesophageal or    | Consider non-urgent, direct access upper       |\n| raised platelet count  | stomach           | gastrointestinal endoscopy [1.2.3] [1.2.9]     |\n| or nausea or           |                   |                                                |\n| vomiting, 55 and       |                   |                                                |\n| over                   |                   |                                                |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nWeight loss\n(unexplained) in\nwomen\tOvarian\tConsider carrying out tests in primary care\n[1.5.3]\nMeasure serum CA125 in primary care\n[1.5.6]\nSee the section on primary care\ninvestigations for information on tests for\novarian cancer\nThese recommendations apply to women\naged 18 and over\nWeight loss with\ndiarrhoea or back\npain or abdominal\npain or nausea or\nvomiting or\nconstipation or\nnew-onset diabetes,\n60 and over\tPancreatic\tConsider an urgent, direct access CT scan\n(to be done within 2 weeks), or an urgent\nultrasound scan if CT is not available [1.2.5]\nWeight loss with\nraised platelet count\nor nausea or\nvomiting, 55 and\nover\tOesophageal or\nstomach\tConsider non-urgent, direct access upper\ngastrointestinal endoscopy [1.2.3] [1.2.9]"
  },
  {
    "element_id": "page_68",
    "page_number": 68,
    "element_type": "table",
    "markdown": "Table 2 on Page 68\n\n| Investigation findings and specific features   | Possible cancer   | Recommendation            |\n|:-----------------------------------------------|:------------------|:--------------------------|\n| Anaemia (iron-deficiency)                      | Colorectal        | Offer quantitative faecal |\n|                                                |                   | immunochemical testing    |\n|                                                |                   | [1.3.1]                   |\n| Anaemia (non-iron-deficiency), 60 and over     | Colorectal        | Offer quantitative faecal |\n|                                                |                   | immunochemical testing    |\n|                                                |                   | [1.3.1]                   |",
    "raw_text": "Investigation findings and specific features\tPossible cancer\tRecommendation\nAnaemia (iron-deficiency)\tColorectal\tOffer quantitative faecal\nimmunochemical testing\n[1.3.1]\nAnaemia (non-iron-deficiency), 60 and over\tColorectal\tOffer quantitative faecal\nimmunochemical testing\n[1.3.1]"
  },
  {
    "element_id": "page_69_seq_0",
    "page_number": 69,
    "element_type": "text",
    "markdown": "Investigation findings and specific features Possible cancer Recommendation\nBlood glucose levels high with visible Consider a direct access\nEndometrial\nhaematuria in women 55 and over ultrasound scan [1.5.12]\nConsider an urgent, direct\naccess CT scan (to be\nDiabetes (new-onset) with weight loss, done within 2 weeks), or\nPancreatic\n60 and over an urgent ultrasound scan\nif CT is not available\n[1.2.5]\nHaemoglobin levels low with visible Consider a direct access\nEndometrial\nhaematuria in women 55 and over ultrasound scan [1.5.12]\nConsider non-urgent,\nHaemoglobin levels low with upper Oesophageal direct access upper\nabdominal pain, 55 and over or stomach gastrointestinal\nendoscopy [1.2.3] [1.2.9]\nHypercalcaemia or leukopenia with Refer using a suspected\npersistent bone pain, particularly back pain, Myeloma cancer pathway referral\nor unexplained fracture, 60 and over [1.10.5]\nPlasma viscosity or erythrocyte\nRefer using a suspected\nsedimentation rate suggests myeloma, plus\nMyeloma cancer pathway referral\npersistent bone pain, particularly back pain,\n[1.10.5]\nor unexplained fracture\nPlatelet count raised with nausea or Consider non-urgent,\nvomiting or weight loss or reflux or Oesophageal direct access upper\ndyspepsia or upper abdominal pain, 55 and or stomach gastrointestinal\nover endoscopy [1.2.3] [1.2.9]\nProstate-specific antigenlevels above the\nage-specific threshold in table 1 plus lower\nConsider a suspected\nurinary tract symptoms such as nocturia,\nProstate cancer pathway referral\nurinary frequency, hesitancy, urgency or\n[1.6.3]\nretention or erectile dysfunction or visible\nhaematuria",
    "raw_text": "Investigation findings and specific features Possible cancer Recommendation\nBlood glucose levels high with visible Consider a direct access\nEndometrial\nhaematuria in women 55 and over ultrasound scan [1.5.12]\nConsider an urgent, direct\naccess CT scan (to be\nDiabetes (new-onset) with weight loss, done within 2 weeks), or\nPancreatic\n60 and over an urgent ultrasound scan\nif CT is not available\n[1.2.5]\nHaemoglobin levels low with visible Consider a direct access\nEndometrial\nhaematuria in women 55 and over ultrasound scan [1.5.12]\nConsider non-urgent,\nHaemoglobin levels low with upper Oesophageal direct access upper\nabdominal pain, 55 and over or stomach gastrointestinal\nendoscopy [1.2.3] [1.2.9]\nHypercalcaemia or leukopenia with Refer using a suspected\npersistent bone pain, particularly back pain, Myeloma cancer pathway referral\nor unexplained fracture, 60 and over [1.10.5]\nPlasma viscosity or erythrocyte\nRefer using a suspected\nsedimentation rate suggests myeloma, plus\nMyeloma cancer pathway referral\npersistent bone pain, particularly back pain,\n[1.10.5]\nor unexplained fracture\nPlatelet count raised with nausea or Consider non-urgent,\nvomiting or weight loss or reflux or Oesophageal direct access upper\ndyspepsia or upper abdominal pain, 55 and or stomach gastrointestinal\nover endoscopy [1.2.3] [1.2.9]\nProstate-specific antigenlevels above the\nage-specific threshold in table 1 plus lower\nConsider a suspected\nurinary tract symptoms such as nocturia,\nProstate cancer pathway referral\nurinary frequency, hesitancy, urgency or\n[1.6.3]\nretention or erectile dysfunction or visible\nhaematuria"
  },
  {
    "element_id": "page_69",
    "page_number": 69,
    "element_type": "table",
    "markdown": "Table 1 on Page 69\n\n| Investigation findings and specific features   | Possible cancer   | Recommendation             |\n|:-----------------------------------------------|:------------------|:---------------------------|\n| Blood glucose levels high with visible         | Endometrial       | Consider a direct access   |\n| haematuria in women 55 and over                |                   | ultrasound scan [1.5.12]   |\n| Diabetes (new-onset) with weight loss,         | Pancreatic        | Consider an urgent, direct |\n| 60 and over                                    |                   | access CT scan (to be      |\n|                                                |                   | done within 2 weeks), or   |\n|                                                |                   | an urgent ultrasound scan  |\n|                                                |                   | if CT is not available     |\n|                                                |                   | [1.2.5]                    |\n| Haemoglobin levels low with visible            | Endometrial       | Consider a direct access   |\n| haematuria in women 55 and over                |                   | ultrasound scan [1.5.12]   |\n| Haemoglobin levels low with upper              | Oesophageal       | Consider non-urgent,       |\n| abdominal pain, 55 and over                    | or stomach        | direct access upper        |\n|                                                |                   | gastrointestinal           |\n|                                                |                   | endoscopy [1.2.3] [1.2.9]  |\n| Hypercalcaemia or leukopenia with              | Myeloma           | Refer using a suspected    |\n| persistent bone pain, particularly back pain,  |                   | cancer pathway referral    |\n| or unexplained fracture, 60 and over           |                   | [1.10.5]                   |\n| Plasma viscosity or erythrocyte                | Myeloma           | Refer using a suspected    |\n| sedimentation rate suggests myeloma, plus      |                   | cancer pathway referral    |\n| persistent bone pain, particularly back pain,  |                   | [1.10.5]                   |\n| or unexplained fracture                        |                   |                            |\n| Platelet count raised with nausea or           | Oesophageal       | Consider non-urgent,       |\n| vomiting or weight loss or reflux or           | or stomach        | direct access upper        |\n| dyspepsia or upper abdominal pain, 55 and      |                   | gastrointestinal           |\n| over                                           |                   | endoscopy [1.2.3] [1.2.9]  |\n| Prostate-specific antigenlevels above the      | Prostate          | Consider a suspected       |\n| age-specific threshold in table 1 plus lower   |                   | cancer pathway referral    |\n| urinary tract symptoms such as nocturia,       |                   | [1.6.3]                    |\n| urinary frequency, hesitancy, urgency or       |                   |                            |\n| retention or erectile dysfunction or visible   |                   |                            |\n| haematuria                                     |                   |                            |",
    "raw_text": "Investigation findings and specific features\tPossible cancer\tRecommendation\nBlood glucose levels high with visible\nhaematuria in women 55 and over\tEndometrial\tConsider a direct access\nultrasound scan [1.5.12]\nDiabetes (new-onset) with weight loss,\n60 and over\tPancreatic\tConsider an urgent, direct\naccess CT scan (to be\ndone within 2 weeks), or\nan urgent ultrasound scan\nif CT is not available\n[1.2.5]\nHaemoglobin levels low with visible\nhaematuria in women 55 and over\tEndometrial\tConsider a direct access\nultrasound scan [1.5.12]\nHaemoglobin levels low with upper\nabdominal pain, 55 and over\tOesophageal\nor stomach\tConsider non-urgent,\ndirect access upper\ngastrointestinal\nendoscopy [1.2.3] [1.2.9]\nHypercalcaemia or leukopenia with\npersistent bone pain, particularly back pain,\nor unexplained fracture, 60 and over\tMyeloma\tRefer using a suspected\ncancer pathway referral\n[1.10.5]\nPlasma viscosity or erythrocyte\nsedimentation rate suggests myeloma, plus\npersistent bone pain, particularly back pain,\nor unexplained fracture\tMyeloma\tRefer using a suspected\ncancer pathway referral\n[1.10.5]\nPlatelet count raised with nausea or\nvomiting or weight loss or reflux or\ndyspepsia or upper abdominal pain, 55 and\nover\tOesophageal\nor stomach\tConsider non-urgent,\ndirect access upper\ngastrointestinal\nendoscopy [1.2.3] [1.2.9]\nProstate-specific antigenlevels above the\nage-specific threshold in table 1 plus lower\nurinary tract symptoms such as nocturia,\nurinary frequency, hesitancy, urgency or\nretention or erectile dysfunction or visible\nhaematuria\tProstate\tConsider a suspected\ncancer pathway referral\n[1.6.3]"
  },
  {
    "element_id": "page_70_seq_0",
    "page_number": 70,
    "element_type": "text",
    "markdown": "Investigation findings and specific features Possible cancer Recommendation\nSerum protein electrophoresis result\nRefer people using a\nsuggests myeloma, plus persistent bone\nMyeloma suspected cancer\npain, particularly back pain, or unexplained\npathway referral [1.10.5]\nfracture\nIf serum CA125 is 35 IU/ml\nor greater, arrange an\nultrasound scan of the\nabdomen and pelvis\n[1.5.7]\nNormal serum CA125 (less\nthan 35 IU/ml), or CA125\nof 35 IU/ml or greater but\na normal ultrasound:\nassess her carefully for\nother clinical causes of\nSerum CA125 results Ovarian\nher symptoms and\ninvestigate if appropriate\nif no other clinical cause is\napparent, advise her to\nreturn to her GP if her\nsymptoms become more\nfrequent and/or\npersistent. [1.5.9]\nThese recommendations\napply to women aged\n18 and over\nSerum free light chain testing suggests\nRefer people using a\nmyeloma, plus persistent bone pain,\nMyeloma suspected cancer\nparticularly back pain, or unexplained\npathway referral [1.10.5]\nfracture\nConsider an urgent chest\nThrombocytosis, 40 and over Lung X-ray (to be done within\n2 weeks) [1.1.3]",
    "raw_text": "Investigation findings and specific features Possible cancer Recommendation\nSerum protein electrophoresis result\nRefer people using a\nsuggests myeloma, plus persistent bone\nMyeloma suspected cancer\npain, particularly back pain, or unexplained\npathway referral [1.10.5]\nfracture\nIf serum CA125 is 35 IU/ml\nor greater, arrange an\nultrasound scan of the\nabdomen and pelvis\n[1.5.7]\nNormal serum CA125 (less\nthan 35 IU/ml), or CA125\nof 35 IU/ml or greater but\na normal ultrasound:\nassess her carefully for\nother clinical causes of\nSerum CA125 results Ovarian\nher symptoms and\ninvestigate if appropriate\nif no other clinical cause is\napparent, advise her to\nreturn to her GP if her\nsymptoms become more\nfrequent and/or\npersistent. [1.5.9]\nThese recommendations\napply to women aged\n18 and over\nSerum free light chain testing suggests\nRefer people using a\nmyeloma, plus persistent bone pain,\nMyeloma suspected cancer\nparticularly back pain, or unexplained\npathway referral [1.10.5]\nfracture\nConsider an urgent chest\nThrombocytosis, 40 and over Lung X-ray (to be done within\n2 weeks) [1.1.3]"
  },
  {
    "element_id": "page_70",
    "page_number": 70,
    "element_type": "table",
    "markdown": "Table 1 on Page 70\n\n| Investigation findings and specific features   | Possible cancer   | Recommendation                |\n|:-----------------------------------------------|:------------------|:------------------------------|\n| Serum protein electrophoresis result           | Myeloma           | Refer people using a          |\n| suggests myeloma, plus persistent bone         |                   | suspected cancer              |\n| pain, particularly back pain, or unexplained   |                   | pathway referral [1.10.5]     |\n| fracture                                       |                   |                               |\n| Serum CA125 results                            | Ovarian           | If serum CA125 is 35 IU/ml    |\n|                                                |                   | or greater, arrange an        |\n|                                                |                   | ultrasound scan of the        |\n|                                                |                   | abdomen and pelvis            |\n|                                                |                   | [1.5.7]                       |\n|                                                |                   | Normal serum CA125 (less      |\n|                                                |                   | than 35 IU/ml), or CA125      |\n|                                                |                   | of 35 IU/ml or greater but    |\n|                                                |                   | a normal ultrasound:          |\n|                                                |                   | assess her carefully for      |\n|                                                |                   | other clinical causes of      |\n|                                                |                   | her symptoms and              |\n|                                                |                   | investigate if appropriate    |\n|                                                |                   | if no other clinical cause is |\n|                                                |                   | apparent, advise her to       |\n|                                                |                   | return to her GP if her       |\n|                                                |                   | symptoms become more          |\n|                                                |                   | frequent and/or               |\n|                                                |                   | persistent. [1.5.9]           |\n|                                                |                   | These recommendations         |\n|                                                |                   | apply to women aged           |\n|                                                |                   | 18 and over                   |\n| Serum free light chain testing suggests        | Myeloma           | Refer people using a          |\n| myeloma, plus persistent bone pain,            |                   | suspected cancer              |\n| particularly back pain, or unexplained         |                   | pathway referral [1.10.5]     |\n| fracture                                       |                   |                               |\n| Thrombocytosis, 40 and over                    | Lung              | Consider an urgent chest      |\n|                                                |                   | X-ray (to be done within      |\n|                                                |                   | 2 weeks) [1.1.3]              |",
    "raw_text": "Investigation findings and specific features\tPossible cancer\tRecommendation\nSerum protein electrophoresis result\nsuggests myeloma, plus persistent bone\npain, particularly back pain, or unexplained\nfracture\tMyeloma\tRefer people using a\nsuspected cancer\npathway referral [1.10.5]\nSerum CA125 results\tOvarian\tIf serum CA125 is 35 IU/ml\nor greater, arrange an\nultrasound scan of the\nabdomen and pelvis\n[1.5.7]\nNormal serum CA125 (less\nthan 35 IU/ml), or CA125\nof 35 IU/ml or greater but\na normal ultrasound:\nassess her carefully for\nother clinical causes of\nher symptoms and\ninvestigate if appropriate\nif no other clinical cause is\napparent, advise her to\nreturn to her GP if her\nsymptoms become more\nfrequent and/or\npersistent. [1.5.9]\nThese recommendations\napply to women aged\n18 and over\nSerum free light chain testing suggests\nmyeloma, plus persistent bone pain,\nparticularly back pain, or unexplained\nfracture\tMyeloma\tRefer people using a\nsuspected cancer\npathway referral [1.10.5]\nThrombocytosis, 40 and over\tLung\tConsider an urgent chest\nX-ray (to be done within\n2 weeks) [1.1.3]"
  },
  {
    "element_id": "page_71_seq_0",
    "page_number": 71,
    "element_type": "text",
    "markdown": "Investigation findings and specific features Possible cancer Recommendation\nThrombocytosis with visible haematuria or\nConsider a direct access\nvaginal discharge (unexplained) in women Endometrial\nultrasound scan [1.5.12]\n55 and over\nWhite cell count raised on a blood test with Refer people using a\nunexplained non-visible haematuria, 60 and Bladder suspected cancer\nover pathway referral [1.6.4]\nDermoscopy findings\nInvestigation findings and specific Possible\nRecommendation\nfeatures cancer\nDermoscopy suggests Refer people using a suspected cancer\nMelanoma\nmelanoma of the skin pathway referral [1.7.2]\nDigital rectal examination findings\nPossible\nExamination findings and specific features Recommendation\ncancer\nProstate feels malignant on digital Refer men using a suspected cancer\nProstate\nrectal examination pathway referral [1.6.1]\nFaecal tests\nInvestigation findings and specific Possible\nRecommendation\nfeatures cancer\nRefer adults using a suspected cancer pathway\nOccult blood in faeces Colorectal\nreferral [1.3.2]\nImaging tests\nInvestigation findings and\nPossible cancer Recommendation\nspecific features\nChest X-ray\nRefer people using a suspected cancer pathway\nsuggests lung Lung\nreferral [1.1.1]\ncancer\nChest X-ray\nRefer people using a suspected cancer pathway\nsuggests Mesothelioma\nreferral [1.1.4]\nmesothelioma",
    "raw_text": "Investigation findings and specific features Possible cancer Recommendation\nThrombocytosis with visible haematuria or\nConsider a direct access\nvaginal discharge (unexplained) in women Endometrial\nultrasound scan [1.5.12]\n55 and over\nWhite cell count raised on a blood test with Refer people using a\nunexplained non-visible haematuria, 60 and Bladder suspected cancer\nover pathway referral [1.6.4]\nDermoscopy findings\nInvestigation findings and specific Possible\nRecommendation\nfeatures cancer\nDermoscopy suggests Refer people using a suspected cancer\nMelanoma\nmelanoma of the skin pathway referral [1.7.2]\nDigital rectal examination findings\nPossible\nExamination findings and specific features Recommendation\ncancer\nProstate feels malignant on digital Refer men using a suspected cancer\nProstate\nrectal examination pathway referral [1.6.1]\nFaecal tests\nInvestigation findings and specific Possible\nRecommendation\nfeatures cancer\nRefer adults using a suspected cancer pathway\nOccult blood in faeces Colorectal\nreferral [1.3.2]\nImaging tests\nInvestigation findings and\nPossible cancer Recommendation\nspecific features\nChest X-ray\nRefer people using a suspected cancer pathway\nsuggests lung Lung\nreferral [1.1.1]\ncancer\nChest X-ray\nRefer people using a suspected cancer pathway\nsuggests Mesothelioma\nreferral [1.1.4]\nmesothelioma"
  },
  {
    "element_id": "page_71",
    "page_number": 71,
    "element_type": "table",
    "markdown": "Table 1 on Page 71\n\n| Investigation findings and specific features   | Possible cancer   | Recommendation           |\n|:-----------------------------------------------|:------------------|:-------------------------|\n| Thrombocytosis with visible haematuria or      | Endometrial       | Consider a direct access |\n| vaginal discharge (unexplained) in women       |                   | ultrasound scan [1.5.12] |\n| 55 and over                                    |                   |                          |\n| White cell count raised on a blood test with   | Bladder           | Refer people using a     |\n| unexplained non-visible haematuria, 60 and     |                   | suspected cancer         |\n| over                                           |                   | pathway referral [1.6.4] |",
    "raw_text": "Investigation findings and specific features\tPossible cancer\tRecommendation\nThrombocytosis with visible haematuria or\nvaginal discharge (unexplained) in women\n55 and over\tEndometrial\tConsider a direct access\nultrasound scan [1.5.12]\nWhite cell count raised on a blood test with\nunexplained non-visible haematuria, 60 and\nover\tBladder\tRefer people using a\nsuspected cancer\npathway referral [1.6.4]"
  },
  {
    "element_id": "page_71",
    "page_number": 71,
    "element_type": "table",
    "markdown": "Table 2 on Page 71\n\n| Investigation findings and specific   | Possible   | Recommendation                        |\n| features                              | cancer     |                                       |\n|:--------------------------------------|:-----------|:--------------------------------------|\n| Dermoscopy suggests                   | Melanoma   | Refer people using a suspected cancer |\n| melanoma of the skin                  |            | pathway referral [1.7.2]              |",
    "raw_text": "Investigation findings and specific\nfeatures\tPossible\ncancer\tRecommendation\nDermoscopy suggests\nmelanoma of the skin\tMelanoma\tRefer people using a suspected cancer\npathway referral [1.7.2]"
  },
  {
    "element_id": "page_71",
    "page_number": 71,
    "element_type": "table",
    "markdown": "Table 3 on Page 71\n\n| Examination findings and specific features   | Possible   | Recommendation                     |\n|                                              | cancer     |                                    |\n|:---------------------------------------------|:-----------|:-----------------------------------|\n| Prostate feels malignant on digital          | Prostate   | Refer men using a suspected cancer |\n| rectal examination                           |            | pathway referral [1.6.1]           |",
    "raw_text": "Examination findings and specific features\tPossible\ncancer\tRecommendation\nProstate feels malignant on digital\nrectal examination\tProstate\tRefer men using a suspected cancer\npathway referral [1.6.1]"
  },
  {
    "element_id": "page_71",
    "page_number": 71,
    "element_type": "table",
    "markdown": "Table 4 on Page 71\n\n| Investigation findings and specific   | Possible   | Recommendation                                |\n| features                              | cancer     |                                               |\n|:--------------------------------------|:-----------|:----------------------------------------------|\n| Occult blood in faeces                | Colorectal | Refer adults using a suspected cancer pathway |\n|                                       |            | referral [1.3.2]                              |",
    "raw_text": "Investigation findings and specific\nfeatures\tPossible\ncancer\tRecommendation\nOccult blood in faeces\tColorectal\tRefer adults using a suspected cancer pathway\nreferral [1.3.2]"
  },
  {
    "element_id": "page_71",
    "page_number": 71,
    "element_type": "table",
    "markdown": "Table 5 on Page 71\n\n| Investigation findings and   | Possible cancer   | Recommendation                                |\n| specific features            |                   |                                               |\n|:-----------------------------|:------------------|:----------------------------------------------|\n| Chest X-ray                  | Lung              | Refer people using a suspected cancer pathway |\n| suggests lung                |                   | referral [1.1.1]                              |\n| cancer                       |                   |                                               |\n| Chest X-ray                  | Mesothelioma      | Refer people using a suspected cancer pathway |\n| suggests                     |                   | referral [1.1.4]                              |\n| mesothelioma                 |                   |                                               |",
    "raw_text": "Investigation findings and\nspecific features\tPossible cancer\tRecommendation\nChest X-ray\nsuggests lung\ncancer\tLung\tRefer people using a suspected cancer pathway\nreferral [1.1.1]\nChest X-ray\nsuggests\nmesothelioma\tMesothelioma\tRefer people using a suspected cancer pathway\nreferral [1.1.4]"
  },
  {
    "element_id": "page_72_seq_0",
    "page_number": 72,
    "element_type": "text",
    "markdown": "Investigation findings and\nPossible cancer Recommendation\nspecific features\nRefer women using a suspected cancer pathway\nUltrasound\nreferral [1.5.8]\nsuggests ovarian Ovarian\nThese recommendations apply to women aged\ncancer\n18 and over\nAssess carefully for other clinical causes of her\nsymptoms and investigate if appropriate\nUltrasound normal If no other clinical cause is apparent, advise her to\nwith CA125 of Ovarian return to her GP if her symptoms become more\n35 IU/ml or greater frequent and/or persistent [1.5.9]\nThese recommendations apply to women aged\n18 and over\nConsider a suspected cancer pathway referral\n[1.11.5]\nUltrasoundsuggests\nSeparate recommendations have been made for\nsoft tissue sarcoma\nSoft tissue adults and for children and young people to\nor is uncertain and\nsarcoma reflect that there are different referral pathways.\nclinical concern\nIn practice young people (aged 16 to 24) may be\npersists in adults\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral\n[1.11.1]\nSeparate recommendations have been made for\nX-ray suggests the\nBone adults and for children and young people to\npossibility of bone\nsarcoma reflect that there are different referral pathways.\nsarcoma in adults\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nJaundice\nInvestigation findings and Possible\nRecommendation\nspecific features cancer\nRefer people using a suspected cancer pathway\nJaundice, 40 and over Pancreatic\nreferral [1.2.4]",
    "raw_text": "Investigation findings and\nPossible cancer Recommendation\nspecific features\nRefer women using a suspected cancer pathway\nUltrasound\nreferral [1.5.8]\nsuggests ovarian Ovarian\nThese recommendations apply to women aged\ncancer\n18 and over\nAssess carefully for other clinical causes of her\nsymptoms and investigate if appropriate\nUltrasound normal If no other clinical cause is apparent, advise her to\nwith CA125 of Ovarian return to her GP if her symptoms become more\n35 IU/ml or greater frequent and/or persistent [1.5.9]\nThese recommendations apply to women aged\n18 and over\nConsider a suspected cancer pathway referral\n[1.11.5]\nUltrasoundsuggests\nSeparate recommendations have been made for\nsoft tissue sarcoma\nSoft tissue adults and for children and young people to\nor is uncertain and\nsarcoma reflect that there are different referral pathways.\nclinical concern\nIn practice young people (aged 16 to 24) may be\npersists in adults\nreferred using either pathway depending on their\nage and local arrangements\nConsider a suspected cancer pathway referral\n[1.11.1]\nSeparate recommendations have been made for\nX-ray suggests the\nBone adults and for children and young people to\npossibility of bone\nsarcoma reflect that there are different referral pathways.\nsarcoma in adults\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nJaundice\nInvestigation findings and Possible\nRecommendation\nspecific features cancer\nRefer people using a suspected cancer pathway\nJaundice, 40 and over Pancreatic\nreferral [1.2.4]"
  },
  {
    "element_id": "page_72",
    "page_number": 72,
    "element_type": "table",
    "markdown": "Table 1 on Page 72\n\n| Investigation findings and   | Possible cancer   | Recommendation                                        |\n| specific features            |                   |                                                       |\n|:-----------------------------|:------------------|:------------------------------------------------------|\n| Ultrasound                   | Ovarian           | Refer women using a suspected cancer pathway          |\n| suggests ovarian             |                   | referral [1.5.8]                                      |\n| cancer                       |                   | These recommendations apply to women aged             |\n|                              |                   | 18 and over                                           |\n| Ultrasound normal            | Ovarian           | Assess carefully for other clinical causes of her     |\n| with CA125 of                |                   | symptoms and investigate if appropriate               |\n| 35 IU/ml or greater          |                   | If no other clinical cause is apparent, advise her to |\n|                              |                   | return to her GP if her symptoms become more          |\n|                              |                   | frequent and/or persistent [1.5.9]                    |\n|                              |                   | These recommendations apply to women aged             |\n|                              |                   | 18 and over                                           |\n| Ultrasoundsuggests           | Soft tissue       | Consider a suspected cancer pathway referral          |\n| soft tissue sarcoma          | sarcoma           | [1.11.5]                                              |\n| or is uncertain and          |                   | Separate recommendations have been made for           |\n| clinical concern             |                   | adults and for children and young people to           |\n| persists in adults           |                   | reflect that there are different referral pathways.   |\n|                              |                   | In practice young people (aged 16 to 24) may be       |\n|                              |                   | referred using either pathway depending on their      |\n|                              |                   | age and local arrangements                            |\n| X-ray suggests the           | Bone              | Consider a suspected cancer pathway referral          |\n| possibility of bone          | sarcoma           | [1.11.1]                                              |\n| sarcoma in adults            |                   | Separate recommendations have been made for           |\n|                              |                   | adults and for children and young people to           |\n|                              |                   | reflect that there are different referral pathways.   |\n|                              |                   | In practice young people (aged 16 to 24) may be       |\n|                              |                   | referred using either pathway depending on their      |\n|                              |                   | age and local arrangements                            |",
    "raw_text": "Investigation findings and\nspecific features\tPossible cancer\tRecommendation\nUltrasound\nsuggests ovarian\ncancer\tOvarian\tRefer women using a suspected cancer pathway\nreferral [1.5.8]\nThese recommendations apply to women aged\n18 and over\nUltrasound normal\nwith CA125 of\n35 IU/ml or greater\tOvarian\tAssess carefully for other clinical causes of her\nsymptoms and investigate if appropriate\nIf no other clinical cause is apparent, advise her to\nreturn to her GP if her symptoms become more\nfrequent and/or persistent [1.5.9]\nThese recommendations apply to women aged\n18 and over\nUltrasoundsuggests\nsoft tissue sarcoma\nor is uncertain and\nclinical concern\npersists in adults\tSoft tissue\nsarcoma\tConsider a suspected cancer pathway referral\n[1.11.5]\nSeparate recommendations have been made for\nadults and for children and young people to\nreflect that there are different referral pathways.\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nX-ray suggests the\npossibility of bone\nsarcoma in adults\tBone\nsarcoma\tConsider a suspected cancer pathway referral\n[1.11.1]\nSeparate recommendations have been made for\nadults and for children and young people to\nreflect that there are different referral pathways.\nIn practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_72",
    "page_number": 72,
    "element_type": "table",
    "markdown": "Table 2 on Page 72\n\n| Investigation findings and   | Possible   | Recommendation                                |\n| specific features            | cancer     |                                               |\n|:-----------------------------|:-----------|:----------------------------------------------|\n| Jaundice, 40 and over        | Pancreatic | Refer people using a suspected cancer pathway |\n|                              |            | referral [1.2.4]                              |",
    "raw_text": "Investigation findings and\nspecific features\tPossible\ncancer\tRecommendation\nJaundice, 40 and over\tPancreatic\tRefer people using a suspected cancer pathway\nreferral [1.2.4]"
  },
  {
    "element_id": "page_73_seq_0",
    "page_number": 73,
    "element_type": "text",
    "markdown": "Urine test findings\nPossible\nInvestigation findings and specific features Recommendation\ncancer\nBence\u2013Jones protein urine results (used if serum free Refer people using\nlight chain testing is not available)suggest myeloma, a suspected\nMyeloma\nplus persistent bone pain, particularly back pain, or cancer pathway\nunexplained fracture referral [1.10.5]\nSymptoms in children and young people\nAbdominal symptoms\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nHepatosplenomegaly\n(unexplained) in Refer for immediate specialist assessment\nLeukaemia\nchildren and young [1.10.2]\npeople\nAbdominal mass\n(palpable) or Neuroblastoma Consider very urgent referral (for an\nenlarged abdominal or Wilms' appointment within 48 hours) for specialist\norgan (unexplained) tumour assessment [1.12.1] [1.12.3]\nin children\nConsider a very urgent referral (for an\nappointment within 48 hours) for specialist\nassessment. When considering referral, take\ninto account any associated symptoms,\nSplenomegaly particularly fever, night sweats, shortness of\n(unexplained) in Non-Hodgkin's breath, pruritus or weight loss [1.10.7]\nchildren and young lymphoma Separate recommendations have been made\npeople for adults and for children and young people to\nreflect that there are different referral\npathways. In practice young people (aged 16 to\n24) may be referred using either pathway\ndepending on their age and local arrangements",
    "raw_text": "Urine test findings\nPossible\nInvestigation findings and specific features Recommendation\ncancer\nBence\u2013Jones protein urine results (used if serum free Refer people using\nlight chain testing is not available)suggest myeloma, a suspected\nMyeloma\nplus persistent bone pain, particularly back pain, or cancer pathway\nunexplained fracture referral [1.10.5]\nSymptoms in children and young people\nAbdominal symptoms\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nHepatosplenomegaly\n(unexplained) in Refer for immediate specialist assessment\nLeukaemia\nchildren and young [1.10.2]\npeople\nAbdominal mass\n(palpable) or Neuroblastoma Consider very urgent referral (for an\nenlarged abdominal or Wilms' appointment within 48 hours) for specialist\norgan (unexplained) tumour assessment [1.12.1] [1.12.3]\nin children\nConsider a very urgent referral (for an\nappointment within 48 hours) for specialist\nassessment. When considering referral, take\ninto account any associated symptoms,\nSplenomegaly particularly fever, night sweats, shortness of\n(unexplained) in Non-Hodgkin's breath, pruritus or weight loss [1.10.7]\nchildren and young lymphoma Separate recommendations have been made\npeople for adults and for children and young people to\nreflect that there are different referral\npathways. In practice young people (aged 16 to\n24) may be referred using either pathway\ndepending on their age and local arrangements"
  },
  {
    "element_id": "page_73",
    "page_number": 73,
    "element_type": "table",
    "markdown": "Table 1 on Page 73\n\n| Investigation findings and specific features          | Possible   | Recommendation     |\n|                                                       | cancer     |                    |\n|:------------------------------------------------------|:-----------|:-------------------|\n| Bence\u2013Jones protein urine results (used if serum free | Myeloma    | Refer people using |\n| light chain testing is not available)suggest myeloma, |            | a suspected        |\n| plus persistent bone pain, particularly back pain, or |            | cancer pathway     |\n| unexplained fracture                                  |            | referral [1.10.5]  |",
    "raw_text": "Investigation findings and specific features\tPossible\ncancer\tRecommendation\nBence\u2013Jones protein urine results (used if serum free\nlight chain testing is not available)suggest myeloma,\nplus persistent bone pain, particularly back pain, or\nunexplained fracture\tMyeloma\tRefer people using\na suspected\ncancer pathway\nreferral [1.10.5]"
  },
  {
    "element_id": "page_73",
    "page_number": 73,
    "element_type": "table",
    "markdown": "Table 2 on Page 73\n\n| Symptom and specific   | Possible cancer   | Recommendation                                  |\n| features               |                   |                                                 |\n|:-----------------------|:------------------|:------------------------------------------------|\n| Hepatosplenomegaly     | Leukaemia         | Refer for immediate specialist assessment       |\n| (unexplained) in       |                   | [1.10.2]                                        |\n| children and young     |                   |                                                 |\n| people                 |                   |                                                 |\n| Abdominal mass         | Neuroblastoma     | Consider very urgent referral (for an           |\n| (palpable) or          | or Wilms'         | appointment within 48 hours) for specialist     |\n| enlarged abdominal     | tumour            | assessment [1.12.1] [1.12.3]                    |\n| organ (unexplained)    |                   |                                                 |\n| in children            |                   |                                                 |\n| Splenomegaly           | Non-Hodgkin's     | Consider a very urgent referral (for an         |\n| (unexplained) in       | lymphoma          | appointment within 48 hours) for specialist     |\n| children and young     |                   | assessment. When considering referral, take     |\n| people                 |                   | into account any associated symptoms,           |\n|                        |                   | particularly fever, night sweats, shortness of  |\n|                        |                   | breath, pruritus or weight loss [1.10.7]        |\n|                        |                   | Separate recommendations have been made         |\n|                        |                   | for adults and for children and young people to |\n|                        |                   | reflect that there are different referral       |\n|                        |                   | pathways. In practice young people (aged 16 to  |\n|                        |                   | 24) may be referred using either pathway        |\n|                        |                   | depending on their age and local arrangements   |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nHepatosplenomegaly\n(unexplained) in\nchildren and young\npeople\tLeukaemia\tRefer for immediate specialist assessment\n[1.10.2]\nAbdominal mass\n(palpable) or\nenlarged abdominal\norgan (unexplained)\nin children\tNeuroblastoma\nor Wilms'\ntumour\tConsider very urgent referral (for an\nappointment within 48 hours) for specialist\nassessment [1.12.1] [1.12.3]\nSplenomegaly\n(unexplained) in\nchildren and young\npeople\tNon-Hodgkin's\nlymphoma\tConsider a very urgent referral (for an\nappointment within 48 hours) for specialist\nassessment. When considering referral, take\ninto account any associated symptoms,\nparticularly fever, night sweats, shortness of\nbreath, pruritus or weight loss [1.10.7]\nSeparate recommendations have been made\nfor adults and for children and young people to\nreflect that there are different referral\npathways. In practice young people (aged 16 to\n24) may be referred using either pathway\ndepending on their age and local arrangements"
  },
  {
    "element_id": "page_74_seq_0",
    "page_number": 74,
    "element_type": "text",
    "markdown": "Bleeding, bruising or rashes\nPossible\nSymptom and specific features Recommendation\ncancer\nPetechiae (unexplained) in children Refer for immediate specialist\nLeukaemia\nand young people assessment [1.10.2]\nBleeding or bruising (unexplained) in Offer a very urgent full blood count\nLeukaemia\nchildren and young people (within 48 hours) [1.10.3]\nLumps or masses\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms, particularly fever, night\nLymphadenopathy Non-Hodgkin's sweats, shortness of breath, pruritus or weight\n(unexplained) in lymphoma or loss [1.10.7] [1.10.9]\nchildren and Hodgkin's Separate recommendations have been made for\nyoung people lymphoma adults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nLymphadenopathy\n(generalised) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people",
    "raw_text": "Bleeding, bruising or rashes\nPossible\nSymptom and specific features Recommendation\ncancer\nPetechiae (unexplained) in children Refer for immediate specialist\nLeukaemia\nand young people assessment [1.10.2]\nBleeding or bruising (unexplained) in Offer a very urgent full blood count\nLeukaemia\nchildren and young people (within 48 hours) [1.10.3]\nLumps or masses\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms, particularly fever, night\nLymphadenopathy Non-Hodgkin's sweats, shortness of breath, pruritus or weight\n(unexplained) in lymphoma or loss [1.10.7] [1.10.9]\nchildren and Hodgkin's Separate recommendations have been made for\nyoung people lymphoma adults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nLymphadenopathy\n(generalised) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people"
  },
  {
    "element_id": "page_74",
    "page_number": 74,
    "element_type": "table",
    "markdown": "Table 1 on Page 74\n\n| Symptom and specific features         | Possible   | Recommendation                       |\n|                                       | cancer     |                                      |\n|:--------------------------------------|:-----------|:-------------------------------------|\n| Petechiae (unexplained) in children   | Leukaemia  | Refer for immediate specialist       |\n| and young people                      |            | assessment [1.10.2]                  |\n| Bleeding or bruising (unexplained) in | Leukaemia  | Offer a very urgent full blood count |\n| children and young people             |            | (within 48 hours) [1.10.3]           |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nPetechiae (unexplained) in children\nand young people\tLeukaemia\tRefer for immediate specialist\nassessment [1.10.2]\nBleeding or bruising (unexplained) in\nchildren and young people\tLeukaemia\tOffer a very urgent full blood count\n(within 48 hours) [1.10.3]"
  },
  {
    "element_id": "page_74",
    "page_number": 74,
    "element_type": "table",
    "markdown": "Table 2 on Page 74\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Lymphadenopathy        | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| (unexplained) in       | lymphoma or       | within 48 hours) for specialist assessment. When    |\n| children and           | Hodgkin's         | considering referral, take into account any         |\n| young people           | lymphoma          | associated symptoms, particularly fever, night      |\n|                        |                   | sweats, shortness of breath, pruritus or weight     |\n|                        |                   | loss [1.10.7] [1.10.9]                              |\n|                        |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Lymphadenopathy        | Leukaemia         | Offer a very urgent full blood count (within        |\n| (generalised) in       |                   | 48 hours) [1.10.3]                                  |\n| children and           |                   |                                                     |\n| young people           |                   |                                                     |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nLymphadenopathy\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms, particularly fever, night\nsweats, shortness of breath, pruritus or weight\nloss [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nLymphadenopathy\n(generalised) in\nchildren and\nyoung people\tLeukaemia\tOffer a very urgent full blood count (within\n48 hours) [1.10.3]"
  },
  {
    "element_id": "page_75_seq_0",
    "page_number": 75,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent, direct access ultrasound\nscan (to be done within 48 hours) [1.11.6]\nSee the section on primary care investigations for\nLump\nmore information on ultrasound scans\n(unexplained) that\nSoft tissue\nSeparate recommendations have been made for\nis increasing in\nsarcoma\nadults and for children and young people to reflect\nsize in children\nthat there are different referral pathways. In\nand young people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nSee also the section on abdominal symptoms for abdominal mass or unexplained enlarged\nabdominal organ, splenomegaly and hepatosplenomegaly.\nNeurological symptoms\nSymptom and specific features Possible cancer Recommendation\nNewly abnormal cerebellar or other Brain or central Consider a very urgent\ncentral neurological function in nervous referral (for an appointment\nchildren and young people system cancer within 48 hours) [1.9.2]\nRespiratory symptoms\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nShortness of\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nbreath with\nlymphoma or Separate recommendations have been made for\nlymphadenopathy\nHodgkin's adults and for children and young people to reflect\nin children and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent, direct access ultrasound\nscan (to be done within 48 hours) [1.11.6]\nSee the section on primary care investigations for\nLump\nmore information on ultrasound scans\n(unexplained) that\nSoft tissue\nSeparate recommendations have been made for\nis increasing in\nsarcoma\nadults and for children and young people to reflect\nsize in children\nthat there are different referral pathways. In\nand young people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nSee also the section on abdominal symptoms for abdominal mass or unexplained enlarged\nabdominal organ, splenomegaly and hepatosplenomegaly.\nNeurological symptoms\nSymptom and specific features Possible cancer Recommendation\nNewly abnormal cerebellar or other Brain or central Consider a very urgent\ncentral neurological function in nervous referral (for an appointment\nchildren and young people system cancer within 48 hours) [1.9.2]\nRespiratory symptoms\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nShortness of\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nbreath with\nlymphoma or Separate recommendations have been made for\nlymphadenopathy\nHodgkin's adults and for children and young people to reflect\nin children and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_75",
    "page_number": 75,
    "element_type": "table",
    "markdown": "Table 1 on Page 75\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Lump                   | Soft tissue       | Consider a very urgent, direct access ultrasound    |\n| (unexplained) that     | sarcoma           | scan (to be done within 48 hours) [1.11.6]          |\n| is increasing in       |                   | See the section on primary care investigations for  |\n| size in children       |                   | more information on ultrasound scans                |\n| and young people       |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nLump\n(unexplained) that\nis increasing in\nsize in children\nand young people\tSoft tissue\nsarcoma\tConsider a very urgent, direct access ultrasound\nscan (to be done within 48 hours) [1.11.6]\nSee the section on primary care investigations for\nmore information on ultrasound scans\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_75",
    "page_number": 75,
    "element_type": "table",
    "markdown": "Table 2 on Page 75\n\n| Symptom and specific features      | Possible cancer   | Recommendation               |\n|:-----------------------------------|:------------------|:-----------------------------|\n| Newly abnormal cerebellar or other | Brain or central  | Consider a very urgent       |\n| central neurological function in   | nervous           | referral (for an appointment |\n| children and young people          | system cancer     | within 48 hours) [1.9.2]     |",
    "raw_text": "Symptom and specific features\tPossible cancer\tRecommendation\nNewly abnormal cerebellar or other\ncentral neurological function in\nchildren and young people\tBrain or central\nnervous\nsystem cancer\tConsider a very urgent\nreferral (for an appointment\nwithin 48 hours) [1.9.2]"
  },
  {
    "element_id": "page_75",
    "page_number": 75,
    "element_type": "table",
    "markdown": "Table 3 on Page 75\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Shortness of           | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| breath with            | lymphoma or       | within 48 hours) for specialist assessment. When    |\n| lymphadenopathy        | Hodgkin's         | considering referral, take into account any         |\n| in children and        | lymphoma          | associated symptoms [1.10.7] [1.10.9]               |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nShortness of\nbreath with\nlymphadenopathy\nin children and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_76_seq_0",
    "page_number": 76,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nShortness of considering referral, take into account any\nbreath with associated symptoms [1.10.7]\nsplenomegaly Non-Hodgkin's Separate recommendations have been made for\n(unexplained) in lymphoma adults and for children and young people to reflect\nchildren and that there are different referral pathways. In\nyoung people practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nSkeletal symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nBone pain (persistent or\nOffer a very urgent full blood count\nunexplained) in children and Leukaemia\n(within 48 hours) [1.10.3]\nyoung people\nConsider a very urgent, direct access\nX-ray (to be done within 48 hours)\nBone pain (unexplained) in Bone [1.11.3]\nchildren and young people sarcoma See the section on primary care\ninvestigations for more information on\nX-rays\nConsider a very urgent, direct access\nX-ray (to be done within 48 hours)\nBone swelling (unexplained) in Bone [1.11.3]\nchildren and young people sarcoma See the section on primary care\ninvestigations for more information on\nX-rays\nSkin or surface symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nPetechiae (unexplained) in Refer for immediate specialist\nLeukaemia\nchildren and young people assessment [1.10.2]",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nShortness of considering referral, take into account any\nbreath with associated symptoms [1.10.7]\nsplenomegaly Non-Hodgkin's Separate recommendations have been made for\n(unexplained) in lymphoma adults and for children and young people to reflect\nchildren and that there are different referral pathways. In\nyoung people practice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nSkeletal symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nBone pain (persistent or\nOffer a very urgent full blood count\nunexplained) in children and Leukaemia\n(within 48 hours) [1.10.3]\nyoung people\nConsider a very urgent, direct access\nX-ray (to be done within 48 hours)\nBone pain (unexplained) in Bone [1.11.3]\nchildren and young people sarcoma See the section on primary care\ninvestigations for more information on\nX-rays\nConsider a very urgent, direct access\nX-ray (to be done within 48 hours)\nBone swelling (unexplained) in Bone [1.11.3]\nchildren and young people sarcoma See the section on primary care\ninvestigations for more information on\nX-rays\nSkin or surface symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nPetechiae (unexplained) in Refer for immediate specialist\nLeukaemia\nchildren and young people assessment [1.10.2]"
  },
  {
    "element_id": "page_76",
    "page_number": 76,
    "element_type": "table",
    "markdown": "Table 1 on Page 76\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Shortness of           | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| breath with            | lymphoma          | within 48 hours) for specialist assessment. When    |\n| splenomegaly           |                   | considering referral, take into account any         |\n| (unexplained) in       |                   | associated symptoms [1.10.7]                        |\n| children and           |                   | Separate recommendations have been made for         |\n| young people           |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nShortness of\nbreath with\nsplenomegaly\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_76",
    "page_number": 76,
    "element_type": "table",
    "markdown": "Table 2 on Page 76\n\n| Symptom and specific features   | Possible   | Recommendation                         |\n|                                 | cancer     |                                        |\n|:--------------------------------|:-----------|:---------------------------------------|\n| Bone pain (persistent or        | Leukaemia  | Offer a very urgent full blood count   |\n| unexplained) in children and    |            | (within 48 hours) [1.10.3]             |\n| young people                    |            |                                        |\n| Bone pain (unexplained) in      | Bone       | Consider a very urgent, direct access  |\n| children and young people       | sarcoma    | X-ray (to be done within 48 hours)     |\n|                                 |            | [1.11.3]                               |\n|                                 |            | See the section on primary care        |\n|                                 |            | investigations for more information on |\n|                                 |            | X-rays                                 |\n| Bone swelling (unexplained) in  | Bone       | Consider a very urgent, direct access  |\n| children and young people       | sarcoma    | X-ray (to be done within 48 hours)     |\n|                                 |            | [1.11.3]                               |\n|                                 |            | See the section on primary care        |\n|                                 |            | investigations for more information on |\n|                                 |            | X-rays                                 |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nBone pain (persistent or\nunexplained) in children and\nyoung people\tLeukaemia\tOffer a very urgent full blood count\n(within 48 hours) [1.10.3]\nBone pain (unexplained) in\nchildren and young people\tBone\nsarcoma\tConsider a very urgent, direct access\nX-ray (to be done within 48 hours)\n[1.11.3]\nSee the section on primary care\ninvestigations for more information on\nX-rays\nBone swelling (unexplained) in\nchildren and young people\tBone\nsarcoma\tConsider a very urgent, direct access\nX-ray (to be done within 48 hours)\n[1.11.3]\nSee the section on primary care\ninvestigations for more information on\nX-rays"
  },
  {
    "element_id": "page_76",
    "page_number": 76,
    "element_type": "table",
    "markdown": "Table 3 on Page 76\n\n| Symptom and specific features   | Possible   | Recommendation                 |\n|                                 | cancer     |                                |\n|:--------------------------------|:-----------|:-------------------------------|\n| Petechiae (unexplained) in      | Leukaemia  | Refer for immediate specialist |\n| children and young people       |            | assessment [1.10.2]            |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nPetechiae (unexplained) in\nchildren and young people\tLeukaemia\tRefer for immediate specialist\nassessment [1.10.2]"
  },
  {
    "element_id": "page_77_seq_0",
    "page_number": 77,
    "element_type": "text",
    "markdown": "Possible\nSymptom and specific features Recommendation\ncancer\nBruising (unexplained) in children Offer a very urgent full blood count\nLeukaemia\nand young people (within 48 hours) [1.10.3]\nPallor in children and young Offer a very urgent full blood count\nLeukaemia\npeople (within 48 hours) [1.10.3]\nUrological symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nHaematuria (visible and Wilms' Consider very urgent referral (for an appointment\nunexplained) in children tumour within 48 hours) for specialist assessment [1.12.3]\nNon-specific features of cancer\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nFatigue\n(persistent) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nFever with\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nlymphadenopathy\nlymphoma or Separate recommendations have been made for\n(unexplained) in\nHodgkin's adults and for children and young people to reflect\nchildren and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Possible\nSymptom and specific features Recommendation\ncancer\nBruising (unexplained) in children Offer a very urgent full blood count\nLeukaemia\nand young people (within 48 hours) [1.10.3]\nPallor in children and young Offer a very urgent full blood count\nLeukaemia\npeople (within 48 hours) [1.10.3]\nUrological symptoms\nPossible\nSymptom and specific features Recommendation\ncancer\nHaematuria (visible and Wilms' Consider very urgent referral (for an appointment\nunexplained) in children tumour within 48 hours) for specialist assessment [1.12.3]\nNon-specific features of cancer\nSymptom and specific\nPossible cancer Recommendation\nfeatures\nFatigue\n(persistent) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nFever with\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nlymphadenopathy\nlymphoma or Separate recommendations have been made for\n(unexplained) in\nHodgkin's adults and for children and young people to reflect\nchildren and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_77",
    "page_number": 77,
    "element_type": "table",
    "markdown": "Table 1 on Page 77\n\n| Symptom and specific features      | Possible   | Recommendation                       |\n|                                    | cancer     |                                      |\n|:-----------------------------------|:-----------|:-------------------------------------|\n| Bruising (unexplained) in children | Leukaemia  | Offer a very urgent full blood count |\n| and young people                   |            | (within 48 hours) [1.10.3]           |\n| Pallor in children and young       | Leukaemia  | Offer a very urgent full blood count |\n| people                             |            | (within 48 hours) [1.10.3]           |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nBruising (unexplained) in children\nand young people\tLeukaemia\tOffer a very urgent full blood count\n(within 48 hours) [1.10.3]\nPallor in children and young\npeople\tLeukaemia\tOffer a very urgent full blood count\n(within 48 hours) [1.10.3]"
  },
  {
    "element_id": "page_77",
    "page_number": 77,
    "element_type": "table",
    "markdown": "Table 2 on Page 77\n\n| Symptom and specific features   | Possible   | Recommendation                                      |\n|                                 | cancer     |                                                     |\n|:--------------------------------|:-----------|:----------------------------------------------------|\n| Haematuria (visible and         | Wilms'     | Consider very urgent referral (for an appointment   |\n| unexplained) in children        | tumour     | within 48 hours) for specialist assessment [1.12.3] |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nHaematuria (visible and\nunexplained) in children\tWilms'\ntumour\tConsider very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment [1.12.3]"
  },
  {
    "element_id": "page_77",
    "page_number": 77,
    "element_type": "table",
    "markdown": "Table 3 on Page 77\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Fatigue                | Leukaemia         | Offer a very urgent full blood count (within        |\n| (persistent) in        |                   | 48 hours) [1.10.3]                                  |\n| children and           |                   |                                                     |\n| young people           |                   |                                                     |\n| Fever with             | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| lymphadenopathy        | lymphoma or       | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       | Hodgkin's         | considering referral, take into account any         |\n| children and           | lymphoma          | associated symptoms [1.10.7] [1.10.9]               |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nFatigue\n(persistent) in\nchildren and\nyoung people\tLeukaemia\tOffer a very urgent full blood count (within\n48 hours) [1.10.3]\nFever with\nlymphadenopathy\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_78_seq_0",
    "page_number": 78,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nFever with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nFever\n(unexplained) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people\nInfection\n(unexplained and\nOffer a very urgent full blood count (within\npersistent) in Leukaemia\n48 hours) [1.10.3]\nchildren and\nyoung people\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms, particularly fever, night\nLymphadenopathy Non-Hodgkin's sweats, shortness of breath, pruritus or weight\n(unexplained) in lymphoma or loss [1.10.7] [1.10.9]\nchildren and Hodgkin's Separate recommendations have been made for\nyoung people lymphoma adults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nFever with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nFever\n(unexplained) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people\nInfection\n(unexplained and\nOffer a very urgent full blood count (within\npersistent) in Leukaemia\n48 hours) [1.10.3]\nchildren and\nyoung people\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms, particularly fever, night\nLymphadenopathy Non-Hodgkin's sweats, shortness of breath, pruritus or weight\n(unexplained) in lymphoma or loss [1.10.7] [1.10.9]\nchildren and Hodgkin's Separate recommendations have been made for\nyoung people lymphoma adults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_78",
    "page_number": 78,
    "element_type": "table",
    "markdown": "Table 1 on Page 78\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Fever with             | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| splenomegaly           | lymphoma          | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       |                   | considering referral, take into account any         |\n| children and           |                   | associated symptoms [1.10.7]                        |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Fever                  | Leukaemia         | Offer a very urgent full blood count (within        |\n| (unexplained) in       |                   | 48 hours) [1.10.3]                                  |\n| children and           |                   |                                                     |\n| young people           |                   |                                                     |\n| Infection              | Leukaemia         | Offer a very urgent full blood count (within        |\n| (unexplained and       |                   | 48 hours) [1.10.3]                                  |\n| persistent) in         |                   |                                                     |\n| children and           |                   |                                                     |\n| young people           |                   |                                                     |\n| Lymphadenopathy        | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| (unexplained) in       | lymphoma or       | within 48 hours) for specialist assessment. When    |\n| children and           | Hodgkin's         | considering referral, take into account any         |\n| young people           | lymphoma          | associated symptoms, particularly fever, night      |\n|                        |                   | sweats, shortness of breath, pruritus or weight     |\n|                        |                   | loss [1.10.7] [1.10.9]                              |\n|                        |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nFever with\nsplenomegaly\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nFever\n(unexplained) in\nchildren and\nyoung people\tLeukaemia\tOffer a very urgent full blood count (within\n48 hours) [1.10.3]\nInfection\n(unexplained and\npersistent) in\nchildren and\nyoung people\tLeukaemia\tOffer a very urgent full blood count (within\n48 hours) [1.10.3]\nLymphadenopathy\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms, particularly fever, night\nsweats, shortness of breath, pruritus or weight\nloss [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_79_seq_0",
    "page_number": 79,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nLymphadenopathy\n(generalised) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nNight sweats with\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nlymphadenopathy\nlymphoma or Separate recommendations have been made for\n(unexplained) in\nHodgkin's adults and for children and young people to reflect\nchildren and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nNight sweats with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nPruritus with\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nlymphadenopathy\nlymphoma or Separate recommendations have been made for\n(unexplained) in\nHodgkin's adults and for children and young people to reflect\nchildren and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nLymphadenopathy\n(generalised) in Offer a very urgent full blood count (within\nLeukaemia\nchildren and 48 hours) [1.10.3]\nyoung people\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nNight sweats with\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nlymphadenopathy\nlymphoma or Separate recommendations have been made for\n(unexplained) in\nHodgkin's adults and for children and young people to reflect\nchildren and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nNight sweats with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nPruritus with\nNon-Hodgkin's associated symptoms [1.10.7] [1.10.9]\nlymphadenopathy\nlymphoma or Separate recommendations have been made for\n(unexplained) in\nHodgkin's adults and for children and young people to reflect\nchildren and\nlymphoma that there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_79",
    "page_number": 79,
    "element_type": "table",
    "markdown": "Table 1 on Page 79\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Lymphadenopathy        | Leukaemia         | Offer a very urgent full blood count (within        |\n| (generalised) in       |                   | 48 hours) [1.10.3]                                  |\n| children and           |                   |                                                     |\n| young people           |                   |                                                     |\n| Night sweats with      | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| lymphadenopathy        | lymphoma or       | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       | Hodgkin's         | considering referral, take into account any         |\n| children and           | lymphoma          | associated symptoms [1.10.7] [1.10.9]               |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Night sweats with      | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| splenomegaly           | lymphoma          | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       |                   | considering referral, take into account any         |\n| children and           |                   | associated symptoms [1.10.7]                        |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Pruritus with          | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| lymphadenopathy        | lymphoma or       | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       | Hodgkin's         | considering referral, take into account any         |\n| children and           | lymphoma          | associated symptoms [1.10.7] [1.10.9]               |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nLymphadenopathy\n(generalised) in\nchildren and\nyoung people\tLeukaemia\tOffer a very urgent full blood count (within\n48 hours) [1.10.3]\nNight sweats with\nlymphadenopathy\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nNight sweats with\nsplenomegaly\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nPruritus with\nlymphadenopathy\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_80_seq_0",
    "page_number": 80,
    "element_type": "text",
    "markdown": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nPruritus with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment in\nchildren and young people. When considering\nWeight loss with referral, take into account any associated\nNon-Hodgkin's\nlymphadenopathy symptoms [1.10.7] [1.10.9]\nlymphoma or\n(unexplained) in Separate recommendations have been made for\nHodgkin's\nchildren and adults and for children and young people to reflect\nlymphoma\nyoung people that there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nWeight loss with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements",
    "raw_text": "Symptom and specific\nPossible cancer Recommendation\nfeatures\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nPruritus with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment in\nchildren and young people. When considering\nWeight loss with referral, take into account any associated\nNon-Hodgkin's\nlymphadenopathy symptoms [1.10.7] [1.10.9]\nlymphoma or\n(unexplained) in Separate recommendations have been made for\nHodgkin's\nchildren and adults and for children and young people to reflect\nlymphoma\nyoung people that there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nWeight loss with\nassociated symptoms [1.10.7]\nsplenomegaly\nNon-Hodgkin's Separate recommendations have been made for\n(unexplained) in\nlymphoma adults and for children and young people to reflect\nchildren and\nthat there are different referral pathways. In\nyoung people\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_80",
    "page_number": 80,
    "element_type": "table",
    "markdown": "Table 1 on Page 80\n\n| Symptom and specific   | Possible cancer   | Recommendation                                      |\n| features               |                   |                                                     |\n|:-----------------------|:------------------|:----------------------------------------------------|\n| Pruritus with          | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| splenomegaly           | lymphoma          | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       |                   | considering referral, take into account any         |\n| children and           |                   | associated symptoms [1.10.7]                        |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Weight loss with       | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| lymphadenopathy        | lymphoma or       | within 48 hours) for specialist assessment in       |\n| (unexplained) in       | Hodgkin's         | children and young people. When considering         |\n| children and           | lymphoma          | referral, take into account any associated          |\n| young people           |                   | symptoms [1.10.7] [1.10.9]                          |\n|                        |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |\n| Weight loss with       | Non-Hodgkin's     | Consider a very urgent referral (for an appointment |\n| splenomegaly           | lymphoma          | within 48 hours) for specialist assessment. When    |\n| (unexplained) in       |                   | considering referral, take into account any         |\n| children and           |                   | associated symptoms [1.10.7]                        |\n| young people           |                   | Separate recommendations have been made for         |\n|                        |                   | adults and for children and young people to reflect |\n|                        |                   | that there are different referral pathways. In      |\n|                        |                   | practice young people (aged 16 to 24) may be        |\n|                        |                   | referred using either pathway depending on their    |\n|                        |                   | age and local arrangements                          |",
    "raw_text": "Symptom and specific\nfeatures\tPossible cancer\tRecommendation\nPruritus with\nsplenomegaly\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nWeight loss with\nlymphadenopathy\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma or\nHodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment in\nchildren and young people. When considering\nreferral, take into account any associated\nsymptoms [1.10.7] [1.10.9]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements\nWeight loss with\nsplenomegaly\n(unexplained) in\nchildren and\nyoung people\tNon-Hodgkin's\nlymphoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment. When\nconsidering referral, take into account any\nassociated symptoms [1.10.7]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In\npractice young people (aged 16 to 24) may be\nreferred using either pathway depending on their\nage and local arrangements"
  },
  {
    "element_id": "page_81_seq_0",
    "page_number": 81,
    "element_type": "text",
    "markdown": "Ocular examination\nExamination findings and\nPossible cancer Recommendation\nspecific features\nAbsent fundal\nConsider referral for ophthalmological assessment\n('red') reflex in Retinoblastoma\nusing a suspected cancer pathway referral [1.12.2]\nchildren\nParental concern\nPossible\nSymptom and specific features Recommendation\ncancer\nTake into account the insight and knowledge of\nparents and carers when considering making a\nParental or carer insight,\nreferral for suspected cancer in a child or young\nconcern or anxiety about\nChildhood person\nthe child's or young\ncancer Consider referral for children if their parent or\nperson's symptoms\ncarer has persistent concern or anxiety about\n(persistent)\nthe child's symptoms, even if the symptoms are\nmost likely to have a benign cause [1.13.1]\nPrimary care investigations\nPossible\nSymptom and specific features Recommendation\ncancer\nConsider a very urgent referral (for an appointment\nUltrasound scan\nwithin 48 hours) for specialist assessment [1.11.7]\nsuggests soft tissue\nSeparate recommendations have been made for\nsarcoma or is Soft\nadults and for children and young people to reflect\nuncertain and clinical tissue\nthat there are different referral pathways. In practice\nconcern persists in sarcoma\nyoung people (aged 16 to 24) may be referred using\nchildren and young\neither pathway depending on their age and local\npeople\narrangements",
    "raw_text": "Ocular examination\nExamination findings and\nPossible cancer Recommendation\nspecific features\nAbsent fundal\nConsider referral for ophthalmological assessment\n('red') reflex in Retinoblastoma\nusing a suspected cancer pathway referral [1.12.2]\nchildren\nParental concern\nPossible\nSymptom and specific features Recommendation\ncancer\nTake into account the insight and knowledge of\nparents and carers when considering making a\nParental or carer insight,\nreferral for suspected cancer in a child or young\nconcern or anxiety about\nChildhood person\nthe child's or young\ncancer Consider referral for children if their parent or\nperson's symptoms\ncarer has persistent concern or anxiety about\n(persistent)\nthe child's symptoms, even if the symptoms are\nmost likely to have a benign cause [1.13.1]\nPrimary care investigations\nPossible\nSymptom and specific features Recommendation\ncancer\nConsider a very urgent referral (for an appointment\nUltrasound scan\nwithin 48 hours) for specialist assessment [1.11.7]\nsuggests soft tissue\nSeparate recommendations have been made for\nsarcoma or is Soft\nadults and for children and young people to reflect\nuncertain and clinical tissue\nthat there are different referral pathways. In practice\nconcern persists in sarcoma\nyoung people (aged 16 to 24) may be referred using\nchildren and young\neither pathway depending on their age and local\npeople\narrangements"
  },
  {
    "element_id": "page_81",
    "page_number": 81,
    "element_type": "table",
    "markdown": "Table 1 on Page 81\n\n| Examination findings and   | Possible cancer   | Recommendation                                     |\n| specific features          |                   |                                                    |\n|:---------------------------|:------------------|:---------------------------------------------------|\n| Absent fundal              | Retinoblastoma    | Consider referral for ophthalmological assessment  |\n| ('red') reflex in          |                   | using a suspected cancer pathway referral [1.12.2] |\n| children                   |                   |                                                    |",
    "raw_text": "Examination findings and\nspecific features\tPossible cancer\tRecommendation\nAbsent fundal\n('red') reflex in\nchildren\tRetinoblastoma\tConsider referral for ophthalmological assessment\nusing a suspected cancer pathway referral [1.12.2]"
  },
  {
    "element_id": "page_81",
    "page_number": 81,
    "element_type": "table",
    "markdown": "Table 2 on Page 81\n\n| Symptom and specific features   | Possible   | Recommendation                                    |\n|                                 | cancer     |                                                   |\n|:--------------------------------|:-----------|:--------------------------------------------------|\n| Parental or carer insight,      | Childhood  | Take into account the insight and knowledge of    |\n| concern or anxiety about        | cancer     | parents and carers when considering making a      |\n| the child's or young            |            | referral for suspected cancer in a child or young |\n| person's symptoms               |            | person                                            |\n| (persistent)                    |            | Consider referral for children if their parent or |\n|                                 |            | carer has persistent concern or anxiety about     |\n|                                 |            | the child's symptoms, even if the symptoms are    |\n|                                 |            | most likely to have a benign cause [1.13.1]       |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nParental or carer insight,\nconcern or anxiety about\nthe child's or young\nperson's symptoms\n(persistent)\tChildhood\ncancer\tTake into account the insight and knowledge of\nparents and carers when considering making a\nreferral for suspected cancer in a child or young\nperson\nConsider referral for children if their parent or\ncarer has persistent concern or anxiety about\nthe child's symptoms, even if the symptoms are\nmost likely to have a benign cause [1.13.1]"
  },
  {
    "element_id": "page_81",
    "page_number": 81,
    "element_type": "table",
    "markdown": "Table 3 on Page 81\n\n| Symptom and specific features   | Possible   | Recommendation                                          |\n|                                 | cancer     |                                                         |\n|:--------------------------------|:-----------|:--------------------------------------------------------|\n| Ultrasound scan                 | Soft       | Consider a very urgent referral (for an appointment     |\n| suggests soft tissue            | tissue     | within 48 hours) for specialist assessment [1.11.7]     |\n| sarcoma or is                   | sarcoma    | Separate recommendations have been made for             |\n| uncertain and clinical          |            | adults and for children and young people to reflect     |\n| concern persists in             |            | that there are different referral pathways. In practice |\n| children and young              |            | young people (aged 16 to 24) may be referred using      |\n| people                          |            | either pathway depending on their age and local         |\n|                                 |            | arrangements                                            |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nUltrasound scan\nsuggests soft tissue\nsarcoma or is\nuncertain and clinical\nconcern persists in\nchildren and young\npeople\tSoft\ntissue\nsarcoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment [1.11.7]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In practice\nyoung people (aged 16 to 24) may be referred using\neither pathway depending on their age and local\narrangements"
  },
  {
    "element_id": "page_82_seq_0",
    "page_number": 82,
    "element_type": "text",
    "markdown": "Possible\nSymptom and specific features Recommendation\ncancer\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment [1.11.2]\nX-ray suggests the Separate recommendations have been made for\npossibility of bone Bone adults and for children and young people to reflect\nsarcoma in children sarcoma that there are different referral pathways. In practice\nand young people young people (aged 16 to 24) may be referred using\neither pathway depending on their age and local\narrangements",
    "raw_text": "Possible\nSymptom and specific features Recommendation\ncancer\nConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment [1.11.2]\nX-ray suggests the Separate recommendations have been made for\npossibility of bone Bone adults and for children and young people to reflect\nsarcoma in children sarcoma that there are different referral pathways. In practice\nand young people young people (aged 16 to 24) may be referred using\neither pathway depending on their age and local\narrangements"
  },
  {
    "element_id": "page_82",
    "page_number": 82,
    "element_type": "table",
    "markdown": "Table 1 on Page 82\n\n| Symptom and specific features   | Possible   | Recommendation                                          |\n|                                 | cancer     |                                                         |\n|:--------------------------------|:-----------|:--------------------------------------------------------|\n| X-ray suggests the              | Bone       | Consider a very urgent referral (for an appointment     |\n| possibility of bone             | sarcoma    | within 48 hours) for specialist assessment [1.11.2]     |\n| sarcoma in children             |            | Separate recommendations have been made for             |\n| and young people                |            | adults and for children and young people to reflect     |\n|                                 |            | that there are different referral pathways. In practice |\n|                                 |            | young people (aged 16 to 24) may be referred using      |\n|                                 |            | either pathway depending on their age and local         |\n|                                 |            | arrangements                                            |",
    "raw_text": "Symptom and specific features\tPossible\ncancer\tRecommendation\nX-ray suggests the\npossibility of bone\nsarcoma in children\nand young people\tBone\nsarcoma\tConsider a very urgent referral (for an appointment\nwithin 48 hours) for specialist assessment [1.11.2]\nSeparate recommendations have been made for\nadults and for children and young people to reflect\nthat there are different referral pathways. In practice\nyoung people (aged 16 to 24) may be referred using\neither pathway depending on their age and local\narrangements"
  },
  {
    "element_id": "page_83_seq_0",
    "page_number": 83,
    "element_type": "text",
    "markdown": "Terms used in this guideline\nChildren\nFrom birth to 15 years.\nChildren and young people\nFrom birth to 24 years.\nConsistent with\nThe finding has characteristics that could be caused by many things, including cancer.\nDirect access\nWhen a test is done and primary care retain clinical responsibility throughout, including\nacting on the result.\nImmediate\nAn acute admission or referral occurring within a few hours, or even more quickly if\nnecessary.\nNon-urgent\nThe timescale generally used for a referral or investigation that is not considered very\nurgent or urgent.\nPersistent\nThe continuation of specified symptoms and/or signs beyond a period that would normally\nbe associated with self-limiting problems. The precise period will vary depending on the",
    "raw_text": "Terms used in this guideline\nChildren\nFrom birth to 15 years.\nChildren and young people\nFrom birth to 24 years.\nConsistent with\nThe finding has characteristics that could be caused by many things, including cancer.\nDirect access\nWhen a test is done and primary care retain clinical responsibility throughout, including\nacting on the result.\nImmediate\nAn acute admission or referral occurring within a few hours, or even more quickly if\nnecessary.\nNon-urgent\nThe timescale generally used for a referral or investigation that is not considered very\nurgent or urgent.\nPersistent\nThe continuation of specified symptoms and/or signs beyond a period that would normally\nbe associated with self-limiting problems. The precise period will vary depending on the"
  },
  {
    "element_id": "page_84_seq_0",
    "page_number": 84,
    "element_type": "text",
    "markdown": "severity of symptoms and associated features, as assessed by the health professional.\nRaises the suspicion of\nA mass or lesion that has an appearance or a feel that makes the healthcare professional\nbelieve cancer is a significant possibility.\nSafety netting\nThe active monitoring in primary care of people who have presented with symptoms. It has\n2 separate aspects:\n\u2022 timely review and action after investigations\n\u2022 active monitoring of symptoms in people at low risk (but not no risk) of having cancer\nto see if their risk of cancer changes.\nSuspected cancer pathway referral\nPerson to receive a diagnosis or ruling out of cancer within 28 days of being referred\nurgently by their GP for suspected cancer. For further details, see NHS England's webpage\non faster diagnosis of cancer.\nUnexplained\nSymptoms or signs that have not led to a diagnosis being made by the healthcare\nprofessional in primary care after initial assessment (including history, examination and any\nprimary care investigations).\nUrgent\nTo happen or be done before 2 weeks.\nVery urgent\nTo happen within 48 hours.",
    "raw_text": "severity of symptoms and associated features, as assessed by the health professional.\nRaises the suspicion of\nA mass or lesion that has an appearance or a feel that makes the healthcare professional\nbelieve cancer is a significant possibility.\nSafety netting\nThe active monitoring in primary care of people who have presented with symptoms. It has\n2 separate aspects:\n\u2022 timely review and action after investigations\n\u2022 active monitoring of symptoms in people at low risk (but not no risk) of having cancer\nto see if their risk of cancer changes.\nSuspected cancer pathway referral\nPerson to receive a diagnosis or ruling out of cancer within 28 days of being referred\nurgently by their GP for suspected cancer. For further details, see NHS England's webpage\non faster diagnosis of cancer.\nUnexplained\nSymptoms or signs that have not led to a diagnosis being made by the healthcare\nprofessional in primary care after initial assessment (including history, examination and any\nprimary care investigations).\nUrgent\nTo happen or be done before 2 weeks.\nVery urgent\nTo happen within 48 hours."
  },
  {
    "element_id": "page_85_seq_0",
    "page_number": 85,
    "element_type": "text",
    "markdown": "Young people\nAged 16 to 24 years.",
    "raw_text": "Young people\nAged 16 to 24 years."
  },
  {
    "element_id": "page_86_seq_0",
    "page_number": 86,
    "element_type": "text",
    "markdown": "Recommendations for research\nThe guideline committee has made the following recommendations for research.\nKey recommendations for research\n1 Age thresholds in cancer\nLongitudinal studies should be carried out to identify and quantify factors in adults that are\nassociated with development of specific cancers at a younger age than the norm. They\nshould be designed to inform age thresholds in clinical guidance. The primary outcome\nshould be likelihood ratios and positive predictive values for cancer occurring in younger\nage groups.\n2 Primary care testing\nDiagnostic accuracy studies of tests accessible to primary care should be carried out for a\ngiven cancer in symptomatic people. Priority areas for research should include tests for\npeople with cough, non-visible haematuria, suspected prostate cancer, suspected\npancreatic cancer, suspected cancer in childhood and young people and other suspected\nrare cancers. Outcomes of interest are the performance characteristics of the test,\nparticularly sensitivity, specificity and positive and negative predictive values.\n3 Cancers insufficiently researched in primary care\nObservational studies of symptomatic primary care patients should be used to estimate\nthe positive predictive value of different symptoms for specific cancers. Priority areas for\nresearch are those where the evidence base is currently insufficient and should include\nprostate cancer, pancreatic cancer, cancer in childhood and young people and other rare\ncancers. Outcomes of interest are positive predictive values and likelihood ratios for\ncancer.\n4 Patient experience\nQualitative studies are needed to assess the key issues in patient experience and patient",
    "raw_text": "Recommendations for research\nThe guideline committee has made the following recommendations for research.\nKey recommendations for research\n1 Age thresholds in cancer\nLongitudinal studies should be carried out to identify and quantify factors in adults that are\nassociated with development of specific cancers at a younger age than the norm. They\nshould be designed to inform age thresholds in clinical guidance. The primary outcome\nshould be likelihood ratios and positive predictive values for cancer occurring in younger\nage groups.\n2 Primary care testing\nDiagnostic accuracy studies of tests accessible to primary care should be carried out for a\ngiven cancer in symptomatic people. Priority areas for research should include tests for\npeople with cough, non-visible haematuria, suspected prostate cancer, suspected\npancreatic cancer, suspected cancer in childhood and young people and other suspected\nrare cancers. Outcomes of interest are the performance characteristics of the test,\nparticularly sensitivity, specificity and positive and negative predictive values.\n3 Cancers insufficiently researched in primary care\nObservational studies of symptomatic primary care patients should be used to estimate\nthe positive predictive value of different symptoms for specific cancers. Priority areas for\nresearch are those where the evidence base is currently insufficient and should include\nprostate cancer, pancreatic cancer, cancer in childhood and young people and other rare\ncancers. Outcomes of interest are positive predictive values and likelihood ratios for\ncancer.\n4 Patient experience\nQualitative studies are needed to assess the key issues in patient experience and patient"
  },
  {
    "element_id": "page_87_seq_0",
    "page_number": 87,
    "element_type": "text",
    "markdown": "information needs in the cancer diagnostic pathway, particularly in the interval between\nfirst presentation to primary care and first appointment in secondary care. Outcomes of\ninterest are patient satisfaction, quality of life and patient perception of the quality of care\nand information.\n5 Prostate-specific antigen testing\nWhat is the diagnostic accuracy of using age-adjusted and fixed prostate-specific antigen\nthresholds for people with symptoms of prostate cancer, including those at high risk of\ndeveloping prostate cancer (such as those with an African family background or a family\nhistory of prostate cancer)?\nFor a short explanation of why the committee made the recommendation for research\nsee the rationale section on prostate-specific antigen testing for prostate cancer.\nFull details of the evidence and the committee's discussion are in evidence review A:\nPSA testing for prostate cancer.",
    "raw_text": "information needs in the cancer diagnostic pathway, particularly in the interval between\nfirst presentation to primary care and first appointment in secondary care. Outcomes of\ninterest are patient satisfaction, quality of life and patient perception of the quality of care\nand information.\n5 Prostate-specific antigen testing\nWhat is the diagnostic accuracy of using age-adjusted and fixed prostate-specific antigen\nthresholds for people with symptoms of prostate cancer, including those at high risk of\ndeveloping prostate cancer (such as those with an African family background or a family\nhistory of prostate cancer)?\nFor a short explanation of why the committee made the recommendation for research\nsee the rationale section on prostate-specific antigen testing for prostate cancer.\nFull details of the evidence and the committee's discussion are in evidence review A:\nPSA testing for prostate cancer."
  },
  {
    "element_id": "page_88_seq_0",
    "page_number": 88,
    "element_type": "text",
    "markdown": "Rationale and impact\nThis section briefly explains why the committee made the recommendation and how it\nmight affect practice.\nProstate-specific antigen testing for prostate\ncancer\nRecommendation 1.6.3\nWhy the committee made the recommendation\nThe evidence on the diagnostic accuracy of fixed and age-specific prostate-specific\nantigen (PSA) thresholds was very uncertain because all of the studies were based on a\npopulation that had already been referred to secondary care. The 2019 guideline\nrecommended referral if PSA levels were above the age-specific reference range. The\ncommittee agreed that referral should be considered based on PSA thresholds, but did not\nmake a stronger recommendation because of the uncertainty in the evidence and the\nlikely low positive predictive value of the PSA test for prevalence estimates based on UK\npopulation data. The committee noted that many prostate cancers are slow growing and\nmight never impact a person's life expectancy. Some people might choose not to be\nreferred to secondary care to avoid invasive investigations and treatment that might not\nbenefit them. Therefore, the committee agreed that a patient-centred approach to referral\nis important, and recommended that the person's preferences and any comorbidities\nshould be taken into account.\nThe committee agreed that more research is needed in this area to better understand the\nmost appropriate thresholds that should prompt referral to secondary care for each age\ngroup. The committee noted that ethnicity and family history are important factors that\naffect the risk of prostate cancer. Therefore, they recommended that the data from\nresearch be stratified by these factors to determine whether different PSA levels should\nprompt referral in these groups. Research in this area may also help to address health\ninequalities in prostate cancer diagnosis and outcomes in the UK.\nThere was no strong evidence to differentiate between using age-specific or fixed PSA",
    "raw_text": "Rationale and impact\nThis section briefly explains why the committee made the recommendation and how it\nmight affect practice.\nProstate-specific antigen testing for prostate\ncancer\nRecommendation 1.6.3\nWhy the committee made the recommendation\nThe evidence on the diagnostic accuracy of fixed and age-specific prostate-specific\nantigen (PSA) thresholds was very uncertain because all of the studies were based on a\npopulation that had already been referred to secondary care. The 2019 guideline\nrecommended referral if PSA levels were above the age-specific reference range. The\ncommittee agreed that referral should be considered based on PSA thresholds, but did not\nmake a stronger recommendation because of the uncertainty in the evidence and the\nlikely low positive predictive value of the PSA test for prevalence estimates based on UK\npopulation data. The committee noted that many prostate cancers are slow growing and\nmight never impact a person's life expectancy. Some people might choose not to be\nreferred to secondary care to avoid invasive investigations and treatment that might not\nbenefit them. Therefore, the committee agreed that a patient-centred approach to referral\nis important, and recommended that the person's preferences and any comorbidities\nshould be taken into account.\nThe committee agreed that more research is needed in this area to better understand the\nmost appropriate thresholds that should prompt referral to secondary care for each age\ngroup. The committee noted that ethnicity and family history are important factors that\naffect the risk of prostate cancer. Therefore, they recommended that the data from\nresearch be stratified by these factors to determine whether different PSA levels should\nprompt referral in these groups. Research in this area may also help to address health\ninequalities in prostate cancer diagnosis and outcomes in the UK.\nThere was no strong evidence to differentiate between using age-specific or fixed PSA"
  },
  {
    "element_id": "page_89_seq_0",
    "page_number": 89,
    "element_type": "text",
    "markdown": "thresholds. The committee also noted that no cost-effectiveness evidence comparing\nage-specific thresholds with fixed thresholds was identified. However, because PSA levels\nincrease naturally with age, the committee agreed a lower fixed PSA threshold would\ndetect more cases of prostate cancer but also lead to unnecessary biopsies and\novertreatment in some age groups. This would also be likely to result in more referrals to\nsecondary care and have a significant impact on NHS resources. The committee therefore\nrecommended the use of age-specific thresholds, which are already established in current\npractice and were recommended in the previous version of the guideline. Because of\nregional variations in practice (particularly in the 50 to 69 age range), the committee\ndecided to define the age-specific PSA thresholds. The committee agreed that the\nthresholds used in the reviewed studies on people with symptoms of possible prostate\ncancer should be used in the absence of evidence to support alternative values, because\nthese studies were most applicable to the population that the recommendation applies to.\nNo evidence was available specifically for people under 40 or over 79, and so the\ncommittee recommended that clinical judgement is used when deciding whether to refer\npeople in these groups to secondary care.\nHow the recommendation might affect practice\nReferral based on age-specific PSA thresholds is already recommended, so practice\nshould not change significantly. Also, clarifying the age-specific thresholds will help\nstandardise care. Taking into account patient preferences and comorbidities should also\nlead to a more patient-centred approach to referral.\nReturn to recommendation",
    "raw_text": "thresholds. The committee also noted that no cost-effectiveness evidence comparing\nage-specific thresholds with fixed thresholds was identified. However, because PSA levels\nincrease naturally with age, the committee agreed a lower fixed PSA threshold would\ndetect more cases of prostate cancer but also lead to unnecessary biopsies and\novertreatment in some age groups. This would also be likely to result in more referrals to\nsecondary care and have a significant impact on NHS resources. The committee therefore\nrecommended the use of age-specific thresholds, which are already established in current\npractice and were recommended in the previous version of the guideline. Because of\nregional variations in practice (particularly in the 50 to 69 age range), the committee\ndecided to define the age-specific PSA thresholds. The committee agreed that the\nthresholds used in the reviewed studies on people with symptoms of possible prostate\ncancer should be used in the absence of evidence to support alternative values, because\nthese studies were most applicable to the population that the recommendation applies to.\nNo evidence was available specifically for people under 40 or over 79, and so the\ncommittee recommended that clinical judgement is used when deciding whether to refer\npeople in these groups to secondary care.\nHow the recommendation might affect practice\nReferral based on age-specific PSA thresholds is already recommended, so practice\nshould not change significantly. Also, clarifying the age-specific thresholds will help\nstandardise care. Taking into account patient preferences and comorbidities should also\nlead to a more patient-centred approach to referral.\nReturn to recommendation"
  },
  {
    "element_id": "page_90_seq_0",
    "page_number": 90,
    "element_type": "text",
    "markdown": "Context\nCancer has an enormous impact, both in terms of the number of people affected by it and\nthe individual impact it has on people with cancer and those close to them. More than\n300,000 new cancers (excluding skin cancers) are diagnosed annually in the UK, across\nover 200 different cancer types. Each of these cancer types has different presenting\nfeatures, though they sometimes overlap. Approximately one-third of the population will\ndevelop a cancer in their lifetime. There is considerable variation in referral and testing for\npossible cancer, which cannot be fully explained by variation in the population.\nThe identification of people with possible cancer usually happens in primary care, because\nmost people first present to a primary care clinician. Therefore, evidence from primary\ncare should inform the identification process and was used as the basis for this guideline.\nThe recommendations were developed using a 'risk threshold', whereby if the risk of\nsymptoms being caused by cancer is above a certain level, then action (investigation or\nreferral) is warranted. The positive predictive value (PPV) was used to determine the\nthreshold. In the previous guideline, a disparate range of percentage risks of cancer was\nused to form the recommendations. Few corresponded with a PPV of lower than 5%. The\nguideline development group (GDG) felt that, in order to improve diagnosis of cancer, a\nPPV threshold lower than 5% was preferable. Taking into account the financial and clinical\ncosts of broadening the recommendations, the GDG agreed to use a 3% PPV threshold\nvalue to underpin the recommendations for suspected cancer pathway referrals and\nurgent direct access investigations, such as brain scanning or endoscopy. Certain\nexceptions to a 3% PPV threshold were agreed. Recommendations were made for children\nand young people at below the 3% PPV threshold, although no explicit threshold value was\nset. The threshold was not applied to recommendations relating to tests routinely available\nin primary care (including blood tests such as prostate-specific antigen and imaging such\nas chest X-ray), primary care tests that could be used in place of specialist referral,\nnon-urgent direct access tests and routine referrals for specialist opinion. Further\ninformation about the methods used to underpin the recommendations can be found in the\nfull guideline.\nIt is well recognised that some risk factors increase the chance of a person developing\ncancer in the future, for example, increasing age and a family history of cancer. However,\nrisk factors do not affect the way in which cancer presents. Of the risk factors that were\nreported in the evidence, only smoking (in lung cancer) and age were found to significantly",
    "raw_text": "Context\nCancer has an enormous impact, both in terms of the number of people affected by it and\nthe individual impact it has on people with cancer and those close to them. More than\n300,000 new cancers (excluding skin cancers) are diagnosed annually in the UK, across\nover 200 different cancer types. Each of these cancer types has different presenting\nfeatures, though they sometimes overlap. Approximately one-third of the population will\ndevelop a cancer in their lifetime. There is considerable variation in referral and testing for\npossible cancer, which cannot be fully explained by variation in the population.\nThe identification of people with possible cancer usually happens in primary care, because\nmost people first present to a primary care clinician. Therefore, evidence from primary\ncare should inform the identification process and was used as the basis for this guideline.\nThe recommendations were developed using a 'risk threshold', whereby if the risk of\nsymptoms being caused by cancer is above a certain level, then action (investigation or\nreferral) is warranted. The positive predictive value (PPV) was used to determine the\nthreshold. In the previous guideline, a disparate range of percentage risks of cancer was\nused to form the recommendations. Few corresponded with a PPV of lower than 5%. The\nguideline development group (GDG) felt that, in order to improve diagnosis of cancer, a\nPPV threshold lower than 5% was preferable. Taking into account the financial and clinical\ncosts of broadening the recommendations, the GDG agreed to use a 3% PPV threshold\nvalue to underpin the recommendations for suspected cancer pathway referrals and\nurgent direct access investigations, such as brain scanning or endoscopy. Certain\nexceptions to a 3% PPV threshold were agreed. Recommendations were made for children\nand young people at below the 3% PPV threshold, although no explicit threshold value was\nset. The threshold was not applied to recommendations relating to tests routinely available\nin primary care (including blood tests such as prostate-specific antigen and imaging such\nas chest X-ray), primary care tests that could be used in place of specialist referral,\nnon-urgent direct access tests and routine referrals for specialist opinion. Further\ninformation about the methods used to underpin the recommendations can be found in the\nfull guideline.\nIt is well recognised that some risk factors increase the chance of a person developing\ncancer in the future, for example, increasing age and a family history of cancer. However,\nrisk factors do not affect the way in which cancer presents. Of the risk factors that were\nreported in the evidence, only smoking (in lung cancer) and age were found to significantly"
  },
  {
    "element_id": "page_91_seq_0",
    "page_number": 91,
    "element_type": "text",
    "markdown": "influence the chance of symptoms being predictive of cancer. Therefore, these are\nincluded in the recommendations where relevant. For all other risk factors, the\nrecommendations would be the same for people with possible symptoms of cancer,\nirrespective of whether they had a risk factor. However, an exception was made to include\nasbestos exposure in the recommendations because of the high relative risk of\nmesothelioma in people who have been exposed to asbestos.",
    "raw_text": "influence the chance of symptoms being predictive of cancer. Therefore, these are\nincluded in the recommendations where relevant. For all other risk factors, the\nrecommendations would be the same for people with possible symptoms of cancer,\nirrespective of whether they had a risk factor. However, an exception was made to include\nasbestos exposure in the recommendations because of the high relative risk of\nmesothelioma in people who have been exposed to asbestos."
  },
  {
    "element_id": "page_92_seq_0",
    "page_number": 92,
    "element_type": "text",
    "markdown": "Finding more information and committee\ndetails\nTo find NICE guidance on related topics, including guidance in development, see the NICE\ntopic page on cancer.\nFor full details of the evidence and the guideline committee's discussions, see the full\nguideline. You can also find information about how the guideline was developed, including\ndetails of the committee.\nNICE has produced tools and resources to help you put this guideline into practice. For\ngeneral help and advice on putting NICE guidelines into practice, see resources to help\nyou put guidance into practice.",
    "raw_text": "Finding more information and committee\ndetails\nTo find NICE guidance on related topics, including guidance in development, see the NICE\ntopic page on cancer.\nFor full details of the evidence and the guideline committee's discussions, see the full\nguideline. You can also find information about how the guideline was developed, including\ndetails of the committee.\nNICE has produced tools and resources to help you put this guideline into practice. For\ngeneral help and advice on putting NICE guidelines into practice, see resources to help\nyou put guidance into practice."
  },
  {
    "element_id": "page_93_seq_0",
    "page_number": 93,
    "element_type": "text",
    "markdown": "Update information\nJanuary 2026: We have removed an incorrect recommendation on blood tests for\nmyeloma.\nMay 2025: We amended recommendations 1.2.1 and 1.2.7 to recommend a suspected\ncancer referral for people with symptoms indicating a 3% or more probability of having\noesophageal or stomach cancer (rather than an urgent, direct access referral for an\nendoscopy). We have made these changes following stakeholder feedback. The tables of\nsymptoms have also been updated to reflect these changes.\nApril 2025: We amended the recommendations on blood tests for myeloma in response to\na series of NHS England National cancer programme reviews looking at opportunities for\nearlier diagnosis, including for myeloma. The tables of symptoms and primary care\ninvestigation findings have also been updated to reflect these changes. Amended\nrecommendations are marked [2015, amended 2025].\nOctober 2023: We updated the definition of suspected cancer pathway referral in line with\nNHS England's standard on faster diagnosis of cancer.\nAugust 2023: We updated the recommendations on criteria for faecal testing and referral\nfor suspected colorectal cancer in line with NICE's diagnostics guidance on quantitative\nfaecal immunochemical testing to guide colorectal cancer pathway referral in primary care.\nThe tables of symptoms and primary care investigation findings have been updated to\nreflect these changes. New and amended recommendations are marked [2023] or [2015\namended 2023].\nDecember 2021: We reviewed the evidence on fixed and age-adjusted thresholds for PSA\ntesting and updated recommendation 1.6.3.\nJanuary 2021: We amended the recommendations in the section on colorectal cancer to\ninclude the full list of criteria for faecal testing.\nSeptember 2020: We amended the recommendations in the section on colorectal cancer\nto clarify when to offer faecal testing for colorectal cancer to adults without rectal\nbleeding.",
    "raw_text": "Update information\nJanuary 2026: We have removed an incorrect recommendation on blood tests for\nmyeloma.\nMay 2025: We amended recommendations 1.2.1 and 1.2.7 to recommend a suspected\ncancer referral for people with symptoms indicating a 3% or more probability of having\noesophageal or stomach cancer (rather than an urgent, direct access referral for an\nendoscopy). We have made these changes following stakeholder feedback. The tables of\nsymptoms have also been updated to reflect these changes.\nApril 2025: We amended the recommendations on blood tests for myeloma in response to\na series of NHS England National cancer programme reviews looking at opportunities for\nearlier diagnosis, including for myeloma. The tables of symptoms and primary care\ninvestigation findings have also been updated to reflect these changes. Amended\nrecommendations are marked [2015, amended 2025].\nOctober 2023: We updated the definition of suspected cancer pathway referral in line with\nNHS England's standard on faster diagnosis of cancer.\nAugust 2023: We updated the recommendations on criteria for faecal testing and referral\nfor suspected colorectal cancer in line with NICE's diagnostics guidance on quantitative\nfaecal immunochemical testing to guide colorectal cancer pathway referral in primary care.\nThe tables of symptoms and primary care investigation findings have been updated to\nreflect these changes. New and amended recommendations are marked [2023] or [2015\namended 2023].\nDecember 2021: We reviewed the evidence on fixed and age-adjusted thresholds for PSA\ntesting and updated recommendation 1.6.3.\nJanuary 2021: We amended the recommendations in the section on colorectal cancer to\ninclude the full list of criteria for faecal testing.\nSeptember 2020: We amended the recommendations in the section on colorectal cancer\nto clarify when to offer faecal testing for colorectal cancer to adults without rectal\nbleeding."
  },
  {
    "element_id": "page_94_seq_0",
    "page_number": 94,
    "element_type": "text",
    "markdown": "July 2017: Recommendation 1.3.4 was replaced by NICE diagnostics guidance on\nquantitative faecal immunochemical tests to guide referral for colorectal cancer in primary\ncare and other recommendations were amended accordingly. In December 2017, some of\nthe wording in the section on colorectal cancer was clarified, and the tables on abdominal\nand pelvic pain, change in bowel habit and primary care investigations updated in line with\nthis.\nJune 2016: Recommendations in the section on colorectal cancer have been changed to\nsay 'adults' instead of 'people' to more accurately reflect the populations they cover.\nJune 2015: This guideline updates and replaces NICE guideline CG27 (published\nJune 2005).\nRecommendations are marked as [2021], [2020], [2015], [2011], [2011, amended 2020]\nor [2005]:\n\u2022 [2021] indicated that the evidence has been reviewed and the recommendation has\nbeen updated in 2021.\n\u2022 [2020] indicates that the evidence has been reviewed and the recommendation has\nbeen added or updated in 2020.\n\u2022 [2011, amended 2020] indicates that the wording has been changed but the evidence\nhas not been reviewed since 2020.\n\u2022 [2015], [2005] or [2011] indicates the date that the evidence was last reviewed.\nMinor changes since publication\nMarch 2024: In recommendation 1.12.2 and the table on symptoms in children and young\npeople, we changed absent red reflex to absent fundal ('red') reflex. See the surveillance\nreport for more information.\nOctober 2021: In recommendation 1.12.2 we added a cross-reference to NICE's guideline\non suspected neurological conditions for advice for children who have new-onset squint\nwith an absent fundal 'red' reflex. See the surveillance report for more information. We also\nadded a link to NICE's guideline on babies, children and young people's experience of\nhealthcare in the sections on childhood cancers and symptoms in children and young\npeople.",
    "raw_text": "July 2017: Recommendation 1.3.4 was replaced by NICE diagnostics guidance on\nquantitative faecal immunochemical tests to guide referral for colorectal cancer in primary\ncare and other recommendations were amended accordingly. In December 2017, some of\nthe wording in the section on colorectal cancer was clarified, and the tables on abdominal\nand pelvic pain, change in bowel habit and primary care investigations updated in line with\nthis.\nJune 2016: Recommendations in the section on colorectal cancer have been changed to\nsay 'adults' instead of 'people' to more accurately reflect the populations they cover.\nJune 2015: This guideline updates and replaces NICE guideline CG27 (published\nJune 2005).\nRecommendations are marked as [2021], [2020], [2015], [2011], [2011, amended 2020]\nor [2005]:\n\u2022 [2021] indicated that the evidence has been reviewed and the recommendation has\nbeen updated in 2021.\n\u2022 [2020] indicates that the evidence has been reviewed and the recommendation has\nbeen added or updated in 2020.\n\u2022 [2011, amended 2020] indicates that the wording has been changed but the evidence\nhas not been reviewed since 2020.\n\u2022 [2015], [2005] or [2011] indicates the date that the evidence was last reviewed.\nMinor changes since publication\nMarch 2024: In recommendation 1.12.2 and the table on symptoms in children and young\npeople, we changed absent red reflex to absent fundal ('red') reflex. See the surveillance\nreport for more information.\nOctober 2021: In recommendation 1.12.2 we added a cross-reference to NICE's guideline\non suspected neurological conditions for advice for children who have new-onset squint\nwith an absent fundal 'red' reflex. See the surveillance report for more information. We also\nadded a link to NICE's guideline on babies, children and young people's experience of\nhealthcare in the sections on childhood cancers and symptoms in children and young\npeople."
  },
  {
    "element_id": "page_95_seq_0",
    "page_number": 95,
    "element_type": "text",
    "markdown": "ISBN: 978-1-4731-8184-7",
    "raw_text": "ISBN: 978-1-4731-8184-7"
  }
]